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ABSTRACT 
Experimental autoimmune thyroiditis (EAT), a murine model of Hashimoto's thyroiditis 
in humans, is a T cell-mediated autoimmune disease, characterized by destruction of 
thyroid follicles by infiltrating inflammatory cells. Immunization with thyroglobulin (Tg) 
-one of the major thyroid autoantigens- or Tg peptides in complete Freund's adjuvant is 
the classical way to elicit EAT in susceptible mouse strains. 
The first part of the thesis investigates the critical role of iodine in the 
immunopathogenicity of Tg. I have delineated three iodotyrosyl-containing peptides (aa. 
117-132, 304-318, and 1931-1945) which are not immunogenic in their native form but 
become immunopathogenic in their iodinated form. Iodination of tyrosyls facilitates 
either peptide binding to MHC or T-cell recognition of the peptide. In addition, 
iodotyrosyl formation has increasing, neutral or decreasing effects on the immunogenic 
profiles of other three Tg peptides (a.a. 179-194, 2529-2545, and 2540-2554) which are 
immunogenic in their non-iodinated forms. In a parallel study, I attempt to generate 
highly iodinated Tg in vivo via Nai administration in the drinking water of mice. We 
found that this regimen did not facilitate the generation of highly iodinated Tg in vivo, but 
elicited goitrous hypothyrodism in SJL but not CBA/J mice. The mechanisms behind this 
phenomenon remain poorly understood, but it does not seem to have an autoimmune 
basis. 
2 
In the second part of the thesis, I examined whether release of tissue antigens from 
necrotic thyroid epithelial cells can trigger dendritic cell (DC) maturation and initiation of 
a primary anti-self response. We found that exposure to necrotic - but not viable -
thyrocytes ex vivo triggered phenotypic and functional maturation of bone marrow-
derived DC. This enabled the immunogenic presentation of thyroid antigens, such as Tg, 
on the DC surface, leading to the development of EAT. These results support the view 
that thyroid epithelial cell necrosis may cause autoimmune thyroiditis via maturation of 
intrathyroidal DC. 
Finally, I have examined the intrathymic presence of mRNA transcripts of mouse Tg 
which encode thirteen pathogenic peptides, scattered over a large (8.5 kb) sequence. We 
found that Tg mRNA transcripts in thymus, liver and kidney lack the 1-915 bp (including 
peptide 1-12) and 961-5013 bp (including peptide 1579-91) segments, spanning exons 1-7 
and 9-22, respectively. These data demonstrate that certain known and perhaps other as 
yet unmapped pathogenic T-cell epitopes of Tg cannot be encoded by the truncated 
isoform(s) of intrathymic Tg mRNA. These findings also imply that central tolerance to 
endogenous Tg produced by thymic epithelial cells may be incomplete. It is not known, 
however, to what extent blood-home Tg molecules that leak from the thyroid in small 
amounts contribute to the process of tolerance induction. 
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CHAPTER! 
INTRODUCTION & OVERVIEW 
1.1 THE ANATOMY AND FUNCTION OF THE THYROID 
The thyroid gland is the largest organ that functions exclusively as an endocrine gland in 
humans. It is located in the neck, below and in front of the larynx, and contains two lobes 
connected by the isthmus. The gland is composed of follicles with varying sizes that 
contain a colloid-filled lumen surrounded by a single layer of epithelial cells (follicular 
cells) enclosed by a basement membrane where parafollicular cells reside (Capen 2000). 
The function of the thyroid is to secrete thyroid hormones, triiodothyronine (T3) and 
thyroxine (T4), which are essential for the regulation of metabolic processes throughout 
the body. The biosynthesis of thyroid hormones requires the availability of exogenous 
iodine and protein matrix, the thyroglobulin (Tg). Thyroglobulin is synthesized on the 
rough endoplasmic reticulum (ER), packaged in the large Golgi apparatus of follicular 
cells, then secreted and stored as colloid in the lumen. Inorganic iodide in the thyroid 
comes from two distinct sources: iodide trapped from interfollicular capillaries and 
actively transported by sodium iodide symporter (NIS) across the basolateral membrane 
of follicular cells (Spitzweg and Morris 2002), or internal iodide produced by 
deiodination of organic iodine compounds. Another chloride -iodide transporter, pendrin, 
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probably mediates the subsequent transportation of iodide from the apical membrane to 
the follicular lumen (Royaux et al. 2000). 
Human Tg contains 66 Tyr residues per monomeric unit and some of them are subject to 
iodination under physiological conditions. Within the follicular lumen, iodide is rapidly 
oxidized and binds to tyrosyl residues in Tg, generating monoiodotyrosine (MIT) and 
diiodotyrosine (DIT). A few specific iodotyrosyl precursors will serve as acceptor and 
donor to synthesize the thyroid hormones, T3 and T4, through intramolecular coupling 
(Dunn and Dunn 2000). This iodination process occurs at the apical plasma membrane-
follicle lumen boundary and is mediated by thyroid peroxidase (TPO) in the presence of 
an H202-generating system. In the thyroid, the H20 2 generator is the thyroid nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase (THOX) (De Deken et al. 2000, 
Dupuy et al. 2000), designated as Dual Oxidase (DUOX) by The HUGO Human Gene 
Nomenclature Committee (http://www.gene.ucl.ac.uk/ nomenclature). 
Hormone-containing Tg molecules are resorted from the colloid and transported from the 
apical to the basolateral surface of the follicular cells. Enzymatic degradation by 
intracellular lysosomes frees the T4 and T3 molecules contained within Tg, with T4 being 
the preferred secretory product. T4 and T3 are eventually secreted into the extracellular 
space. Synthesis of thyroid hormones is stimulated by the pituitary-derived thyroid 
stimulating hormone (TSH), which interacts with the TSH receptor (TSHR) at the 
basolateral membrane of the thyrocytes (Carrasco et al. 2000). 
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T4 is a pro-hormone, with little intrinsic hormonal activity, and it must be converted to 
the potent T3 to render biological action. These thyroid hormones have important effects 
on development, growth, and metabolism. In childhood, lack of thyroid hormone can 
cause delayed growth. The effects are probably metabolic rather than developmental, as 
growth is restored rapidly after the institution of thyroid hormone treatment. In adults, the 
primary effects of thyroid hormones are manifested by alterations in metabolism, such as 
changes in oxygen consumption, protein, carbohydrate, lipid, and vitamin metabolism 
(Capen 2000). 
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1.2 AUTOIMMUNE THYROIDITIS (AT) 
1.2.1 Autoimmune thyroid disease (AITD) 
Autoimmune disease occurs when the body's tmmune system becomes misdirected, 
attacking self-tissue Ags. Autoimmune diseases involve either a specific organ (organ-
specific autoimmune disease) or many tissues of the body (systemic autoimmune 
disease), and are often demonstrated by the presence of autoantibodies (A-Abs) or self-
reactive T lymphocytes. Autoimmune thyroid disease (AITD) is a thyroid-specific 
autoimmune disorder, affecting women 5-l 0 times as often as men. AITDs encompass a 
diverse range of clinical entities, including Grave's disease (GD, a form of 
hyperthyroidism or excessive thyroid hormone production), Hashimoto's thyroiditis (HT, 
a form of hypothyroidism with deficient thyroid hormone production), and primary 
thyroid failure or myxedema. All these disorders share the common histological features 
of thyroid lymphocytic infiltration, but result in diametrically opposed endocrine 
outcomes. 
HT is also named autoimmune thyroiditis (AT} or lymphocytic thyroiditis (L T). The 
major characteristic of HT is the inflammatory infiltration of mononuclear cells that 
replace the parenchyma, which eventually leads to gland fibrosis. Progressive loss of 
thyroid cells and gradual destruction of the gland lead to thyroid hormone deficiency and 
clinical hypothyroidism. Subclinical HT is determined by an elevated serum TSH 
concentration (>4.8 miUIL) but with a normal range of free T3 and T4. Under clinical 
presenting (overt) hypothyroidism, serum concentrations of both TSH and thyroid 
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hormones are out of the normal range (Hueston 2001). The immunopathology of HT is 
highlighted with mononuclear cell infiltration of the thyroid gland and the production of 
A-Abs. Diagnosis ofHT is usually made by the finding of A-Abs to TPO or Tg in serum, 
but the presence of such A-Abs does not necessarily indicate the occurrence of HT as 
they are present in 5-10% of normal individuals without thyroid damage (Weetman and 
McGregor 1994). 
1.2.2 Experimental autoimmune thyroiditis 
Experimental autoimmune thyroiditis (EAT), the animal model of HT, can be 
experimentally induced or spontaneously develop in susceptible animals. These models 
provide valuable tools to investigate the pathogenesis and immunoregulation of AlTO. 
However, animals with EAT may not develop hypothyroidism. The criteria for EAT 
diagnosis include: (1) circulating anti-Tg Abs and, (2) lymphocytic infiltration of the 
thyroid gland. Of note, these two criteria for EAT are not equivalent; EAT can develop in 
the absence of A-Ab production (Salamero et al. 1987, Verginis et al. 2002). EAT closely 
resembles the autoimmune characteristics of HT but differs in a few aspects as discussed 
below. 
Direct EAT induced by immunization with thyroid autoantigens 
In 1956, EAT was first described in a pioneering study performed by Witebsky and Rose 
(Rose and Witebsky 1956, Witebsky and Rose 1956). In their studies, EAT - as revealed 
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by mononuclear infiltration of the thyroid gland and A-Ab production - was induced in 
rabbits by subcutaneous injection of homologous thyroid extracts together with complete 
Freund adjuvant (CF A), which contains inactivated mycobacteria in mineral oil. EAT was 
later induced in a variety of animal species such as dog (Terplan et al. 1960), guinea pig 
(Terplan et al. 1960), rat (Jones and Roitt 1961), monkey (Kite et al. 1966) and mouse 
(Rose et al. 1971) by injection of homologous or heterologous thyroid extract in adjuvant. 
Moreover, Shulman et al. have shown that EAT can be induced by the soluble fraction of 
the thyroid gland, where Tg represents 75-80% of the protein (Shulman 1971). Other 
early studies used heterologous or chemically modified Tg to induce thyroiditis in rabbits 
(Weigle 1965, Kite et al. 1966, Mangkomkanok et al. 1972). When homologous and 
heterologous Tg preparations were used simultaneously for EAT induction (Romball and 
Weigle 1984), it was found heterologous Tg is more immunogenic but less 
thyroiditogenic than self Tg. It was proposed later by Wan et al. that certain epitopes 
within the Tg conserved between species may be more thyroiditogenic than unique 
species-specific epitopes (Wan et al. 1997). 
In the above studies, a strong adjuvant, such as CF A or lipopolysaccharide (LPS), is 
required for induction of thyroid autoantigen (A-Ag)-specific immune responses. 
Interestingly, repeated intravenous injections of foreign (Terplan et al. 1960) or self Tg 
(Eirehewy et al. 1981), or altered Tg coupled to diazonium derivatives of arsenilic and 
sulfanilic acid (Weigle 1965), into rabbits or good responder mice sometimes elicited 
thyroid autoimmunity in the absence of adjuvant. Furthermore, injection of Tg conjugated 
to anti-Ak monoclonal Abs (mAbs) without adjuvant by Balasa et al. successfully induced 
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host lgG-responses, but failed to induce mononuclear infiltration of the thyroid, thereby 
suggesting lack of activation ofT -cell subsets with pathogenic potential in EAT (Balasa 
and Carayanniotis 1993). 
Among these various methods, a commonly used procedure was subcutaneous injection 
of self Tg mixed in CF A followed by a booster injection with Tg in incomplete Freund 
adjuvant (IFA) in 2-3 week intervals (Weetman and McGregor 1984, Weetman and 
McGregor 1994, Charreire 1989). Lastly, Tg peptides, derived from either human or 
mouse Tg sequences, can also cause EAT in susceptible animals either by injection of 
peptide in CF A or by adoptive transfer of peptide-primed lymph node cells (LNC) after in 
vitro pulsing with the priming peptide (Carayanniotis 2003). Of note, none of these 
pathogenic Tg peptides has been classified as immunodominant since they were not 
readily processed and presented from intact Tg in vivo and in vitro as revealed by LNC 
recall assays (Carayanniotis 2003). 
Other thyroid A-Ags have also been used for EAT induction. For example, immunization 
with crude thyroid microsomal preparations was shown to induce thyroiditis in rabbits or 
Rhesus monkeys (Weigle 1965, Kite et al. 1966, Mangkomkanok et al. 1972). It has been 
clarified that TPO is the primary thyroid microsomal Ag involved in AITD (Czamocka et 
al. 1985, Kohno et al. 1986, Kotani et al. 1986). The development of EAT induced with 
TPO has been difficult, principally due to difficulties in purifying substantial quantities of 
TPO and excluding Tg contamination. An alternative source is recombinant human TPO 
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(rhTPO) prepared in eukaryotic expression systems such as insect cells, but rhTPO is 
poorly glycosylated and not fully enzymatically active with significant contamination of 
denatured TPO (Gardas et al. 1999). Despite these difficulties, murine EAT was 
successfully elicited in C57BL/6 mice (H-2b) by challenging them with either porcine 
TPO purified from thyroid by trypsinization (Kotani et al. 1990), or a 15 mer TPO 
peptide (Kotani et al. 1992). In a recent study, a variety of TPO preparations -purified 
hTPO, insect-derived rhTPO, trypsinized porcine TPO and plasmid-encoded hTPO- were 
used to thoroughly investigate the thyroiditogenic role of these TPO preparations in DR3-
transgenic mice (Flynn et al. 2004a). The results showed that plasmid DNA encoding 
hTPO was superior to other TPO preparations in eliciting thyroid autoimmunity, in terms 
of both anti-TPO Ab responses and infiltration of the gland. 
Besides Tg and TPO, TSHR is a third A-Ag within the thyroid. In 1994, a new animal 
model was established showing the development of AITD in Balb/c mice immunized with 
the extracellular domain of human TSHR expressed as a fusion protein linked to a 
maltose-binding protein (Costagliola et al. 1994). Fifty percent of immunized Balb/c mice 
(H-2d) had thyrotropin-binding inhibiting A-Abs, accompanied by low T4 levels and 
lymphocytic infiltration in the thyroid. Later studies found that NOD mice immunized 
with TSHR display severe thyroid infiltration of immune cells, predominantly T cells, but 
there was lack of A-Ab production (Many et al. 1996). 
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Of particular note, signs of hypothyroidism were rarely evaluated in animals with induced 
EAT, and it is unclear whether thyroid functions are altered in most of these animals. 
However, one study reported T4 levels and iodine uptake were significantly decreased in 
susceptible mice from 2 to 8 weeks after immunization with Tg in CF A (Vladutiu and 
Kenney 1985). In rats, serum Tg and TSH levels were strongly augmented to 
approximately 10 times above the basal level at 5 weeks postimmunization with Tg 
(Hassman et al. 1988). 
Indirect EAT induced by transfer or depletion of lymphocyte subsets 
Penhale et a/. have shown that typical EAT can be induced in rats depleted of T 
lymphocytes by neonatal thymectomy (NTx), followed by several low doses of irradiation 
(Penhale et al. 1973, Penhale et al. 1976). This disease can be ameliorated by 
reconstitution with syngeneic lymphocytes. Similarly, Wick et al (Wick et al. 1974) 
reported that Tx of newly hatched Obese Strain (OS) chicken - which develop 
spontaneous thyroiditis - accelerated and aggravated the lymphoid infiltration of the 
thyroid gland. These experiments provided basic support for the argument that EAT can 
be caused by selective depletion of a T cell subpopulation responsible for the suppression 
of thyroid-specific autoreactivity, which is now known as T regulatory cells (Treg). 
The second approach, using T cells as EAT inducers, was demonstrated using adoptive 
transfer experiments. In numerous experiments, EAT was induced in mice or guinea pigs 
using syngeneic spleen or LNC previously stimulated by Tg (Braley-Mullen et al. 1981, 
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Okayasu 1985, Simon et al. 1986) or syngeneic thyroid epithelial cells (TEC) (Charreire 
and Michel-Bechet 1982). Similarly, transfer of Tg-specific T-cell clones or lines into 
naYve recipients induced development of lymphocytic infiltration in the thyroid (Maron et 
al. 1983, Romball and Weigle 1987), further supporting the effector role ofT cells in 
EAT induction. According to another study, Tg-primed T-cells which were activated in 
vitro with concanavalin A (con A), were also able to transfer EAT (Okayasu 1985). 
Moreover, several studies have shown that Tg peptide-primed-LNC after restimulation in 
vitro with the respective peptide were also able to transfer EAT in syngeneic nai"ve 
recipients (Carayanniotis and Rao 1997). A more severe form of EAT, called 
granulomatous thyroiditis, can be induced in naive recipient mice by adoptive transfer of 
mTg-primed spleen cells activated in vitro in the presence of either anti-IL-2R (Braley-
Mullen et al. 1991), anti-IFN-y mAbs (Stull et al. 1992) or IL-12 (Braley-Mullen et al. 
1998). 
Professional antigen presenting cells (APC) loaded with A-Ags have also been used to 
elicit EAT. Intravenous (i.v.) injection of 105 dendritic cells (DC), either pulsed with 
large amounts of Tg in vitro, or obtained from the spleens of Tg-primed mice, can induce 
thyroiditis in recipient hosts (Knight et al. 1988). Interestingly, A-Ab to Tg were only 
detected in mice that received DC loaded with Tg in vivo, but not in vitro. More recently, 
DC purified from high responder B10BR mice were pulsed in vitro with porcine Tg, then 
transferred into syngeneic mice, resulting in the development of thyroiditis and IgG2a A-
Abs, indicating the activation ofTh1 cells (Watanabe et al. 1999). 
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Comparisons of EAT developed after injection of Tg in CF A to that induced by transfer 
of Tg-specific T cells or Tg-pulsed DC showed that a uniform feature of the disease is 
lymphocytic infiltration of the thyroid gland. The presence of the A-Ab is a variable 
parameter, independent of the severity of the disease. Among the animal models of 
induced EAT, the mouse model is the most extensively studied due to the extensive 
characterization of the MHC molecules and the great availability of congenic, intra H-2-
recombinant and congenic mutant strains. Also, mice can be easily handled and 
maintained in large numbers at a lower cost than any other animals developing EAT. 
Furthermore, there is an enormous variety of mouse-specific reagents such as Abs 
specific for cell surface markers or cytokines which can be used in phenotypic and 
functional analyses of the cells involved in the immune response. 
Spontaneous animal model of thyroiditis 
Spontaneous autoimmune thyroiditis (SAT) has been reported in the OS chicken, non-
obese diabetic (NOD) mice, Bio-breeding/Worchester (BB/W) and buffalo (BUF) rats, as 
well as Praomys, a desert rodent, as reviewed in (Charreire 1989). 
The OS chicken 
The first established and best studied model of SAT is the OS chicken, which was derived 
from Comell-C Strain (CS) chicken by selective breeding for hypothyroidism (Cole 
1966). The OS chicken develops SAT during the first 3 weeks after hatching, which 
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closely resembles the human HT in all clinical, histopathological, endocrinological and 
serological aspects. SAT in OS chicken is characterized by massive infiltration of the 
thyroid gland by mononuclear cells and the occurrence of large numbers of germinal 
center, with consequent hypothyroidism, as well as circulating A-Abs to Tg and TPO. 
The phenotypic symptoms in these chickens are small body size, abundant subcutaneous 
and abdominal fat deposits, cold sensitivity and long silky feathers (Wick et al. 1982). 
OS chickens have abnormal immune system and thyroid gland functions , which may link 
to SAT (Sundick et al. 1996, Wicket al. 1982, Wicket al. 1989), including: (1) a general 
T lymphocyte hyperactivity, accompanied by reduced size, weight and total cell number 
of lymphoid organs; (2) a significant increase in lgM-positive B cells in lymphoid organs, 
especially in the thymus; (3) a hyperactive thyroid gland: elevated iodine uptake, elevated 
release of organified iodine, leading to low iodine content in Tg; ( 4) a deficiency of the 
neuroendocrine feedback control of the thyroid gland. These defects were suggested to 
play a potential etiological role in SAT. 
The OS chicken has proven a particularly useful animal model for HT for two reasons. 
First, germinal centers, a hallmark of HT but absent in induced EAT, develop at 6-8 
weeks of age and replace functional thyroid tissue, resulting in fibrosis of the thyroid 
gland (Rose et al. 1981, Wick et al. 1982). Second, at the time of hatching, immune 
complexes consisting of Tg and maternal anti-Tg Abs deposit in the basal lamina of 
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thyroid gland, which could prevent the immune system from interacting with these Ags 
during the tolerance induction period (Charreire 1989). 
The NOD mouse 
The NOD is an inbred strain developed from a cataract-prone subline of outbred ICR 
mice, and has been a useful model for insulin-dependent diabetes mellitus (IDDM). 
Bernard et al. have reported a very high incidence (67-90%) of thyroiditis in 2-25 week 
old female and male NOD mice, with the presence of circulating A-Abs to TPO in 35% 
of the mice (Bernard et al. 1992). In addition, the severity of thyroiditis was not 
significantly different between NOD diabetic and nondiabetic mice. However, the 
incidence of thyroiditis, as that of diabetes, can vary among colonies, and a very low ( < 
5%) incidence of thyroiditis has been reported in NOD mice of similar age from two 
different colonies (Many et al. 1996). 
Recently, a NOD MHC congeneic strain, NOD.H-2h4, was derived by crossing NOD to 
B10.A(4R) mice with repetitive backcrosses to NOD. These mice express H-2Kk and 1-Ak 
on the NOD background and spontaneously develop thyroid lesions and anti-Tg A-Abs. 
Although 20-30% of NOD.H-2h4 mice develop insulitis, they do not develop diabetes 
(Weatherall et al. 1992). About 60-70% of these mice develop SAT at 7-10 months of 
age, and iodine intake enhances A-Ab levels and incidence of thyroiditis to nearly 100% 
(Braley-Mullen et al. 1999, Rasooly et al. 1996). However, these mice maintain normal 
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levels of thyroid hormones, even after iodine administration (Yu et al. 2006b). 
Essentially, all NOD.H-2h4 mice that developed thyroid lesions produced readily 
detectable IgG A-Abs against Tg, primarily of lgG2a and IgG2b subclasses (Rasooly et 
al. 1996). 
BUF and BB/W Rats 
In 1969, BUF rats were first reported to exhibit spontaneous histopathological changes of 
their thyroids comparable to those of HT (Rasooly et al. 1996). Subsequent studies by 
Silverman and Rose (Silverman and Rose 1971, Silverman and Rose 1975) demonstrated 
that 14% of female BUF rats developed SAT between 9-12-weeks of age, accompanied 
by the formation of intrathyroidal germinal centres. The incidence and severity of 
thyroiditis can be greatly increased in both males and females by neonatal thymectomy or 
simultaneous administration of Tg (Silverman and Rose 1974a) and other agents 
(Silverman and Rose 1974b). The NTx-induced EAT in BUF rats is a transient disease 
(Cohen et al. 1988), which closely resembles human HT in terms of the level of anti-Tg 
A-Abs, enlargement of the thyroid gland, elevated TSH and severity of the disease 
(Cohen and Weetman 1987). 
Another strain of rat, the BB/W, was found to develop SAT in parallel to IDDM, 
similarly as the NOD mice (Stemthal et al. 1981). However, the incidence of SAT was 
strikingly higher in 8-10-month old diabetic rats (59%), as compared to their nondiabetic 
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cohorts (11 %). Thyroiditis in diabetic BB/W rats was not accompanied by any consistent 
changes in serum T4, T3, and TSH concentrations. 
1.2.3 The major thyroid A-Ags: Tg, TPO, TSHR 
As mentioned above, Tg, TPO and TSHR are the major thyroid A-Ags identified in 
AITD. Although autoreactivity has been demonstrated to all three A-Ags in both HT and 
GO, Abs to the first two Ags are frequently detected in patients with HT and, the last one 
is believed to be the main Ag in GO. Recently, NIS was proposed as another potential A-
Ag in AlTO (Spitzweg and Morris 2002, Stemthal et al. 1981 ). 
Tg and its epitope mapping 
Tg represents the most abundant Ag of the thyroid gland and provides a matrix for 
incorporation and storage of available inorganic iodide for subsequent synthesis of the 
thyroid hormones (Section 1.1.2). It is the largest A-Ag known, consisting of two 
monomeric polypeptide chains joined together by disulfide bonds, which make up a 
mature 660 kDa, 19S dimer. Tg is not a sequestered Ag since it is present in the 
circulation with an average concentration of 5, 10 and 133 ng/ml in humans, mice and 
rats, respectively (Carayanniotis and Rao 1997). 
To date, the complete primary structure of human (Malthiery and Lissitzky 1987), bovine 
(Mercken et al. 1985), rat (Musti et al. 1986) and mouse (Caturegli et al. 1997, Kim et al. 
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1998) Tg have been deduced from their respective mRNAs. Partial sequences of Tg from 
several other species, including goat (van Ommen et al. 1989), sheep (Durand et al. 
1987), rabbit (Dunn et al. 1987) and turtle (Roe et al. 1989), have been reported. The Tg 
gene is localized on different chromosomes among species, for example, it is found on 
chromosome 8 in humans (Brocas et al. 1985), chromosome 15 in mice (Taylor and Rowe 
1987) and chromosome 7 in rats (Brocas et al. 1985). Tg is a highly conserved protein, 
and identity at the a.a. level among different species is above 70% (Vali et al. 2000). An 
analysis of the primary a.a. sequence of Tg reveals a highly organized internal structure. 
The amino portion of the molecule (approximately, a. a. 1-2170) shows a high degree of 
internal homology with three types of repetitive domains, in which the positions of 
cysteine and, to a lesser extent, proline and glycine residues are conserved (Malthiery and 
Lissitzky 1987, Mercken et al. 1985). The repetitive structure suggests that this part ofthe 
T g gene evolved as a result of the serial duplication of 3 basic primordial genes, and was 
hypothesized to be involved in proteolytic processing (Parma et al. 1987). In contrast, the 
C-terminal portion(- 550 a.a.) contains no internal repetitive domains, but shows- 28% 
of homology to acetylcholinesterase (AchE), a type B carboxylesterase (Swillens et al. 
1986), which indicates this portion of Tg may have a function similar to that of AchE for 
cell membrane binding. The absence of homology between the amino and carboxyl 
portions ofTg suggests they arose from different ancestral genes. 
Tg is a highly glycosylated molecule with carbohydrate moieties, making up- 10% of its 
mass (Charreire 1989). The polypeptide chain of Tg is synthesized on the surface of 
rough ER in thyroid follicular cells. Then it is directed into the ER lumen by a signal 
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peptide which contains the first 19 or 20 a.a. (Ring et al. 1987). As this translocation 
occurs, Tg undergoes a series of conformational changes aided by folding enzymes. Upon 
formation of stable dimers, the nascent proteins migrate to the Golgi complex where 
addition of carbohydrate units are completed (glycosylation) (Ring et al. 1987), and 
sulfation occurs (Herzog 1986). Phosphorylation of Tg also appears to be an intracellular 
event, although the precise sub-cellular compartment has not been identified (Herzog 
I 986). Finally, the molecule is secreted into the follicular lumen, where iodination of 
tyrosine residues of Tg occurs extracellularly, especially at the surface of the apical 
membrane of the thyrocyte. Sixty seven tyrosyls are present in monomeric Tg, and only 
some of the tyrosyls are available for iodination and hormonogenesis. Four major 
hormonogenic sites (a.a. 5, 1291, 2554, 2747), as well as three minor or limited ones (a.a. 
513, 685, 2568) have been established (de Vijlder and den Hartog 1998, Lamas et al. 
1989). Iodinated Tg re-enters the thyrocyte via receptor-mediated endocytosis and is 
enzymatically cleaved within lysosomes to generate free T4 and T3 that are eventually 
secreted into the extracellular space (Section 1.1 ). The iodine content of Tg and its 
function is discussed in detail in Section 1.3. 
In the past two decades, diverse strategies have been used to search for pathogenic 
immunodominant T cell epitopes in Tg. One of them used mTg-specific, T-cell 
hybridoma clones as a tool to screen antigenic T cell epitopes in Tg (Champion et al. 
1991, Texier et al. 1992). A second strategy used computerized algorithms to predict 
potential T-cell epitopes based on MHC binding (Verginis and Carayanniotis 2004). To 
date, several algorithms have been described for epitope prediction of various MHC class 
33 
I and II - binding peptides, based either on the analysis of natural MHC ligands or on the 
binding properties of synthetic peptides (Schirle et al. 2001 ). The selected candidate 
peptides were subsequently tested for their immunogenicity and pathogenicity in 
experimental animals. 
So far, eight EAT-causing peptides have been identified in mTg through the use of the 
computerized algorithms (Carayanniotis et al. 1994, Chronopoulou and Carayanniotis 
1992, Rao et al. 1994, Rao and Carayanniotis 1997, Verginis et al. 2002). Six out of the 8 
epitopes (306-20, 1579-91, 1826-35, 2102-16, 2498-06, 2596-08) are Ak-restricted, one 
(2694-2705) is As -restricted and interestingly, the 9mer (2495-2503) is restricted by Ek 
but elicits EAT in mice of either k or s haplotype. The first EAT-causing peptide in hTg, 
the 40mer (1671-10), was identified using a MHC class !-restricted CTL hybridoma as a 
searching tool (Texier et al. 1992). Subsequently, two more pathogenic epitopes were 
identified in hTg: the 14 mer (2730-43) and the 20mer (2340-29). The former induced 
EAT in CBA (H-2k) mice only after adoptive transfer of LNC that were primed in vivo 
with mTg and stimulated in vitro with this peptide (Hoshioka et al. 1993), and the latter 
contains several Ek-binding motifs and elicits EAT and T cell responses in AKR (H-2k) 
mice (Karras et al. 2003). Studies in Tg fragments containing hormonogenic sites 
revealed two additional epitopes containing T4, T4 (5)(a.a.l-12) and T4 (2553)(a.a. 2549-
2560), that cause thyroiditis in susceptible strains of mice (Hutchings et al. 1992, Wan et 
al. 1997). Of note, none of these epitopes has been characterized as immunodominant, 
since they cannot be readily detected by proliferative LNC assay following processing of 
intact Tg in vivo and/or in vitro (Carayanniotis 2003). Moreover, Flynn J. C. et al. (Flynn 
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et al. 2004b) have recently reported four human Tg peptides (a.a. 181-195, 418-432, 
1518-1532, 2079-2093), which encompass naturally processed Tg epitopes and 
stimulated a proliferative response of Tg-primed splenocytes. Among these four peptides, 
only p2079 (a.a. 2079-2093) consistently mediated thyroiditis by both direct challenge 
with the peptides and adoptive transfer ofTg-primed, p2079-activated splenocytes. 
TPO 
Shortly after the discovery of Abs to Tg in HT, a second group of Abs against thyroid 
microsomal protein was identified in HT patients (Roitt et al. 1964, TROTTER et al. 
1957). Later studies have found TPO accounts for virtually all the antigenic determinants 
recognized by microsomal Abs (Czamocka et al. 1985, Kotani et al. 1986, Mariotti et al. 
1989). Anti-TPO Abs are the most frequently represented A-Abs in the sera of patients 
suffering from AITD; they are present in 90% ofHT and 74% ofGD patients (Mariotti et 
al. 1990). These Abs can fix complement and are cytotoxic to thyroid epithelial cells in 
culture (Dawe et al. 1993). However, TPO is normally inaccessible to circulating Abs 
since it is present only on the apical portion of the follicular cells, suggesting that some 
prior damage to the tissue may be required before anti-TPO Abs can exert pathogenic 
effects in vivo (Khoury et al. 1984). 
TPO is a membrane-bound, glycosylated, hemoprotein enzyme that plays a key role in the 
biosynthesis of thyroid hormones, iodination of Tyr residues on Tg, and intramolecular 
coupling of iodotyrosines to form T3 and T4. The primary structures of human (Kimura 
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et al. 1987, Libert et al. 1987), porcine (Magnusson et al. 1987), rat (Derwahl et al. 1989) 
and mouse (Derwahl et al. 1989, Kotani et al. 1993) TPO have been deduced from eDNA, 
and show considerable homology. The human TPO gene maps to the shorter arm of 
chromosome 2 and gives rise to two isoforms of protein through alternative splicing of 
the gene (Kimura et al. 1987). The longer protein, referred to as TP0-1, is 107 kDa in 
size and 933 a.a. in length; and the shorter one, referred to as TP0-2, lacks 57 a.a. 
(residues 533-589) in the middle of the sequence. The mRNA encoding TP0-2 is present 
in much less abundance than that for TP0-1. It has been long recognized that TPO gene 
transcription and translation are both under the positive control ofTSH (Weetman 1990). 
Immunization with thyroid microsome or purified TPO proteins has been used to induce 
thyroiditis in several models (Section 1.2.2.1 ). Epitope analysis of circulating TPO Abs 
has revealed > 90% of these Abs are directed against two conformational epitopes termed 
as immunodominant region A and B, but the Ab fraction within each individual serum 
directed against the A and B region varies from patient to patient (McLachlan and 
Rapoport 1995, Prummel and Wiersinga 2005). Particularly, epitope recognition did not 
differ in patients with GD vs HT, older vs younger, or hypothyroid versus euthyroid 
(Prummel and Wiersinga 2005). It was recently found that the key part of the B domain 
localizes between a.a 713 (Tyr) and 717 (Asp) of TPO (Bresson et al. 2004). Arg at 
position 225 and Lys at position 627 were reported as the key components of A and B 
domains (Gora et al. 2004), yet the exact location of domain A remains unclear. 
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Thyrotropin (TSH) receptor (TSHR) 
TSHR is the major A-Ag in GD, in which thyroid-stimulating A-Abs (TsAb) activate 
TSHR and stimulate subsequent cAMP production by the thyrocytes (Schott et al. 2005). 
Although GD is characterized by the presence of TsAbs to TSHR, another group of 
patients with goitrous HT or atrophic thyroiditis show TSHR A-Abs that block thyroid 
activation, termed as thyroid-blocking Ab (TBAb), leading to hypothyroidism (Chiovato 
et al. 1994). 
The TSHR belongs to the glycoprotein hormone receptor subfamily of G-protein-coupled 
receptors. The TSHR eDNA has a single open reading frame encoding a protein of 764 
a.a, of which 21 a.a. is the signal peptide (Misrahi et al. 1990). The mature TSHR 
(without signal peptide) contains a heavily glycosylated amino-terminal ectodomain of 
397 a.a., and a carboxyl terminal region divided into a 264-a.a. membrane-spanning 
segment and a cytoplasmic tail of 82 a.a. The single chain of TSHR on the cell surface is 
intramolecularly cleaved into disulfide-linked subunits A and B, with removal of 50 
residues from the N-terminal of the B subunit (Davies et al. 2002). This TSHR cleavage 
is followed by the release of ligand-binding A subunit from the membrane-bound B 
subunit, referred to as receptor shedding (Couet et al. 1996). It was proposed that the shed 
A subunit, rather than the full-length receptor, is the crucial A-Ag in the generation of 
TsAb (Chen et al. 2003). It is suggested that the majority of TsAb epitopes are localized 
at the N-terminal and TBAb epitopes are at the C-terminal part of the extracellular 
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domain, despite the fact that TBAb and TsAb do have epitopes in close proximity (Schott 
et al. 2005). 
1.2.4 Pathogenic mechanisms in the induction of AITD and EAT 
Genetic influences on AITD and EAT 
In humans, the cause of AlTO is multifactorial, requiring interplay between genetic, 
endogenous and environmental factors. The association of human leukocyte Ag (HLA) 
genes with GD and HT (Weissel et al. 1980, Farid et al. 1981, Thompson and Farid 1985) 
has been reported in several epidemiological studies, but this linkage is relatively weak 
and inconsistent between populations due to ethnic diversity and linkage disequilibrium 
between DR and DQ genes. Recently, transgenic mice expressing certain HLA molecules 
have been generated to help clarify the role of HLA class II genes in HT susceptibility 
(Kong et al. 1996, Kong et al. 1997, Wan et al. 2002). EAT induction in these transgenic 
mice by immunization with human or mouse Tg indicated that mouse TcR can efficiently 
recognize the HLA-peptide complex, leading to T cell activation. These studies have 
shown that DR3 and DQ8, not DR2, DR4 and DQ6, were susceptible alleles to hTg 
immunization, whereas only mice bearing DR3, but not DQ8 allele developed EAT 
following immunization with mTg. Moreover, Flynn et al. have reported that 
coexpression of DR3 and DQ8 HLA molecule in MHC class II negative strain of mice 
significantly reduced the severity of mTg-induced EAT (Flynn et al. 2002). 
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Other genes, located outside of the HLA region, may also contribute to the genetic 
susceptibility of AITD. The cytotoxic T cell antigen-4 (CTLA-4) is one of strongest 
susceptibility genes that have been extensively studied in different populations. A single 
nucleotide polymorphism, a G allele at position CT60, in the 3' untranslated region of 
CTLA-4 has been associated with increase prevalence of GD in Japanese (Ban et al. 
2005) and Italian (Petrone et al. 2005) populations. Furthermore, elevated serum levels of 
anti-TPO Ab is influcend by other single nucleotide polymorphisms in CTLA-4 promoter 
( -318 CIT) or encoding region ( 49 A/G in exon 1) (Zaletel et al. 2006). In addition, a 
CTLA-4 microsatellite polymorphisms (allele 106) was shown to be significantly 
increased in patients with GD or HT in both USA and UK studies (Kotsa et al. 1997, 
Yanagawa et al. 1995). Interestingly, Tomer and his colleagues (Tomer et al. 2002) have 
reported that a new microsatellite inside intron 27 of the Tg gene was strongly linked to 
AITD in Caucasian patients. In two recent studies, a C/T polymphism in Kozak sequence 
of CD40, a costimulatory molecule expressed on APC, have also been liked to GD and/or 
EAT susceptibility in mice (Jacobson et al. 2005) and humans (Ban et al. 2006). 
In induced murine models of thyroiditis, the type and extent of disease are heavily 
influenced by the MHC haplotype of the animals. In one study (Vladutiu and Rose 
1971a), 33 inbred mouse strains representing 11 different haplotypes were used and were 
classified into excellent (H-2k, s), good (H-2q), fairly good (H-2a, m, P), poor (H-2b, d) and 
very poor (H-2v) responders based on the existence of thyroid infiltration and the extent 
of its follicular destruction. By using intra-H-2 recombinant mouse strains derived from 
recombination of H-2k,d,b alleles, the major control gene for murine EAT was localized to 
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the I-A locus (Beisel et al. 1982a, Tomazic et al. 1974). The importance of this major 
control gene was confirmed in mice that have been treated with anti-I-A mAbs prior to or 
at the time of Tg/CF A challenge, which failed to develop EAT (Vladutiu and Steinman 
1987). Moreover, the genetic restriction of EAT induction varies between immunizing 
Ags. In the TPO-induced model, mice bearing the H-2b haplotype were good responders 
and H-2a,d,k,s strains were not (Kotani et al. 1990, Vladutiu and Rose 1971a). On the other 
hand, the H-2d,u haplotypes were susceptible to TSHR-induced thyroiditis, whereas the H-
2b and H-2k haplotypes were resistant (Many et al. 1996). Class I MHC genes were also 
suggested to modulate the severity of the pathogenic autoimmune responses in animals. 
For instance, BlO.D2 mice, with a Dd gene, showed a markedly reduced cellular 
infiltration than congeneic strains with Dk or Dr allele (Kong et al. 1979). Other studies 
using strains of mice with point mutations at the H-2K gene or intra-H-2 recombinant 
mice showed that mice bearing Kk developed less EAT than those with Kq or Kb, 
suggesting that K-end genes can also modify the responses (Maron and Cohen 1979, 
Maron and Cohen 1980). Similarly as in human studies, non-MHC genes were also 
reported to influence EAT susceptibility, using congeneic mouse strains carrying the 
same H-2 but different background genes (Beisel et al. 1982b, Verginis and Carayanniotis 
2004). 
T -cell mediated injury 
T cells have been considered to be critical for the induction of EAT, not only as effector 
cells, but also as helpers to activate B cells. The influence of MHC haplotype, as 
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discussed above, indirectly suggests T cells are involved in the development of EAT. 
Furthermore, histological examination revealed that T cells were the dominant subset in 
thyroids of mice that developed Tg-induced EAT (Lillehoj and Rose 1982). The direct 
evidence for the role of T cells came from the induction of EAT in na'ive recipients by 
adoptive transfer of Tg-primed LNC or splenic cells (Braley-Mullen et al. 1981, Okayasu 
1985, Simon et al. 1986) or Tg-specific T -cell clones or lines (Maron et al. 1983, Rom ball 
and Weigle 1987). Lastly, nude mice that lack mature T cells failed to develop EAT after 
challenge with either Tg emulsified in CF A (Vladutiu and Rose 1975) or soluble Tg 
followed by LPS injection (Esquivel et al. 1977). 
The role of T cell subsets in pathogenesis of EAT has also been investigated using 
depleting anti-CD4 and anti-CD8 Abs. Flynn et al. (Flynn et al. 1989) reported that CD4+ 
populations were the primary cells mediating the initial transfer and development of the 
disease in syngeneic recipients. CD8+ T cells probably exert cytotoxic effects in the late 
stages, which increased the severity of disease upon cotransfer with CD4+ cells. The role 
of CD4+ T cells as EAT inducers was confirmed in a later study (Stull et al. 1988), in 
which splenocytes isolated from mice treated with anti-CD4 mAb before receiving Tg did 
not proliferate in vitro to Tg and were unable to transfer disease to na'ive mice. 
Furthermore, CD8+ CTL were demonstrated to be involved in thyroid destruction in vivo 
(Creemers et al. 1983, Simon et al. 1986) and in vitro (Kong et al. 1986, Salamero and 
Charreire 1985). Interestingly, injection of anti-CD8 Ab into recipient mice facilitated the 
induction and persistence of granulomous thyroiditis induced by transfer of mTg-primed 
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splenic cells (Braley-Mullen et al. 1994), suggesting CD8+ T cells may be required for the 
resolution of granulomous thyroiditis. 
Many efforts have been devoted to study the process of initial activation of thyroid-
specific autoreactive T cells. The discovery of MHC class II expression on thyroid cells 
in AITD (Bottazzo et al. 1983, Hanafusa et al. 1983) raised the hypothesis that aberrant 
MHC expression in the thyroid could initiate or perpetuate the autoimmune response. 
Further work demonstrated that IFN-y is the only cytokine capable of inducing class II 
expression on thyrocytes in vitro (Todd et al. 1985, Weetman et al. 1985), and class II 
expression in vivo always follows the appearance of infiltrating lymphocytes which 
secrete IFN-y (Hamilton et al. 1991, Margolick et al. 1988). Recently, Kimura et a/. 
(Kimura et al. 2005) generated transgenic mice that express MHC class II molecules in 
the thyroid to examine the role ofMHC+ thyrocytes in the induction of EAT. They found 
that MHC class II expression on thyrocytes alone did not cause spontaneous thyroiditis, 
but mildly increased its severity following immunization with Tg. Furthermore, it has 
been reported that CD40 is expressed on thyroid follicular cells in both healthy 
individuals and patients, and is upregulated by IL-Ia and IFN-y (Metcalfe et al. 1998). 
Based on these observations, Weetman proposed that autoreactive T cells could be 
activated in AITD through their CD40L binding to CD40 expressed on thyrocytes 
(Weetman 2003). 
42 
B-cell mediated injury 
Exactly how the autoimmune response interferes with thyroid function is unclear, but it 
seems likely that both T- and B- cell mediated mechanisms are involved. Development of 
A-Abs to thyroid Ags, Tg, TPO and TSHR, is one of the most common features of AITD, 
and is used as a diagnostic criterion in humans. Early studies reported that passive 
transfer of immune sera containing anti-Tg Abs instigated mild disease in mice (Weetman 
2003, Tomazic and Rose 1975) and rabbits (Vladutiu and Rose 1971b), but this was not 
confirmed in other studies (Rose et al. 1973, Okayasu 1985). Moreover, there was no 
correlation between Ab titers and severity of disease (Esquivel et al. 1978, Vladutiu and 
Rose 1975). Lastly, mice depleted of B cells by treatment from birth with anti-IgM 
developed EAT following Tg immunization with lower incidence (63% vs 88%) and less 
severity (Rayfield et al. 1989, Vladutiu 1989). Although B cell depletion is not complete 
in these animals, these findings suggest B cells may not be necessary for EAT induction, 
but can increase its severity and prevalence. This has also been confirmed in a model of 
SAT, in which NOD.H-2h4 mice genetically deficient in B cells (NOD.Kilnull) or treated 
by anti-IgM developed minimal SAT (Braley-Mullen and Yu 2000). 
B cells themselves can contribute to the pathogenesis of AITD as professional APC, or 
effector cells that produce Abs mediating complement-mediated damage, Ab-dependent 
cell-mediated cytotoxicity (ADCC) or direct alteration ofthyrocyte function (Stafford and 
Rose 2000). In adult NOD.KJlnull mice as mentioned above, passive transfer B cells or 
anti-Tg A-Abs did not render them susceptible to SAT, suggesting B cells were required 
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for the early activation of CD4+ T cells, functioning either as important APC for T cell 
activation or to amplify responses of effector T cells (Braley-Mullen and Yu 2000). 
Deposition of immune complex or membrane attack complexes has been identified in the 
thyroids ofHT and GD patients (Weetman and McGregor 1994). When anti-Tg Abs were 
passively transferred into mice, immune complexes containing Tg and its Abs were found 
in the follicular basement membrane, followed by neutrophil infiltration (Clagett et al. 
1974). These findings suggest a role for complement-mediated destruction induced by 
immune complexes in the thyroid gland. ADCC has been demonstrated using normal 
lymphocytes as effectors and thyroid cells incubated with HT or normal sera as targets 
(Bogner et al. 1984). Similar findings have been observed in guinea pig and OS chicken, 
where Abs from diseased animals rendered normal lymphocytes cytotoxic for Tg-coated 
erythrocytes (Ringertz et al. 1971, Wick et al. 1982). Abs can also participate in AlTO by 
directly modifying cell function, such as TsAb and TBAb mentioned above. 
Other mechanisms 
Other mechanisms, such as Fas-mediated apoptosis and cytokines (IFN-y and IL-12), 
have also been studied in AITD. Due to the absence of reliable anti-CD178 (FasL) Abs in 
earlier studies, controversial results have been reported. Some authors reported both 
CD95 and CD178 were present in glands from HT patients but CD95 was absent in the 
normal thyrocytes, whereas others showed that CD178 but not CD95 was absent in the 
normal thyrocytes (reviewed in (Stassi and De Maria 2002)). However, there is general 
agreement that both of them are upregulated and simultaneously expressed on thyrocytes 
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in HT (Stassi and De Maria 2002). It has been demonstrated that expression of CD 178 in 
the thyroid, encoded by either plasmid DNA (Batteux et al. 1999) or transgene (Batteux et 
al. 2000), induced cell death of infiltrating T cells, therefore, exerting a protective role by 
limiting the development of EAT. Conversely, interactions between CD95 and CD178 
were reported to mediate thyrocyte destruction in HT but not GD by autocrine or 
paracrine killing (Stassi et al. 2000). 
The contribution of IL-12 and IFN y to EAT has been examined usmg several 
approaches. Administration of anti-IL-12 neutralizing Abs, particularly at the time of 
priming in CBA/J mice, significantly suppressed the development of EAT; while 
injection of recombinant IL-12 enhanced it (Stafford and Rose 2000). Moreover, IL-12 
p40 knockout mice developed very little thyroiditis following immunization with 
mTg/CFA (Zaccone et al. 1999). In contrast to the crucial requirement for IL-12 in 
instigating and accelerating early autoimmune processes in EAT, the role of IFN-y in 
EAT is complex and has not yet been clearly defined. Systemic delivery of IFN-y 
(Kawakami et al. 1990) or anti-IFN-y Abs (Tang et al. 1993) has been shown to facilitate 
or prevent EAT induction, respectively. However, addition of anti-IFN y mAbs during in 
vitro activation of mTg-primed splenic cells resulted in more severe EAT in recipient 
mice upon transfer (Stull et al. 1992). Using knockout mice that lack IFN-'Y or its 
receptor, it has been suggested that deficiency in IFN-'Y signaling may ameliorate (Yu et 
al. 2002) or do not affect (Tang et al. 1998, Alimi et al. 1998) EAT induction. Two other 
studies have reported tha thyroid-specific expression of IFN-'Y transgene can either 
induces hypothyroidism in C57BL/6 mice (Caturegli et al. 2000), or limits SAT in 
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NOD.H-2h4 mice (Barin et al. 2003). Recently, Yu et al. showed that splenic cells or 
bone marrow isolated from IFN-'YR_,_ NOD.H-2h4 mice could not transfer disease to 
either IFN-'YR_,_ or WT mice (Yu et al. 2006a), suggesting that thyrocytes responding to 
IFN-'1 may be essential for development of SAT. Other cytokines, such as TNF u (Chen 
et al. 2006), are also involved in the induction of EAT. 
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1.3 THE ROLE OF IODINE IN AITD 
1.3.1 Variations of iodine content in Tg 
Iodine is not only an essential trace element for synthesis ofTg and thyroid hormones, but 
also directly influences most of the thyroid-specific functions as well as thyrocyte growth. 
The adult human body contains 15 -20 mg of iodine and roughly 80% is located in the 
thyroid gland, mostly in the form of Tg (Underwood 1977). The recommended daily 
iodine intake is variable, depending on the age of the subject: 40 11g/day during the 
neonatal period and 150 11glday in the adult (Roti et al. 1997). Also, iodine requirement 
increases to approximate 200 11g/day during pregnancy. In the United States, the average 
iodine intake is approximately 200 11g daily and may reach as much as 500 11g. As 
summarized in Pennington's review (Pennington 1990), it was proposed by many studies 
that an iodine level ~ 1.0 mg per day was the safe upper limit for adults. 
The thyroid gland is able to actively take up and accumulate iodide by a factor of 20- to 
40- fold with respect to its concentration in the plasma (Carrasco et al. 2000). Inorganic 
iodide actively enters the thyroid follicular cells and is incorporated into tyrosine residues 
on Tg through a series of metabolic steps, forming thyroid hormones (Section 1.1). It is 
well established that iodination of Tg in the thyroid is a posttranslational event, which 
probably occurs on fully aggregated Tg rather than on its subunits. Most of Tg in the 
normal gland is present in the follicular lumen. However, small amounts of Tg could 
enter the circulation either by secretion of newly synthesized Tg through the basolateral 
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membrane (Chambard et al. 1987, Schneider et al. 1983), or transcytosis of stored Tg 
from the lumen (Herzog 1983). Transcytosis must occur at a very low rate since most of 
the endocytosed Tg is degraded intracellularlly to release T3 and T4 hormones. 
T g purified from thyroid tissues varies in total iodine content, depending on the amount 
of iodine intake. For example, normal human Tg purified in a soluble form varies widely 
in iodine content from as low as 0.1% to as high as 1.1 %, which corresponds to about 10-
50 atoms of iodine per mole of Tg (Taurog 2000). However, it has been reported that the 
insoluble fraction of luminal Tg is highly iodinated but contains no hormones (Herzog et 
al. 1992, Bemdorfer et al. 1996, Baudry et al. 1998). In contrast, serum Tg contains little 
or is completely devoid of iodine in normal individuals, because it arises, most likely, 
from poorly-iodinated newly-synthesized Tg (lkekubo et al. 1981, Schneider et al. 1983). 
Yet, in patients with some thyroidal abnormalities, such as GD and thyroid cancers, 
increased iodine content in circulating Tg was reported (Druetta et al. 1999). 
Interestingly, administration of TSH in rats was shown to increase the iodine content of 
circulating Tg to a level similar to intra-thyroidal Tg, suggesting that TSH may facilitate 
the release of previously synthesized, iodinated and stored Tg (Schneider et al. 1985). 
1.3.2 Iodine content of Tg alters its immunogenicity 
Iodine content in Tg modifies its structure via oxidation of -SH groups and/or 
substitution in the phenolic ring of tyrosyl residues (Edelhoch et al. 1969), Tg molecules 
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with different iodine contents adopt different conformational shapes as assessed by 
electron microscopy (Berg and Ekholm 1975). Furthermore, highly iodinated Tg (HI-Tg) 
is less susceptible to hydrolysis by thyroid acid protease (Lamas and Ingbar 1978). Taken 
together, the changes in 3-D structure and proteolysis susceptibility by iodination imply 
that iodine may alter the immunogenic properties ofTg. 
Indeed, iodination of Tg alters its immunogenicity at both T- and B-celllevel, as well as 
its pathogenicity. An earlier study demonstrated that excess iodine intake in CS chicken 
causes a significant increase in iodine content in purified Tg, from less than 13 iodine 
atoms per molecule (NI-Tg) to higher than 60 iodine atoms per molecule (HI-Tg) 
(Sundick et al. 1987). HI-Tg induced stronger Ab responses to HI-Tg, T3 and T4 in 
normal K strain chickens, in comparison to Tg depleted of iodine by propylthiouracil (LI-
Tg). However, no Ab was detected against LI-Tg in either HI-Tg- or LI-Tg- immunized 
chickens. In NB and/or BB Wor rats, treatment with NI-Tg but not LI-Tg- generated by 
methimazole, induced anti-Tg Abs and EAT (Ebner et al. 1992). Similar findings were 
also reported in humans, as Tg iodinated in vitro by iodobeads (150 I atoms per 
molecule), were recognized differentially by anti-Tg mAbs, as compared to NI-Tg, and 
LI-Tg purified from a patient with non-toxic goiter (Saboori et al. 1998). The above 
studies have indicated that the iodine content in Tg can modify its B-cell stimulatory 
capability, which probably results from the 3-D structural change during modification. 
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At the T-cell level, Allen et a/. compared the relative frequency of precursor T cells 
against HI-Tg, NI-Tg or LI-Tg in the LT-prone BB/W rats, and found no difference in 
splenic T lymphocytes (Allen and Thupari 1995). These results suggest that the difference 
in the immunogenicity of Tg with variable iodine content is not due to variations in the 
number ofT cells recognizing these Tg preparations. A critical role of iodination for T 
cell recognition was initially highlighted in studies using Tg peptide containing 
hormonogenic sites. Champion and coworkers first identified two Tg-specific T -cell 
hybridomas that recognize only Tg with sufficient iodine content(> 1 T4 per molecule), 
but not LI-Tg obtained from mice treated with the TPO inhibitor 3-amino-1,2,4-triazole 
(Champion et al. 1987). Using these T-cell hybridomas, they identified an EAT-causing 
peptide which contains thyroxine, T4 (2553) (Champion et al. 1991). Later studies have 
compared peptide T4 (2553) and its thyronine (TO) -containing analog, and found both 
TO (2553) and T4 (2553) peptides were able to stimulate Tg-primed LNC and prime 
thyroditogenic T cells in vivo (Kong et al. 1995b). Subsequently, Kong identified another 
Tg pathogenic peptide containing a hormonogenic site at position 5, and immunization 
with either T4(5) or T0(5) elicited similar EAT (Wan et al. 1997). These findings suggest 
iodine residues on the outer ring of L-thyronine are not necessary for autoreactive T cell 
activation and EAT induction. 
In a recent study, Rasooly and coworkers described for the first time that recognition of 
Tg by peripheral human lymphocytes depends on its iodination content (Rasooly et al. 
1998). Lymphocytes purified from normal individuals or HT patients showed 
50 
proliferation in vitro to NI-Tg and HI-Tg, but not LI-Tg. Iodination ofLI-Tg increased its 
immunogenicity to stimulate lymphocyte proliferation. Our laboratory has also reported 
that HI-Tg is highly immunopathogenic in SJL mice - a strain which does not develop 
spontaneous thyroiditis - causing EAT of higher incidence and severity as well as 
stronger B-and T-cell responses than those elicited by NI-Tg (Dai et al. 2002). In vitro 
experiments demonstrated that altered processing ofHI-Tg in APC can generate a cryptic 
pathogenic peptide (2495-2503) (Dai et al. 2002), which allowed us to postulate that Tg 
iodination may promote generation of pathogenic epitopes to which immune tolerance 
has not been previously established. 
1.3.3 Effect of excess iodine on thyroid function 
Wolff-Chaikoff effect (Acute inhibitory effect of iodine) 
Administration of small to moderate amounts of iodide to rats and/or humans enhances 
intrathyroidal iodine levels, resulting in augmented formation of the thyroid hormone 
(Nagataki and Ingbar 1964). However, when large amounts of iodide were given, organic 
binding of iodine was inhibited in the gland. The decreasing yield of organic iodine from 
increasing doses of inorganic iodide is termed the "acute Wolff-Chaikoff effect" (Wolff 
and Chaikoff 1948). In cultures of bovine or dog thyroid slices, this acute inhibition effect 
was reported to be caused by diminished generation or decreased availability of H202 in 
the thyroid, and can be prevented in the presence of TSH or a H202-generating system 
(Corvilain et al. 1988, Taurog 1970). 
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The Wolff-Chaikoff effect induced by a single dose of iodide is only a transient 
phenomenon, as intrathyroidal organification of iodine resumes in about 26-40 hours after 
iodide administration (Wolff et al. 1949). This "escape" or "adaptation" was shown by 
Braverman and Ingbar to be related to the decreased activity of the iodide-transport 
system, which lowered the intrathyroidal iodine concentration (Braverman and Ingbar 
1963). Later studies revealed that decreased expression of NIS, possibly TPO, in the 
thyroid attributes to the adaptation (Eng et al. 1999, Uyttersprot et al. 1997, Ferreira et al. 
2005). This inhibition of iodide transport prevents the development of hypothyrodism or 
goiter in normal thyroid from humans or animals given excess iodide. However, during 
chronic exposure to excess iodide, the adaptation is not complete in certain subjects, and 
the quantity of iodine accumulated and organified is well higher than normal (Sundick et 
al. 1987). 
Direct toxic effect of iodine 
Excess iodide exerts effects on many aspects of the thyroid, including its growth in vivo 
and cell proliferation in vitro (Pisarev 1985). Naturally occurring iodine toxicity in 
normal individuals is rare, and supplemental iodide is added to virtually all animal diet to 
ensure iodine adequacy. Yet, certain populations who consume large quantities of 
seaweed or kelp, or patients exposed to therapy with iodine-containing medications, are at 
greater risk for iodine toxicity. 
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In animals with thyroid hyperplasia induced by a low iodine diet, oral administration of 
large doses of iodine induced necrosis of thyroid follicular cells as early as 5.5-6 hrs after 
administration (Belshaw and Becker 1973, Mahmoud et al. 1986). Mahmoud et al. also 
suggested in their study that necrosis was due to direct interaction of iodide with the 
epithelial cells, and not by iodide-induced vasoconstriction or increase in TSH level. This 
direct toxic effect of iodide on thyrocytes was also observed in autoimmune-prone 
animals on iodide-supplemented diet, such as BB/W rats (Li and Boyages 1994), OS 
chickens (Bagchi et al. 1985) and NOD mice (Many et al. 1995). The affected cells often 
had swollen and disrupted mitochondria, marked accumulation of secondary lysosomes 
and lipid droplets, extreme dilation of rough endoplasmic reticulum, ruptured luminal cell 
membrane, as well as clumping of chromatin in the nucleus, indicating cell necrosis. The 
above observations were confirmed in vitro in cultured human thyroid follicles (Many et 
al. 1992). Follicles incubated in the presence of high concentrations of iodide (1 o-3 to 10-5 
M) had a significant increase in percentage of necrotic cells, as compared to those grown 
in the presence of low iodide (1 o-7 M). Thyroid cell injury may create an inflammatory 
environment, thus serving as an initial event in iodide-induced AT in these animals. 
1.3.4 Iodide-induced hypothyroidism and/or goiter 
Many individuals are exposed to large quantities of iodine and/or iodide present in 
proprietary medications, in food as preservatives, and in x-ray contrast media. Usually, 
excess iodine is well tolerated by healthy individuals because of escape from its acute 
inhibitory effect on the organification mechanisms (Wolff-Chaikoff effect). Yet, in 
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certain subjects with susceptible genetic background or underlying thyroid dysfunction, 
exposure to large doses of iodine and/or iodide usually results in hypothyroidism and/or 
goiter (Pennington 1990, Markou et al. 2001 ). 
Iodide-induced hypothyroidism and/or goiter in humans 
In patients with underlying or previous thyroid disease 
Thyroid disease is commonly associated with underlying defects in the intrathyroidal 
organic binding of iodide (Vagenakis and Braverman 1975), thus predisposing such 
patients to develop iodide-induced hypothyroidism. Patients with HT frequently develop 
hypothyroidism as a result of the chronic autoimmune destruction of the thyroid. In 
euthyroid patients with HT, the administration of - 180 mg of KI daily induced 
hypothyroidism in 60% of the patients after 4 to 5 weeks (Braverman et al. 1971). The 
same regimen also led to a prompt and sustained decrease in serum T4 and a striking rise 
in TSH in all patients with diffuse goiter previously treated with ml (Braverman et al. 
1969). Furthermore, long-term ( 60-120 days) administration of pharmacological 
quantities of iodide (300-350 mg KI) have been shown to induce hypothyroidism in 
patients with a previous history of thyroid disease, including subacute thyroiditis (Roti et 
al. 1990), post-partum thyroiditis (Roti et al. 1991) and IFNa-induced thyroid disfunction 
(Minelli et al. 1997). All subjects in the above studies had recovered from thyroid 
diseases, and had a normal range of baseline TSH before iodide administration. However, 
undetectable abnormalities in thyroid function may persist in these patients and account 
for the iodide-induced hypothyroidism. 
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In patients without apparent thyroid disease 
Iodine is readily transferred across the placenta and is actively transported and secreted 
by breast tissue into the milk (Roti et al. 1983). Iodide-induced goiter and/or 
hypothyroidism has also been reported in the fetus or newborns when pregnant or nursing 
mothers have received large quantities of iodine (Wolff 1969, De Wolf et al. 1988, 
Pennington 1990, Vicens-Calvet et al. 1998). In order to study the effects of iodide during 
perinatal life, pregnant or nursing Sprague-Dawley rats were fed with either tap water or 
water containing 0.01% Nal. The term fetus and neonatal rats from Nai-treated mothers 
developed hypothyroidism, but the thyroid function returned to normal from 18 to 60 
days of age in spite of continued iodide administration (Theodoropoulos et al. 1979). The 
findings in rats suggest that resistance mechanisms to the inhibitory effect of iodide on 
thyroid hormone synthesis are probably developed after birth. 
Patients with chronic nonthyroidal illnesses do not generally manifest thyroid 
dysfunction. However, a few cases of such patients were reported to develop iodide-
induced hypothyroidism. This condition has been observed in adult patients with chronic 
renal failure (Sato et al. 1992), chronic respiratory disease treated with iodine (OLINER 
and RUBINSTEIN 1957, OPPENHEIMER and McPHERSON 1961 ), or children with 
cystic fibrosis treated with sulfisoxazole (Azizi et al. 1974 ). These patients do not have an 
apparent accompanying thyroid disease, but the failure of other organs, such as kidney, 
may interfere with the metabolism of iodine, thus rendering the patients susceptible to 
iodine excess. 
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Subclinical hypothyroidism, defined as elevated serum TSH but normal T3 and T4 
values, has been detected in healthy school children in rural China, where moderate or 
excessive iodine was taken from water or salt (median urinary iodine= 338 or 631 J.lgiL) 
(Gao et al. 2004). Thyroid A-Abs were negative in all except one of the patients. Similar 
results were obtained in elder residents in iodide-rich regions in Hungary and Denmark 
(Szabolcs et al. 1997, Laurberg et al. 1998). Although the prevalence of subclinical 
hypothyroidism was significantly higher in high-iodide intake regions, the levels of serum 
A-Abs was similar to, or even lower than, those in a low-iodide region. Interestingly, 
iodide-induced hypothyroidism and/or goiter were also observed in apparently healthy 
adults. Increased prevalence of endemic goiter has also been reported in Japanese 
populations consuming the iodine-rich seaweed called kombu (Suzuki et al. 1965) and in 
Chinese communities consuming high iodine (Li et al. 1987, Zhao et al. 1998, Teng et al. 
2006). All goitrous patients in these studies were clinically euthyroid. Other studies have 
shown serum concentration of TSH and thyroid hormones are associated with the amount 
of iodide intake, individuals with excess iodide intake are more susceptible to develop 
hypothyroidism (Konno et al. 1993, Konno et al. 1994, Khan et al. 1998, Vagenakis et al. 
1973). Konno et a!. demonstrated that the presence of thyroid A-Ab was not associated 
with hypothyroidism, however when the iodine intake was restricted, the increased TSH 
levels returned to normal in patients without antithyroid Abs but remained elevated in 
those with Abs (Konno et al. 1993). This finding suggests iodide-induced hypothyrodism 
is transient and may result from inhibition of organic iodine formation, but autoimmune-
based hypothyroidism in HT persists even after iodide withdrawal (Konno et al. 1993, 
Konno et al. 1994, Khan et al. 1998, Vagenakis et al. 1973). 
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In all human studies mentioned above, it remained inconclusive to what extent the effects 
of iodide had an autoimmune basis, since the antithyroid Abs were either untested or 
remain unrelated to the development of hypothyroidism. Usually, iodide-induced 
hypothyrodism is reversible, and thyroid function usually returns to normal when iodide 
is withdrawn (Konno et al. 1993, Vagenakis et al. 1973). The mechanisms underlying 
these phenomena remain unclear but it is postulated that they may involve inhibitory 
effects of iodine excess on: a) iodide organification, i.e. an inability of some subjects to 
escape a persistent Wolff-Chaikoff effect, or b) the release ofT4 or T3 from the thyroid. 
Iodide-accelerated thyroiditis and/or hypothyroidism in animals 
The effect of iodide administration on the development of EAT is largely dependent on 
thyroid function and genetic susceptibility of the experimental animals. In animals 
without underlying thyroid dysfunction, such as W-line and Wistar rats (Allen et al. 
1986), Biozzi and CBA/J mice (Hutchings et al. 1999, Braley-Mullen et al. 1999), no 
thyroiditis was induced after long term exposure to an iodine-rich diet. Indeed, thyroid 
autoimmunity, assessed by the production of anti-Tg Abs, was depressed in Wistar rat 
after iodine administration (Mooij et al. 1994a). However, when animals were 
simultaneously immunized with thyroid A-Ag, such as thyroid extract, treatment with 
excess iodine exacerbated the development of EAT (Evans et al. 1969). 
In 1985, the role of excess iodine on autoimmune-prone animals was first examined in 
chickens (Bagchi et al. 1985). Newly hatched CS chickens, a strain spontaneously 
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developing low incidence ofLT, were supplied with normal water or water containing KI. 
By 10 weeks, the degree of lymphocytic infiltration of the thyroid glands was 
significantly increased in iodide-treated chickens, in a dose-dependent manner, 
accompanied by an increase in Abs against Tg, T3 and T4 Abs. The related OS chickens, 
highly susceptible to LT, were used to determine whether iodine-deficient regimens could 
prevent or reduce thyroid A-Ab responses and thyroiditis. Administration of T4 in the 
presence of iodine transport inhibitor (KCL04) caused a significant reduction in the 
production ofanti-Tg, T3 and T4 Abs. 
Three groups have demonstrated that long-term iodide administration (up to 12 weeks) 
significantly increased the incidence of L T in young BB/W rats (Allen et al. 1986, Li et 
al. 1993, Mooij et al. 1993). However, thyroid weight and serum T3, T4, TSH and anti-Tg 
Ab concentration were not affected by iodine treatment. Of note, the focal infiltrations in 
the diseased glands started with increases in numbers of MHC class 11-positive dendritic 
cells (DC), suggesting iodine may mediate this autoimmune process by stimulating APC, 
thus activating T and B cells. In NOD mice, dietary iodine increased the incidence and 
severity of the thyroid lesions although A-Abs to Tg were absent (Hutchings et al. 1999). 
Yet, both thyroiditis and anti-Tg Abs were accelerated in similarly treated NOD-H-2h4, 
which express I-Ak on the NOD genetic background (Rasooly et al. 1996, Hutchings et al. 
1999, Braley-Mullen et al. 1999). Histological analyses of the thyroids have shown that 
following 1-week of iodide administration, MHC class I expression is elevated on thyroid 
follicular cells and T cells have begun to infiltrate (Verma et al. 2000). Similarly, i.p. 
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injection of iodide elicited thyroiditis in hamsters with thiouracil - induced hyperplastic 
goiter (Follis R.H. 1964). 
In most of the above studies, the effect of iodine on thyroid function remained unclear, 
since the concentration of serum thyroid hormones were either not examined (Rasooly et 
al. 1996, Bagchi et al. 1985, Hutchings et al. 1999, Braley-Mullen et al. 1999) or found 
unchanged despite the accelerated EAT (Allen et al. 1986). To mimic the situation in 
humans with thyroid dysfunction, hemithyroidectomy was performed in rats at 30 days of 
age before they were placed on Nai-supplemented or control water. At 90 days of age, it 
was found that iodine excess did induce thyroid enlargement in the residual lobe and 
hypothyroidism (fTSH, t T3, t T4) in both autoimmune-prone BB/w rats and non 
autoimmune-prone W-line rats (Allen et al. 1986), regardless ofthe development of EAT. 
This regimen strikingly increased the incidence of spontaneous L T in iodide-treated rats 
(68% vs 13%) in BB/W rats, but did not induce LT in W-line, Wistar-Furth, or Sprague-
Dawley rats. Similar findings were reported in NTx- Buffalo rats, which had an 
increased incidence of spontaneous L T over normal Buffalo rats (Allen and Braverman 
1990). Iodide administration significantly increased the incidence of L T in these rats from 
31% in the control group to 73% in the iodide-treated group (p<0.05). Serum TSH 
concentrations and anti-Tg Ab titers were also significantly higher in the iodine-treated 
rats. Changes in thyroid function have also been reported in dogs fed a high iodine 
commercial diet (Castillo et al. 2001). The daily iodine intake of these dogs from food 
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varied from 400-600 J..lg to 2.58-3.75 mg of Kl. Dogs fed a high iodine diet had 
significantly lower total and free T4 and increased TSH in their serum. 
After considering the observations in both humans and animals, one may conclude that 
iodine contributes to the development of hypothyroidism via two independent 
mechanisms: 1) exacerbating preexisting autoimmune thyroiditis via an autoimmune 
mechanism; 2) exerting prolonged inhibitory effects on iodide organification, preventing 
the synthesis or release of thyroid hormones; 3) affecting the thyroid structure and/or 
hormone synthesis through direct tissue damage. 
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1.4 DENDRITIC CELL, CELL DEATH AND AUTOIMMUNITY 
1.4.1 Ag presentation by dendritic cell (DC) 
DC are professional APC, unique in their capacity to maintain self tolerance and initiate 
primary immune responses. DC exist in two functionally and phenotypically distinct 
states according to their developmental stage: immature and mature. Tissue resident DC 
are most likely at an immature stage, and are very efficient in Ag internalization 
(Guermonprez et al. 2002). Pathways employed by DC for Ag capture include: 1) 
receptor-mediated endocytosis using C-type lectin receptors, Fe receptors, complement 
receptors, or scavenger receptors; 2) Phagocytosis of particulate Ags, such as pathogens, 
apoptotic and necrotic bodies; and 3) Macropinocytosis of soluble Ags (Guermonprez et 
al. 2002). Immature DC express low levels of surface MHC class I, class II and little 
costimulatory molecules (CD80, CD86, CD40), and are insufficient for T cell priming. 
Under steady-state non-inflammatory conditions, presentation of self Ags by tissue 
resident DC in the absence of costimulation leads to clonal T cell anergy, which is critical 
for the maintenance of peripheral tolerance (Wilson et al. 2004). In order to acquire the 
capability of T cell stimulation, DC must undergo a characteristic process of terminal 
differentiation called maturation. Mature DC are characterized by decreased capability of 
Ag intake, and upregulated surface expression of MHC and costimulatory molecules, as 
well as secretion of large amounts of proinflammatory cytokines (Banchereau et al. 
2000). These modifications facilitate the formation and transportation of MHC/peptide 
complexes to the cell surface, increasing the T cell priming ability of DC. Maturation is 
also associated with a rapid migration of Ag-bearing DC from the inflamed tissues to the 
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T cell zone of secondary lymphoid organs, where they encounter and activate Ag-specific 
nai"ve T cells. 
Maturation stimuli differ in their ability to educate DC to activate Th 1 or Th2 cells, or 
conversely regulatory T cells (Treg). DC matured by pathogen-related molecules such as 
LPS (Rescigno et al. 1999), CD40L (Cella et al. 1996), oligo CpG nucleotides (Hartmann 
et al. 1999) or double stranded RNA (Cella et al. 1999) produce high levels ofiL-12 and 
preferentially induce Thl responses. On the other hand, stimuli like PGE2, TGF-~, ~2-
agonists (Kalinski et al. 1999), or OX40L (Liu et al. 2001 b) inhibit secretion of IL-12 by 
DC and promote a Th2-polarized priming. Interestingly, Lutz et a/. found semi-mature 
DC treated with TNF-a expressed high levels of MHC and costimulatory molecules but 
secreted little IL-12 (Menges et al. 2002, Lutz and Schuler 2002). Administration of 
TNFa-treated DC induced tolerance mediated by CD4+ IL-l 0+ T regulatory cells (Menges 
et al. 2002, Verginis et al. 2005). As revealed by the above studies, production of 
proinflammatory cytokines, especially IL-12, by DC, seems to be a critical factor in 
determining the outcome ofT -cell stimulation. 
Besides activating nai"ve T cells, DC can also directly activate nai"ve and memory B cells. 
It was reported that DC can retain unprocessed Ags in vitro and in vivo, and transfer these 
Ags to nai"ve B cells to initiate a specific Th2-associated Ab response (Wykes et al. 1998). 
As reviewed in (Banchereau et al. 2000), DC not only induce surface IgA expression on 
CD40-activated naive B cells and help them differentiate into plasma cells, but also 
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enhance the differentiation of CD40-activated memory B cells towards !gO-secreting 
cells. 
1.4.2 DC-mediated induction or inhibition of autoimmunity 
Participation of DC in autoimmune diseases was first indicated by the presence of DC in 
autoimmune lesions in both humans and animals. It was found DC are among the first 
infiltrating cells in the thyroid and pancreas in BB rats and NOD mice that spontaneously 
develop diabetes and thyroiditis (Canning et al. 2003, Turley 2002), as well as in 
rheumatoid synovial fluid and synovial tissue in patients with rheumatoid arthritis 
(Thomas et al. 1994). Furthermore, DC, surrounding islets in NOD mice, have been 
shown to acquire Ag and probably present them to T cells in local draining lymph nodes 
(Clare-Salzler and Mullen 1992, Shimizu et al. 1995). 
The important role of DC as APC in initiation of autoimmunity has been revealed by 
transfer of A-Ag-pulsed DC into susceptible animals. Induction of Tg-loaded DC has 
been discussed in Section 1.2.2.2. In 1999, another study showed that adoptive transfer of 
DC expressing pathogenic self-peptides from myelin basic protein (MBP), Ac 1-11, in 
combination with Ac1-11-specific transgenic CD4+ T cells, were able to induce 
development of experimental autoimmune encephalomyelitis (EAE) in B 1 O.PL mice 
(Dittel et al. 1999). Later studies demonstrated that DC pulsed with self peptide, such as 
myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 (Weir et al. 2002) or cardiac 
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a.-myosm peptide 614-629 (Eriksson et al. 2003), could induce organ-specific 
autoimmune disease, EAE or myocarditis, respectively, in susceptible mice, without 
cotransfer of peptide-specific T cells. Interestingly, in transgenic mice expressing 
lymphocytic choriomeningitis virus glycoprotein (LCMV -GP) in pancreatic ~ islets or ~­
galactosidase in cardiomyocytes, repetitive immunization with DC constitutively 
expressing LCMV -GP immunodominant epitopes or DC propagated in vitro with ~­
galactosidase peptide, induced development of autoimmune diabetes, arthritis and 
myocarditis, respectively (Ludewig et al. 1998, Ludewig et al. 2000). Taken together, the 
above results indicate that splenic DC or BM-DC, loaded with self Ags, could activate 
nai've autoreactive T cells in vivo, thus initiating the progression of the autoimmune 
disease. 
Recent studies indicate that DC act not only as stimulators but also as regulators of 
immune responses. For example, challenge with immature DC (either costimulation low or 
IL-l iow) loaded with self Ags, such as interphotoreceptor retinoid-binding protein 
(IRBP) peptide 161-180 or MBP peptide 68-86, induced a state of tolerance to the 
peptide-specific autoimmunity (Huang et al. 2000, Yang et al. 2000, Jiang et al. 2003). 
The tolerogenic properties of the DC are mediated by three distinct mechanisms: 1) 
Induction of anergy. It has been known that T cells encountering Ag presented by APC, 
which express low levels of co-stimulatory molecules, become anergic. IL-l 0-treated DC, 
characterized by reduced surface expression of MHC and costimulatory molecules and 
reduced expression of proinflammatory cytokines, were reported to induce Ag-specific T 
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cell anergy (Enk et al. 1993). In another study, IL-10-treated human DC, from peripheral 
blood, induced alloreactive CD4+ and CD8+ T cell anergy and an Ag-specific anergy in 
hemagglutinin or melanoma-specific CD4+ and CD8+ T cells (Steinbrink et al. 1997). 2) 
Elimination of autoreactive T cells. Using engineered Ab techniques, DNA coding for 
hen egg lysozyme (HEL) peptide 46---61 with spacing residues on both sides was fused to 
DNA encoding the C terminus of the heavy chain of anti-DEC205 Abs (Hawiger et al. 
2001 ). After delivery of the hybrid Abs, which target specifically to DC in vivo, HEL 
peptide-specific CD4+ T cells were deleted after a short proliferative burst. 3) Generation 
and/or expansion of regulatory T cells. "Semi-mature" , i.e. TNF-a -treated DC show 
increased expression of MHC class II and co stimulatory molecules, but secrete low levels 
of pro-inflammatory cytokines such as IL-12 and TNF-a (Lutz and Schuler 2002). 
Immunization with TNF -a -treated DC expressing the MOG peptide ameliorates 
development of EAE induced by the same peptide, and the protection is probably 
mediated by IL-l 0-producing T cells (Menges et al. 2002). Our study confirmed this 
observation in EAT using Tg-pulsed, TNF-a-treated DC, and further demonstrated that 
the IL-l 0-producing T cells are CD4+CD25+ regulatory T cells, which mediate 
suppression in an Ag-specific, cell-to-cell contact - dependent manner (Verginis et al. 
2005). 
1.4.3 Cell death as a danger signal to break self tolerance 
The term "danger signals" was first coined in 1994, referring to molecules or molecular 
structures that are released or produced by cells undergoing stress or abnormal cell death 
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(Gallucci and Matzinger 2001). During cell death, many proteins and nucleic acids are 
uniquely modified by various processes, including protease-mediated cleavage and 
(de )phosphorylation (Rodenburg et al. 2000), and new molecules, such as cytokines and 
chemokines, are synthesized (Gallucci and Matzinger 2001). These modifications 
uncover cryptic self-epitopes and/or create novel epitopes to which no tolerance exists, or 
recruit and activate resting APC provoking an autoimmune response. 
There are two major types of cell death: apoptosis and necrosis. Apoptosis is a process of 
programmed cell suicide, which occurs during tissue remodeling. Early changes in 
apoptotic cells are nuclear bleb bing, alteration in cell morphology, and eventually, 
fragmentation of the DNA with no loss of membrane integrity (Savill et al. 2002). 
Apoptotic cells are usually cleared by macrophages or DC via a non-inflammatory 
pathway. Immature DC phagocytose apoptotic cells peripherally and transfer the tissue-
derived self peptides to naYve T cells upon reaching the draining lymph nodes, leading to 
induction of T cell anergy (Steinman et al. 2000). However, apoptotic cells in large 
numbers become sufficient to trigger DC maturation, even in the absence of exogenous 
"danger" signals (Ignatius et al. 2000, Rovere et al. 1998). In contrast, necrosis is a 
pathological process of cell disintegration caused by physical/chemical injury, or 
Ab/complement-mediated membrane damage (Savill et al. 2002). Necrotic cells release a 
range of endogenous adjuvant, such as genomic DNA (Ishii et al. 2001 ), heat shock 
proteins (Basu et al. 2000), high-mobility group B1 protein (Rovere-Querini et al. 2004) 
or uric acids (Shi et al. 2003). These components may work alone or together to stimulate 
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DC maturation m situ, turning tolerogenic DC to immunogenic DC. Initially, it was 
reported that only necrotic tumor cells, but not necrotic primary cells - T and B cells, 
monocyte and keratinocytes - were able to mature DC (Sauter et al. 2000). Yet, others 
showed that exposure to necrotic primary fibroblasts was also sufficient to induce DC 
functional maturation (Gallucci et al. 1999, Rovere-Querini et al. 2004). The 
contradictory results may be due to the different cell types used in each study, as well as 
the necrotizing procedures. 
Immature DC are specialized in engulfment of dead cells in vivo and in vitro (Gaipl et al. 
2003, Larsson et al. 2001). Ags derived from these cells are processed and presented onto 
MHC class II molecules for CD4+ priming (Inaba et al. 1998), but they can also be cross-
presented on MHC class I for CDS+ CTL activation, a process defined as "cross 
presentation" (Larsson et al. 2001 ). Cross-priming is essential for the induction of CDS+ T 
cell responses directed towards antigens not expressed in professional APC, such as dead 
cells or their derivatives. Studies with transgenic mice in which MHC class I expression 
is driven selectively in DC provided direct in vivo evidence that DC are sufficient to 
cross-present exogenous self-Ags and induce Ag-specific cell division of CDS+ T cells 
(Kurts et al. 1997). Furthermore, the CD Sa+, but not CD8a-, splenic DC subset was 
reported to mediate the cross presentation of cell-associated Ags in the context of MHC 
class I, after in vivo priming with ovalbumin-loaded B2-microglobulin-deficient 
splenocytes (den Haan et al. 2000). 
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It has been proposed that the development of autoimmune disease is linked to abnormal 
cell death. This association was first noticed in MRL/lpr mice, which develop a lupus-like 
autoimmune syndrome, probably resulting from failure of proper clearance of 
autoreactive T cells caused by defects in Fas molecule (Watanabe-Fukunaga et al. 1992). 
A similar inheritable disorder, autoimmune lymphoproliferative syndrome (ALPS), was 
discovered in humans carrying mutations in genes involved in cell apoptosis, such as 
CD95 and caspase-10 (Straus et al. 1999, Wang et al. 1999). In the above examples, the 
systemic deficiency in cell death (i.e. too little cell death) appears to be a risk factor for 
autoimmunity, probably due to the inability of clearance of autoreactive lymphocytes. In 
NOD mice, however, it is proposed that an increase in~ cell apoptosis at 12d of age may 
provoke the activation of islet-reactive T cells by augmenting release and presentation ~ 
cell-associated Ags by DC (Turley et al. 2003). In the case of iodide-induced EAT, it was 
found that the increased intrathyroidal iodine concentration promotes thyrocyte necrosis 
followed by mononuclear cell infiltration, suggesting thyrocyte necrosis may be an initial 
step in iodide-induced EAT in OS chickens (Bagchi et al. 1995). In the latter two studies, 
increased cell death in the target organ facilitates the development of organ-specific 
autoimmune disease. 
Necrotic cells have been used as a source of Ag and proinflammatory stimuli in tumor 
therapy (Fields et al. 1998, Herr et al. 2000, Nestle et al. 1998a). Yet, only a few groups 
have attempted to induce autoimmune disease using DC exposed to necrotic primary 
cells. Myocarditis, a T cell-mediated organ-specific autoimmune disease, was 
68 
successfully induced in BALB/c mtce by challenge with DC pulsed with apoptotic 
cardiomyocytes, followed by maturation with LPS and anti-CD40 (Eriksson et al. 2003). 
In systemic autoimmune disease, DC exposed to apoptotic thymocytes were reported to 
induce production of anti-nuclear and anti-dsDNA Abs with clinical features of systemic 
autoimmunity in autoimmune-prone (NZB X NZW) F 1 mice, but not in normal mice 
(Bondanza et al. 2003, Bondanza et al. 2004, Georgiev et al. 2005). Even DC alone could 
induce A-Abs in recipient mice (Georgiev et al. 2005), but this remains unexplained and 
requires further investigation. In a recent paper, administration of DC exposed to necrotic 
splenocytes, but not apoptotic cells, induced strong anti-dsDNA antibodies and clinical 
manifestations of lupus in lupus-prone MRL/+ mice (Ma et al. 2005). In normal C57BL/6 
mice, only anti-dsDNA Abs were induced and they were not accompanied by clinical 
symptoms. Furthermore, the A-Ab responses became significant only if adult (11 weeks 
of age) but not young mice (5 weeks of age) were used as recipients. This publication 
highlighted the difference of necrotic vs apoptotic cells in educating DC as immune 
stimulators, and pinpointed the important role of genetic background and age of the 
recipient. 
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1.5 THYMIC EXPRESSION OF AUTOANTIGENS 
Immunological self-tolerance is a state in which the immune system does not 
destructively attack self-tissues. Lack or loss of self-tolerance is likely to result in 
autoimmune responses, eventually leading to the clinical onset of autoimmune disease. 
Induction and maintenance of immunological self-tolerance is mediated by multiple 
mechanisms operating both in the thymus (central tolerance) and the periphery 
(peripheral tolerance). 
1.5.1 Mechanisms of central and peripheral tolerance 
The thymus is considered as the primary site for the shaping of the T cell repertoire 
during intrathymic development (Sprent and Kishimoto 2001 ). T cell progenitors enter 
the thymus from the bone marrow, moving from the cortex to the medullary area during 
their maturation and selection. At the outer edge of the cortex, in the subcapsular region 
of the thymus, large immature CD4TD8- double-negative (DN,) thymocytes proliferate 
vigorously, differentiate into small CD4+CD8+ double positive (DP) thymocytes and 
move to a deeper area of the cortex. DP T lymphocytes recognizing self-peptide/MHC 
complexes on the cortical epithelial cells with low avidity are positively selected 
(Cosgrove et al. 1992). In contrast, developing T lymphocytes recognizing self-Ags on 
stromal or bone marrow-derived cells with high avidity are negatively selected via 
apoptosis in the thymic medulla (Sprent et al. 1996). Ag-specific T cell deletion or 
selection, therefore, requires the given self-Ag or its mimic to be either expressed in the 
thymus or enter the thymus via blood or lymph circulation. Recently, several studies have 
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demonstrated that naturally occurring CD4+CD25+ Treg cells are generated in the thymus 
through interaction with their specific ligands (Apostolou et al. 2002, Jordan et al. 2001, 
Grajewski et al. 2006). T cells that are positively selected in the thymus enter the 
circulation as mature single positive (either CD4+ or CD8+) lymphocytes. 
The process of central tolerance (negative selection) does not preclude the presence of 
autoreactive T cells in the periphery. This is probably caused by either failure to 
encounter their ligands, such as tissue-specific Ags ("privileged Ag") in the thymus or, by 
receptor revision in the periphery (Lantelme et al. 2000, McMahan and Fink 2000). In 
peripheral lymphoid and/or nonlymphoid organs, several mutually nonexclusive 
mechanisms are proposed to secure tolerance of autoreactive T cells. First, the induction 
of anergy (Keir and Sharpe 2005). Activation ofT cells requires not only the interaction 
between TcR and the MHC-peptide complex (first signal), but also costimulation from 
the APC (second signal). One of the most important costimulators is the B7 molecule on 
the APC and its ligand on the T cell designated CD28. At most of the time, the cells 
presenting the self Ags fail to provide the second signal, leading to T cell anergy instead 
of activation. Second, ignorance due to the spatial separation ofT cells from their cognate 
Ags (Klein and Kyewski 2000). Some tissues hidden behind anatomical barriers keep T 
cells from reaching them ("privileged" site). Third, clonal elimination via apoptosis. 
Certain autoreactive T cell clones undergo extensive proliferation upon encounter with 
their ligands, then die by activation-induced cell death mediated by Fas ligand (Rocha and 
von Boehmer 1991, Webb et al. 1990). Fourth, the presence of Treg cells inhibit the 
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activity of potential effector cells, protecting the body from autoimmune attack (Hauben 
and Roncarolo 2005). 
1.5.2 Intrathymic expression of tissue antigen 
Many autoimmune diseases affect tissues that are anatomically sequestered from the 
immune system, such as brain, testis or eye. It was originally assumed that the major A-
Ags in such diseases were expressed exclusively in the target organs, and self-tolerance 
was achieved only through peripheral tolerance (Mason and Powrie 1998, Webb et al. 
1990). However, recent data has indicated that such A-Ags are expressed intrathymically 
at either the mRNA and/or protein level (Klein and Kyewski 2000). This phenomenon of 
promiscuous or ectopic gene expression has been considered to participate in central 
tolerance. The AIRE (autoimmune regulator) gene expressed predominantly in mTECs, 
has now been demonstrated to act as a master regulator of the intrathymic expression of 
many tissue-specific Ags (Gotter and Kyewski 2004). 
A broad range of target A-Ags with tissue-restricted or mainly peripheral expression has 
been investigated for intrathymic expression. Among the pioneering studies, mRNA 
encoding insulin, an islet-specific target A-Ag in IDDM, was detected in mouse thymus 
(Jolicoeur et al. 1994) during fetal development and after birth. Similarly, myelin basic 
protein - a major A-Ag in EAE previously thought to be expressed exclusively in 
oligodendrocytes and Schwann cells, was detected at both the mRNA and protein level in 
normal SJL thymus (Fritz and Kalvakolanu 1995, Fritz and Zhao 1996). In 1997, it was 
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reported that intrathymic expression of two major uveitogenic retinal proteins, S-antigen 
and interphotoreceptor retinoid-binding protein (IRBP), varied significantly among 
different animal species and strains (Egwuagu et al. 1997). Other studies have revealed 
several peripheral antigens that are also expressed in human and/or mouse thymus, 
including proteolipid protein (PLP) - an A-Ag in EAE , glutamic acid decarboxylase 
(GAD) and the tyrosine phosphatase IA2- A-Ags in IDDM, as well as TSHR, Tg and 
TPO -A-Ags in EAT (Egwuagu et al. 1997, Heath et al. 1998, Sospedra et al. 1998, 
Spitzweg et al. 1999a, Derbinski et al. 2001, Pugliese et al. 2001 ). 
Initial studies showed that the mouse thymic medulla contains a small number of 
specialized cells expressing peripheral antigens such as insulin (Smith et al. 1997). Later 
studies by Throsby et al. (Throsby et al. 1998) and Pugliese et al. (Pugliese et al. 2001) 
demonstrated that thymic cells expressing islet cell antigens belonged to the DC and 
macrophage lineage in mice and humans. In contrast, promiscuous gene expression was 
also detected in thymocytes (Mor et al. 1998) and thymic epithelial cells (Derbinski et al. 
2001). In a recent extensive and elegant study, Kyewski et al. have demonstrated that 
nearly all genes encoding autoimmune target antigens are expressed in mTEC (Kyewski 
et al. 2002). Among them, a few are simultaneously detected in BM-derived DC or 
macrophages, or cortical TEC. Negative selection in the thymus is driven most efficiently 
by bone marrow-derived APC, such as DC and macrophages. In addition, both 
thymocytes themselves and thymic epithelial cells have the ability to cause the deletion of 
self-reactive cells (Sprent et al. 1996). Nevertheless, it remains inconclusive as to what 
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extent, and how, each cell subpopulation contributes to the deletion of autoreactive T 
cells. 
1.5.3 "Leakage" of central tolerance 
The presence of potentially autoreactive T cells in the normal thymic repertoire is a well-
documented observation (Klein and Kyewski 2000). Several mechanisms that control the 
quantity and quality of the intrathymic gene expression may contribute to the 
incompleteness of central tolerance. The first mechanism operated at the level of 
transcription in the thymus. In the EAU model, it was shown for the first time that 
constitutive expression of ocular S-antigens and IRBP in the thymus correlated with 
resistance to EAU among different species and strains (Egwuagu et al. 1997). Moreover, 
IRBP-knockout mice had greatly elevated response to IRBP, an altered recognition of 
IRBP epitopes, as well as exacerbated disease, after deliberate immunization (A vichezer 
et al. 2003). Similarly, when two different sets of MHC congeneic strains of mice were 
compared, increased thymic expression of MBP was reported in mice that are more 
resistant to EAE (Liu et al. 2001a). Furthermore, the level of insulin mRNA expression in 
the human thymus is associated with allelic variation at the IDDM2 susceptible locus, and 
the transcription activity in the thymus was found to be about 2-3 fold higher for insulin 
transcripts encoded by IDDM2 alleles that were clinically associated with resistance to 
the development of diabetes (Pugliese et al. 1997). Lastly, it was proposed that reduced 
thymic expression of islet antigens, such insulin (Brimnes et al. 2002) and ICA69 
(Mathews et al. 2003), may predispose NOD mice to spontaneous development ofiDDM. 
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The second mechanism operates when the A-Ag expressed in the thymus is different from 
that in the specific organ. For example, in EAE, the predominant form of PLP expressed 
in thymic epithelial cells is DM, a splice variant that lacks residues 116-150 of the full-
length PLP in the central nervous system (Klein et al. 2000). T cells specific for residues 
that are absent in the thymus do not undergo negative selection and can "escape" from the 
thymus to the periphery, i.e. the PLP139-151 -reactive T cells. Reexpression of PLP 139-151 
in the embryonic thymus results in a significant reduction of PLP139-151-reactive 
precursors in naive SJL mice (Anderson et al. 2000). Similarly, IA-2 transcripts in thymus 
and spleen are present in an alternatively spliced form lacking exon 13, whereas 
pancreatic islets express full-length mRNA and two alternatively spliced transcripts (Diez 
et al. 2001 ). The differential splicing was proposed as a regulatory mechanism to play a 
permissive role in the development of autoimmune responses to IA2. 
The third mechanism operates when thymically expressed A-Ags do not mediate T cell 
deletion due to inefficient antigen presentation by MHC alleles or low affinity recognition 
by TcR. This mechanism has been proposed to explain the escape of MBP I-ll-reactive 
T cells in mice bearing the H-2u haplotype. MBP 1-11 is expressed in mouse thymus, but 
binds only weakly to I-Au and form unstable peptide-MHC complexes (Anderson and 
Kuchroo 2003). Such peptide-MHC complexes are inefficient to mediate thymic deletion, 
leading to the escape ofT cells recognizing the MBP 1-11 epitope; but they are sufficient 
to induce T cell activation in the periphery (Harrington et al. 1998). MHC instability and 
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poor peptide binding may also account for the susceptibility of NOD to autoimmunity, 
since the I-Ag7 alleles have been shown to be structurally unstable and to bind to diabetes-
related self-peptides poorly (Carrasco-Marin et al. 1996). 
All of the mechanisms illustrated above refer to the negative selection mediated by self 
antigens expressed in the thymus. Yet, it is not known whether such promiscuous 
expression is also involved in positive selection or generation of regulatory cells in the 
thymus. On the other hand, lack of thymic expression may not always preclude thymic 
deletion of self-reactive T cells. First, some self antigens can enter the thymus via 
circulation, either in soluble form, e.g. Tg (Pugliese 2004) or are expressed in 
hematopoietic cells, e.g. Tg and PLP (Bugalho et al. 2001, Klein et al. 2000). Second, the 
expression of genes encoding self-molecules is not limited to the thymus but also take 
place in peripheral lymphoid organs, e.g. insulin, where it may contribute to the 
peripheral tolerance (Pugliese 2004). 
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1.6 HYPOTHESIS AND OBJECTIVES OF THE STUDY 
Hypothesis 1 (Chapter 3&4): 
Normal Tg may harbour several pathogenic T -cell epitopes that contain 
monoiodotyrosyl(s) outside the hormonogenic sites. 
Objectives: 
1.1 To identify murine Tg peptides that contain Ak-binding motif flanked by Tyr 
residues(s). 
1.2 To examine the effects of iodotyrosyl formation on the immunopathogenicity of the 
above peptides by determining the immunopathogenic profiles of both non-iodinated 
and iodinated peptides in CBA/J mice. 
1.3 To explore the mechanisms by which iodination of Tyr residue(s) may impart 
immunogenicity to a Tg peptide. 
1.4 To identify Tg peptides encompass (sub)dominant T cell epitope among the 
immunogenic peptides identified in the above study. 
Hypothesis 2 (Chapter 5): 
Administration of iodide to SJL and CBA/J mice might promote Tg iodination in vivo, 
and sensitization of autoreactive T cells of the hosts to pathogenic Tg determinants. 
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Objectives: 
2.1 To determine whether administration of iodide (0.05% Nal in drinking water) to SJL 
and CBA/J mice will facilitate the development ofEAT. 
2.2 To explore the effects of iodide administration on iodide organification and thyroid 
hormone secretion, by examining the iodine content in Tg purified from the 
experimental and control animals, and the serum levels ofthyroid hormones (i.e. total 
T4 and TSH). 
2.3 To examine whether iodide administration exerts differential effects on SJL vs CBA/J 
mice. If there is a difference, to explore the mechanisms by which this phenomenon 
occurs. 
Hypothesis 3 (Chapter 6): 
Exposure to necrotic thyrocytes may trigger DC maturation. This enables the 
immunogenic presentation of thyroid antigen(s)- such as Tg- on the DC surface, leading 
to development of EAT in CBA/J mice. 
Objectives: 
3.1 To establish primary culture of mouse thyrocyte and bone marrow-derived DC. 
3.2 To determine whether necrotic (induced by 4 times of freezing/thawing cycles)- but 
not viable - thyrocytes can mediate both phenotypic and functional maturation of DC. 
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3.3 To examine whether DC that have ingested syngeneic necrotic thyrocytes can elicit 
EAT or thyroid antigen-specific responses, following their adoptive transfer in CBA/J 
hosts. 
Hypothesis 4 (Chapter 7): 
The apparently contrasting results ofRT-PCR detection ofintrathymic Tg expression, the 
large size of the Tg molecule (2748 aa), and the expression of A-Ag isoforms in the 
thymus in other animal models, prompted us to hypothesize that Tg transcripts may be 
present in differential isoforms in thymus vs thyroid in CBA/J mice. 
Objectives: 
4.1 To determine whether Tg transcripts are present in differential isoforms in mouse 
thymus vs thyroid, via RT-PCR using primers amplifying 12 Tg pathogenic peptides 
that scatter through the whole Tg gene. 
4.2 To examine the presence of Tg transcripts in tissues other than thyroid and thymus, 
such as liver, kidney and muscle. 
4.3 To determine whether the expression profile of Tg transcripts encoding the 12 Tg 
pathogenic peptides changes over time after birth. 
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CHAPTER2 
MATERIALS AND METHODS 
2.1 ANIMALS 
Female CBA/J (H-2k), C3H/HeJ (H-2k), SJL/J (H-25) mice and breeding CBA/J pairs 
were purchased from the Jackson Laboratories (Bar Harbor, ME, USA). For some 
experiments, mice were placed on drinking water containing 0.05 %sodium iodide (Nal) 
over a variable time period. All experimental procedures were reviewed and approved by 
the Animal Care Committee at Memorial University of Newfoundland. 
2.2 ANTIGENS AND ANTIBODIES 
2.2.1 Tg and its iodination 
Tg was extracted from Tg thyroids of outbred ICR mtce as previously described 
(Chronopoulou and Carayanniotis 1992). Briefly, frozen thyroid glands (Bioproducts for 
Science, Indianapolis, IN) were homogenized in phosphate buffer in the presence of 
protease inhibitors: Leupeptin 1 o-6 mol/L, Pepstatin A 1 o-5 mol/L, PMSF 1 o-3 mol/L, and 
the supernatant was collected after 3 X centrifugation at 14,000 xg. Tg was obtained from 
the supernatant by gel filtration using Sepharose CL-4B (Pharmacia, Baie d'Urfe, 
Quebec, Canada). The fractions of peak II (Fig 2.1) were pooled, concentrated by using 
ultra-filtration cells (Amicon, Danvers, MA) and filter-sterilized to a final concentration 
of 2-3 mg/ml, and stored at -20 °C until use. In some cases, Tg was lyophilized. 
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Tg iodination was performed in 12 x 75 mm glass tubes coated with IODOGEN (Pierce, 
Rockford, Illinois). As previously described (Dai et al. 2002), 100 Jll of 1 mg/ml Tg was 
incubated with 0.25 mM/1 0 Jll Nal in each tube coated with 10 Jlg of IODOGEN at room 
temperature for 0-20 min. Free iodine was removed by dialysis in PBS. The iodinated Tg 
(HI-Tg) was concentrated and filter-sterilized. The iodine content in Tg samples was 
determined by a modified non-incinerative method based on the catalytic activity of 
iodine in the eerie (Ce)-arsenite (As) reaction (Saboori et al. 1993). The reduction of 
Ce(IV) to Ce(III) by As(III) leads to a decoloration of yellow eerie ion to colorless 
cerious ion, a process which can be followed spectrophotometrically. Construction of the 
standard curve was performed using known concentration of T4 dissolved in 99 vol of 
absolute methanol and 1 vol of 30% ammonium hydroxide. The iodine content in normal 
Tg and HI-Tg was extrapolated by the standard curve. All the HI-Tg used in this study 
contains iodine ranging from 60-75 atoms per Tg monomer. 
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Figure 2. 1 Purification of mouse Tg. 
One hundred thyroid glands from ICR mice were homogenized in 2.5 ml ice-cold PBS in 
the presence of protein inhibitors as described in Materials and Methods. The supernatant 
was loaded on a Sepharose column after 3 times centrifugation at 14,000 xg. Tg was 
eluted with PBS and collected in 2.5 ml per tube for subsequent OD measurement. 
Fractions from tubes 32 - 47 (80 to117 ml of the elution) within peak II were pooled, 
dialyzed and concentrated in double distilled H20. The Tg samples were further filtered, 
lyophilized and stored at -20 °C. 
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2.2.2 Algorithm-based search for Ak-binding peptides in murine Tg 
A computerized algorithm was developed by Altuvia et al. to identify potential Ak-
binding a.a. sequence in peptides or proteins (Altuvia et al. 1994). This approach has been 
used in our laboratory to search for A k -restricted Tg pathogenic peptides (Verginis et al. 
2002). In this study, the complete murine Tg sequence (Kim et al. 1998) was scanned for 
the presence of peptides containing either of the two 1-Ak-binding motifs, a heptamer 
motif A and a pentamer motif B, flanked by one or more Tyr residues within 5 aa 
positions from the N- or C-terminus of the motif. The website "Pole Bio-Informatique 
Lyonnais: Network Protein Sequence Analysis" (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa automat.pl?page=/NPSA/npsa pattinprot.html) was used for Tg scanning in the 
study. Peptides containing Pro residues within the motif or between Tyr residues and the 
motif were excluded because of concerns that Pro may drastically affect the secondary 
structure. 
All candidate peptides and their iodinated analogs (Table 3.1) were synthesized and 
purified by Dalton Chemical Laboratories Inc. (Toronto, Canada). F-moc-3-iodo-tyrosine 
was used for synthesis of iodinated peptide analogs. Iodine content in the noniodinated 
and iodinated analogs was confirmed by method described in Section 2.2.1. Other mouse 
Tg peptides, such as p2494 and p2596, used in the study were previously synthesized at 
the Alberta Peptide Institute (Edmonton, Alberta, Canada). All peptides were blocked 
with an acetyl group at theN-terminal end and an amide group at the C-terminal end, and 
the -SH group of the internal Cys residues was blocked by acetamide. Mass spectrometry 
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and HPLC analysis were performed on each peptide to verify composition and confirm 
>80% purity. 
2.3 CELL LINES AND TISSUE CULTURE 
2.3.1 Cell lines 
MAb-secreting B cell hybridoma clones were purchased from A TCC, including: HB 32 
(14-4-4S, mouse IgG2a against I-Ek), HB 65 (H16-L10-4R5, mouse IgG2a against 
nucleoprotein of influenza type A virus), TIB 92 (10-3.6.2, IgG2a mAb against I-Ak). 
The B cell hybridomas were cultured in a spinner flask, which contained 500 ml medium 
on the 1st day, with 500 ml of medium and 1000 ml of medium added on the 2nd and 3rd 
day, respectively. After a 5-day culture, mAbs were purified from culture supernatants by 
affinity chromatography on protein G-Sepharose 4 Fast Flow columns (Pharmacia, Baie 
d'Urfe, Quebec, Canada). 
The T-cell hybridoma 4Al2 (1-Ak-restricted, p2498-specific) and 8F9.27 (Ek-restricted, 
p2494-specific) were generated and characterized previously (Carayanniotis et al. 1994, 
Rao et al. 1994). The T cell hybridomas (4A6, lOCI and 1H7), specific for Tg peptides I-
pll7, I-p304, I-p1931, were generated following a modified method of Perkins eta/. 
(Perkins et al. 1991). Briefly, mice were primed with lOOnm of the specific Tg peptide in 
CF A, 9 days later draining LNC were removed and cultured in the presence of 20 J.!M of 
respective peptide for 3 days. These cells were then fused at 1:2 ratio with BW5147a·w 
lymphoma variant (White et al. 1989)- a kind gift from Dr. P. Marrack (National Jewish 
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Centre, Denver, CO, USA), using polyethylene glycol (Boehringer Mannheim, 
Indianapolis, IN). Fusion products were selected in medium containing IX oxanthine-
Aminopterin-Thymidine, and gradually through medium containing IX oxanthine-
Thymidine to normal medium. The specificity and sensitivity of the hybridoma was tested 
by activation assay as described below. The peptide - specific hybridomas were cloned by 
limiting dilution at 0.3 cell/well using I% syngeneic red blood cells (RBC) as feeder 
cells. 
The APC cell line TA3 (1-Akld, Ek/d), produced by fusion ofB cells from CAFI mice with 
MI2.4.1 BALB/c B lymphoma (Allen et al. I985), was a kind gift from L. Glimcher 
(Harvard medical school), and courteously provided by Dr. T. Watts (University of 
Toronto). The other two APC cell lines, LS I02.9 (I-A'115, Ed) and LK 35.2 (I-Akld, Ekld) 
are B cell hybridomas obtained from American Type Culture Collection (A TCC, 
Rockville, MD, USA) (Kappler et al. I982). The CTLL-2 cell line (ATCC) (Gillis and 
Smith I977) is was grown in DMEM supplemented with IO% IL-2-containing 
supernatants, obtained from rat splenic cells activated with 5 J..lg/ml of concanavalin-A. 
The XG6 cell line transfected with murine GM-CSF gene and spontaneously secreting 
GM-CSF (Zal et al. I994) was a kind gift from Dr. B. Stockinger (National Institute for 
Medical Research, London, United Kingdom). 
All tissue culture media including Ham's Fl2, RPMI-I640 and Dulbecco's Modified 
Eagle's Medium (DMEM) were supplemented with 10% or 5% heat-inactivated fetal 
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bovine serum (FBS) (Cansera, ON, Canada), 2mM L-glutamine, 100 U/ml penicillin, 100 
J.lg/ml streptomycin (all from Gibco). RPMI-1640 and DMEM were also supplemented 
with 20mM HEPES (Gibco) and 5 x 10-5 M2-ME (Sigma). 
2.3.2 Primary thyrocyte culture 
Fresh mouse thyrocytes were isolated from CBA/J mouse thyroid according to an 
established protocol (Caturegli et al. 2003, Jeker et al. 1999). Briefly, two thyroid lobes 
were fragmented and digested for 30 min in 250 J.ll of digestion medium, which consists 
of 112 units/ml of Type I collagenase (Sigma, St. Louis, MO) and 1.2 units/ml of dispase 
(Roche Diagnostics Corp, Indianapolis, IN) in EMEM. After digestion, thyroid follicles 
were pelleted, resuspended and cultured in a Petri dish or 6-well plate in F-12 medium 
supplemented with Nu-Serum IV (BD Biosciences), 10 ng/ml somatostatin (Sigma), and 
2 ng/ml glycyl-L-histidyl-L-lysine acetate (Sigma). 
To confirm the thyrocyte origin ofthese cells, digested thyroid sections were grown in 8-
well chamber slides (Nalge Nunc Intemationa, Naperville, IL, USA) for one week. The 
cells were fixed in acetone at -20°C for 5 min, and incubated in the presence of rabbit 
polyclonal Abs specific for human Tg which crossreact to murine Tg (DAKO, 
Carpinteria, CA, USA). Following 1 hr incubation, the cells were washed, and a 
secondary Ab, FITC-conjugated goat-anti-rabbit Abs (Sigma), were added and incubated 
for 30 min. Finally, slides were mounted in 50 % glycerol in PBS and sealed for 
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immunofluoresece imaging under an Olympus Fluoview 300 Laser scanning confocal 
microscope. 
One week after culture, thyrocyte necrosis was conducted by four freeze-thaw cycles 
from -80°C to room temperature (Fields et al. 1998, Heimberger et al. 2000, Herr et al. 
2000, Nestle et al. 1998b, Vegh and Mazumder 2003). Disruption of the cell membrane 
was measured by trypan blue staining. 
2.3.3 Generation of bone marrow-derived dendritic cells 
Bone marrow-derived DC were generated according to the protocol developed by Inaba 
(Inaba et al. 1992) and modified by Lutz (Lutz et al. 1999). As described in a previous 
study (Verginis et al. 2005), bone marrow leukocytes were collected from femurs and 
tibias of female CBA mice, and RBCs were lysed by NHtCl. The leukocytes were then 
seeded at 2 X 106 cells per 100 mm2 petri dish in 10 ml complete RPMI 1640 medium 
supplemented with 10% supernatant from the murine- GM-CSF-secreting X63Ag8 cell 
line (Zal et al. 1994). On day 3, another 10 ml of media containing GM-CSF was added to 
each plate. At days 6 and 8, half of the culture supernatant was collected, centrifuged, 
then the cell pellet was resuspended in 10 ml fresh medium containing 10 % X63Ag8 
supernatant and the cells were returned onto the original plate. On day 10, non-adherent 
cells were gently dislodged and collected for future experiments. 
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2.4 T CELL ACTIVATION/INHIBITION ASSAY 
2.4.1 T-cel/ hybridoma activation assay 
Activation of Tg peptide-specific T-cell hybridomas was performed in a 96- well flat 
bottom plate. Briefly, 105 hybridoma T cells and an equal number of APC were cultured 
for 24 h with or without the respective antigen in a total volume of 200 J..Ll/well. Then 100 
Jll of supernatant was harvested from each well, transferred into a new plate and kept 
frozen for more than 2 h at -70°C. Upon subsequent thawing, 104 CTLL-2 cells were 
added per well and 18 h later, 1 J..LCi of eH]-thymidine (PerkinElmer, Life and analytical 
sciences, Boston, MA) was added to each well in 25 J..Ll of complete medium. The cells 
were harvested 6 h later using a Harvester 96® Mach III M (Tomtec, Hamden, CT, USA) 
and incorporated radioactivity was measured using the TopCount NX'fTM microplate 
counter (Canberra Packard Canada, Mississauga, ON, Canada). 
2.4.2 T-cel/ hybridoma blocking assay 
MHC restriction of TcRs expressed on the T cell hybridoma clones was determined in a 
blocking assay. Briefly, in a 96-well plate, 105 T cell hybridomas (4A6, lOCI, 1H7) were 
cocultured with 105 LK35.2 cells in the presence of a constant amount of their respective 
ligand and serially diluted anti-A k (TIB92), anti-Ek (HB32) or control Abs (HB65). 
Following 24 h incubation, 100 Jll of supernatant was removed and stored at -20°C for 
assessment of IL-2 release by CTLL-2 assay. The data are expressed as follows: % 
inhibition= [1 - (cpm in the presence ofmAb)/(cpm in the absence ofmAb)] x 100. 
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2.4.3 T-cell hybridoma competitive inhibition assay 
A competitive inhibition assay was used to determine the peptide binding to Ak. In this 
assay, 105 Ak-restricted T-cell hybridomas (4A12, p2494-specific) were cocultured with 
105 LK35.2 cells in flat-bottom wells of 96-well plates in presence of a constant amount 
of the respective ligand (1 JlM). Serial dilutions of the inhibitor peptides (starting from 
100 JlM) were added in triplicates, in a total volume of 200 f.ll per well. Following 24 h 
incubation, 100 J.d of supernatant was removed and stored at -20°C for assessment of IL-
2 release, as measured by the proliferation of CTLL-2 line. 
2.5 T CELL PROLIFERATION ASSAY 
2.5.1 LNC proliferation assay 
Experimental mice were challenged s.c. with 100 nmol of peptide, or 100 Jlg of Tg, in 
100 f.ll of CFA). Nine days later, inguinal, axillary, and branchial In were collected 
aseptically and single cell suspensions were prepared in complete DMEM medium 
supplemented with 10% fetal bovine serum (FBS) (Cansera, Ontario, CA), 20 mM 
HEPES buffer, 2 mM L-glutamine, 100 U/ml penicillin, 100 f.lg/ml streptomycin (all from 
Gibco) and 5 x 105 M 2-ME (Sigma Chemical Co., St Louis, MO). After centrifugation 
and washing, 4 x 105 cells/well per 200 f.ll were cultured in 96-well plates for 4 days in 
the presence of titrated amounts of the appropriate antigens. During the last 18 hrs, 1 f.lCi 
of [3H]-thymidine was added to each well in 25 f.ll of culture medium. Cells were 
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harvested using the Harvester 96 ® Mach III M (Tomtec, Hamden, Ct, USA) and 
incorporated radioactivity was measured using the TopCount NXTTM Microplate 
Scintillation & Luminescence Counter (Canberra Packard Canada, Mississauga, Ontario, 
Canada). Stimulation index (S.I.) is defined as (cpm in the presence ofpeptide/cpm in the 
absence of peptide). 
2.5.2 Splenic CD,f" T cell proliferation assay 
Mice were challenged s.c. with peptide or Tg in CF A and boosted with respective antigen 
in IF A. Two weeks after boosting, spleens were collected for detection of antigen-specific 
T cells. Briefly, a single cell suspension is made in complete DMEM medium, and RBCs 
lysed by NH4CL. Splenic CD4+ T cells were isolated using MACs separation according to 
the manufacturer's instruction (Miltenyi Biotec Inc., Auburn, CA). Briefly, splenocytes 
were incubated with a cocktail of biotin-conjugated mAbs against CD8a, CD II b, 
CD45R, DX5 and Ter-119, then anti-biotin microbeads were added to the mixer. The 
magnetically labelled non-CD4+ cells were depleted by retaining them in a MACS 
column in the magnetic field of a MACS Separator. CD4+ splenocytes were cultured at 2 
x I 05 cells/well with 2 x I 05 cells/well of mitomycin-treated splenocytes or BM-DC for 3 
days in the presence of titrated amounts of the appropriate antigens in a total of 200 f..ll 
microculture in 96-well plates. During the last 18 hrs, 1 f.!Ci of eH]-thymidine was added 
to each well in 25 f..ll of culture medium. Cells were harvested and S.I. was calculated as 
Section 2.5.1. 
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2.6 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
2.6.1 Detection of IgG Ab 
The presence of Tg or peptide- specific IgG antibodies (Ab) in primed sera was 
determined by ELISA. Briefly, 96-well plates were coated with 1 J.lg of Tg or 0.2 J.lg of 
peptide in 100 J.ll of carbonate buffer (pH 9.6), and incubated overnight at 4°C. Wells 
were then blocked with PBS containing 1% BSA for 1 hr at room temperature. Plates 
were washed 3 times in PBS/Tween and incubated at 4 oc overnight with 1 :2 serially 
diluted sera with a starting dilution of 1:30. The binding of Abs in the sera to the coated 
antigen was detected with alkaline phosphatase-conjugated goat anti-mouse IgG 
antibodies (Sigma), and light absorption of p-nitrophenylate product (Sigma) at 405 nm 
was determined using a Vmax plate reader (Molecular Devices). The comparison of OD 
values of Ab ELISA was performed using t test in GraphPad Prism 4.0 software. 
2.6.2 Detection of cytokines in culture supernatants 
For activated LNC or splenic cells, cytokine production was determined in culture 
supernatants harvested after 48-h stimulation with optimal dose (5-20 J.lM) of antigen. 
Detection of IL-2, IL-4, IL-l 0, and IFN-1 was performed by sandwich ELISA using 
OptEIA ™ ELISA kits (BD PharMingen, San Diego, CA), following the manufacturer's 
protocol. Similarly, culture supernatants were collected from DC treated with various 
stimuli to determine the IL-12 content. According to the manufacturer's protocol, 96-
well polyvinyl chloride microwell plates were coated with capture Abs and blocked with 
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FBS. Cytokine standards and samples were then applied in duplicate (1 00 J.ll/well) and the 
plates were incubated at room temperature for 2 hours. The mixture of biotinylated 
detection antibodies and avidin-conjugated horseradish peroxidase were added, followed 
by the addition of substrate solution- Tetramethylbenzidine and hydrogen peroxide (BD 
Pharmingen). After incubation at room temperature for 30 min, the reaction was stopped 
by 2 N H2S04• Absorbance at 450 nm was measured by using a Vmax plate reader 
(Molecular Devices, Sunnydale, CA, USA). 
2.6.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS) 
Expression of TcR-associated surface markers on T cell hybridomas was determined by 
FACS, using FITC-conjugated hamster anti-CD3E (145-2C11) (BD Biosciences, San 
Jose, CA, USA) as well as PE-conjugated rat anti-CD4 (CT-CD4 ) or anti-CD8 (CT-
CD8a) (Caltag Lab, Burlingame, CA, USA). Similarly, flow cytometry was used to 
determine the expression of MHC class II and co stimulatory molecules on bone marrow-
derived DC using the following antibodies: PE-anti-CD11c (HL3), FITC-anti-1-Ak (10-
3.6), FITC-anti-CD80 (16-10A1), FITC-anti-CD86 (GL1), FITC-anti-CD40 (3/23), and 
FITC-anti-CD8a (53-6.7) (all from BD Biosciences). 
The experiments were performed as follows: cells were harvested, washed and 
resuspended in F ACS buffer (PBS/1% BSA/0.1 % NaN3) to a concentration of 10 7 
cells/mi. 106 cells per 100 J.ll were incubated with 1 J.lg of PE-labeled anti-CD4 Abs 
(CAL TAG laboratories, Burlingame, CA, USA) and FITC-labeled anti-CD3 (BD 
93 
Pharmingen), or similarly labeled isotype control Abs (CAL TAG laboratories). Following 
30 min incubation on ice, the cells were washed 3 times with F ACS buffer and suspended 
in 500 111 of 1x PBS buffer. The fluorescence of 104 cells was measured using BD FACS 
Calibur bench top flow cytometer and data analysis was performed by "Cell Quest Pro" 
(BD Biosciences). 
2.7 EAT INDUCTION 
2. 7.1 Immunization with Tg peptides in CFA 
Mice were immunized subcutaneously (s.c.) under ether anesthesia at 2 sites (base of the 
tail and along the back) with 100 nmol of Tg peptide in 100 111 of 1:1 emulsion of 
PBS:CFA. Three weeks later, they were boosted s.c. with 50 nmol ofTg peptide in IFA. 
Five weeks after the initial challenge, mice were bled to obtain sera for ELISA assays, 
and the thyroids were removed and fixed in 10% buffered formalin for histological 
examination. 
2. 7.2 Adoptive transfer of Tg peptide-primed LNC 
Induction of EAT by adoptive transfer of Tg peptide-primed LNC was performed as 
previously described (Rao et al. 1999). Briefly, CBA/J mice were immunized s.c. with 
100 nmol ofTg peptide in CPA and 9 days later, draining LNC (4 X106/ml) were cultured 
in the presence of the immunizing peptide (20 I!M) for 3 days. The cells were harvested 
and washed completely 3x with PBS and resuspended in PBS at 108 cells/mi. Syngeneic 
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recipient mice were intraperitoneally (i.p.) injected with 200 Jll PBS containing 2X107 
activated LNC. Fourteen days after transfer, mice were sacrificed and their thyroid glands 
were collected in 10% buffered formalin for histological examination. 
2. 7.3 Vaccination with DC exposed to Tg or necrotic thyrocytes 
Freshly isolated DC were gently dislodged and cultured overnight at 2 x 107 cells per 10 
ml in the presence of 200 Jlglml Tg, or control antigen (200 Jlg/ml ovalbumin, OVA), 
followed by treatment with lipopolysaccharide (LPS, 1 Jlglml, 6 hr). Similar numbers of 
DC were also co-cultured with approximately 2 x 106 necrotic or viable thyrocytes for 24 
hr. DC incubated with soluble antigens or thyrocytes were washed twice with PBS and 2 
x 106 cells per 0.2 ml PBS were injected i.p. into syngeneic recipient mice. Two weeks 
later, the mice were boosted with same number of similarly treated DC. Thyroid glands 
were removed 2 weeks after boosting, and were sectioned and stained with hematoxylin 
and eosin (H & E) for histological examination. 
2. 7.4 Thyroid histology 
Thyroid glands were removed and fixed in 10% buffered formalin. Fixed thyroid glands 
were embedded in methacrylate and sectioned serially (approximately 21 sections at 3.0 
Jlm intervals were obtained/gland). They were fixed to glass slides and stained with 
hematoxylin and eosin and the mononuclear cell infiltration index (1.1.) was scored as 
follows: 0 = no infiltration, 1 = interstitial accumulation of cells between two or three 
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follicles, 2 = one or two foci of cells at least the size of one follicle, 3 = extensive 
infiltration 10-40% of total area, 4 = extensive infiltration 40-80% of total area, and 5 = 
extensive infiltration >80% of total area. The highest infiltration score observed per gland 
was assigned to each mouse. Statistical comparison of EAT scores between various 
groups was performed using Wilcoxon signed rank test in GraphPad Prism 4.0 software. 
2.8 IODIDE-INDUCED HYPOTHYROIDISM 
2.8.1 Animal treatment with dietary iodine 
Female CBA/J and SJL mice at age of 4-6 weeks were purchased from the Jackson 
Laboratories (Bar Harbor, ME), and divided into two groups: control group (normal tap 
water), and Nal-treated group (0.05% Nal in drinking water for 10-12 weeks). All 
experiments were conducted in accordance with standard policies of the animal care 
committee at Memorial University ofNewfoundland. 
2.8.2 Determination of TSH and total T4 levels using radioimmunoassay (RIA) 
Serum TSH level was determined by Dr. A.F. Parlow (Harbor-UCLA Med Ctr, Torrance, 
CA, USA). The DYNOtest T4 kit was purchased BRAHMS Diagnostica GmbH (Berlin, 
Germany) for quantitative determination of total thyroxine (T4). As described in the 
manufacturer's guide, reference T4 standards and samples were added to tubes coated 
with anti-T4 antiserum, T4 labeled with 1251 was subsequently added to the tube as tracer 
to compete for antibody binding. After a 2-h incubation at room temperature, the coated 
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tubes were dried on blotting paper and radioactivity was measured in Wallac 1277 
GammaMaster (Perkin Elmer life sciences, Boston, MA, USA). The total T4 value in 
each sample was extrapolated from the T4 standard curve and expressed in J.Lg/dl. 
Statistical comparisons of serum thyroid hormone levels were performed using t test 
(GraphPad Prism 4.0 software). 
2.9 REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION (RT-
PCR) 
2.9.1 Total RNA isolation from tissues 
Total RNA of freshly obtained thyroids from CBA/J or SJLIJ mice was extracted using 
Trizol Reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's 
instructions. Briefly, tissues were homogenized using disposable RNase-free 
homogenizers in 0.8 ml (1-10 mg oftissue) or 1 ml (> 10 mg oftissue) ofTRlzol reagent. 
Following sample lysis, 200 J.Ll of chloroform (Sigma Chemicals) was added, and the 
phase separation was achieved by centrifugation. The upper aqueous phase ( ~ 600 J.Ll) was 
transferred in a new RNase-free tube and RNA was recovered by precipitation with 
isopropyl alcohol (500 J.Ll). For mRNA isolation from small tissues, 5-10 J.Lg of glycogen 
(Invitrogen) were added as carrier to the aqueous phase prior to isopropyl alcohol. The 
isolated RNA was washed with ethanol, air-dried and dissolved in RNase-free water 
(Sigma Chemicals). The RNA yield was measured using a Beckman Du®64 
spectrophotometer (Fullerton, CA, USA) at the optical density of 260 and 280 nm. 
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2.9.2 eDNA synthesis 
First-strand eDNA synthesis was carried out with total RNA using a eDNA synthesis kit 
(Amersham Bioscience, Buckinghamshire, UK). Briefly, 5 Jlg of total RNA was heated at 
65°C for 10 min to remove any RNA secondary structure, and then chilled on ice. The 
RNA was added to a mixture containing 11 Jll first-strand bulk mix and 1 Jll dithiothreitol 
(DTT) solution and 0.2 Jlg {IJ.ll) Notl-d{T)18 (all provided in the kit). The first-strand bulk 
mix contains FPLCPure ™ murine reverse transcriptase, which catalyze the reaction. The 
mixture was incubated for 1 hour at 37°C and terminated by heating at 75 °C for 10 min. 
The eDNA was stored at -20°C. 
2.9.3 Polymerase chain reaction (PCR) 
PCR was performed in 50-J.ll reactions consisting of 2 Jll eDNA, 2 J.d 10 x PCR buffer 
(Life Technologies, Invitrogen, Paisley, UK), 2 Jll of 50 mM MgCL2 (Life Technologies), 
0.4 Jll of 25 mM dNTPs; Gibco), 1.5 Jll forward primer (10 pmol/Jll), 1.5 Jll reverse 
primer (10 pmol/J.ll), 0.2 Jll PlatinumTaq DNA polymerase (Life Technologies) and 37.4 
Jll nuclease-free water. The cycling conditions were as follows: initial denaturation at 
94°C for 5 min, followed by 25-35 cycles of denaturation at 94°C for 1 min, annealing at 
55-65°C for 1 min, extension at 72°C for 1 min, and final extension at 72°C for 10 min. 
The annealing temperature in each PCR reaction was adjusted to at leat 5°C below the 
lowest melting temperature of primers to be used. When using semiquantitative RT-PCR 
to assess the expression levels of multiple transcripts from the same sample, PCR cycles 
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(25 cycles for GAPDH and Tg, and 30 cycles for other genes) were chosen so that none 
of the RNAs analyzed reached a plateau at the end of the amplification protocol, i.e. they 
were in the exponential phase of amplification. These reactions were run on a Perkin-
Elmer thermocycler (Cetus, Norwalk, CT). All primers for genes encoding Tg 
pathogenic peptides used in chapter 7 or genes involved in iodine organification used in 
Chapter 5 were and were synthesized by Integrated DNA Technologies, Inc (Coralville, 
lA, USA). In some primers, artificial start and stop codons (ATG and GAT) as well as 
unique Kpnl and Xbal restriction sites were introduced in the forward and reverse 
primers, respectively. PCR products were separated on agarose gels and were visualized 
by staining with ethidium bromide. The relative intensity of the pCR products was 
quantified by Chemilmager 4000 software (Alpha Innotech, Corp., San Leandro, CA). 
Relative expression was calculated as the ratio of the relative optical density of the Tg 
fragment to that of the ~-actin or GAPDH in the same sample and under similar 
conditions of amplification. 
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CHAPTER3 
IODINATION OF TYROSYLS IN THYROGLOBULIN GENERATES 
NEOANTIGENIC DETERMINANTS THAT CAUSE THYROIDITIS 
(This work was published in J. Immunol. 2006 May; 115 (1): 85-9. This is a modified 
version) 
Haiyan S. Li and George Carayanniotis 
Divisions of Endocrinology and Basic Sciences, Faculty of Medicine, Memorial 
University ofNewfoundland, St. John's, NL, Canada 
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3.1 ABSTRACT 
Thyroglobulin (Tg) is unique in its ability to incorporate and store available iodine in the 
form of iodotyrosyl residues. Iodination of Tg has been known to increase its 
immunopathogenicity in experimental animals, presumably through the formation of 
iodine-containing neoantigenic determinants which can elicit an autoimmune response, 
but defined pathogenic Tg peptides carrying iodotyrosyls have not yet been identified. 
We report here that a systematic, algorithm-based search of mouse Tg has delineated 
three iodotyrosyl-containing peptides that activate autoreactive T cells and cause 
experimental autoimmune thyroiditis (EAT) in normal CBA/J mice. These peptides, (aa. 
117-132, 304-318, and 1931-1945), were not immunogenic in their native form and 
iodination of tyrosyls facilitated either peptide binding to MHC or T-cell recognition of 
the peptide. These results demonstrate that iodotyrosyl formation in normal Tg confers 
pathogenic potential to certain peptides which may otherwise remain innocuous and 
undetectable by conventional mapping methods. 
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3.2 INTRODUCTION 
Among the known A-Ags, Tg is unique in its ability to incorporate and store available 
iodine in the form of iodotyrosyl residues (Dunn and Dunn 2000). This process facilitates 
thyroid hormone - i.e. T4 and T3 -formation through intramolecular coupling of specific 
iodotyrosyls, but it also has immunological consequences: enhanced iodination of Tg has 
been known to increase its immunogenicity at the T- and B-cell level as well as its 
pathogenicity in experimental animals (Champion et al. 1987, Dai et al. 2002, Saboori et 
al. 1998, Sundick et al. 1987). The mechanisms underlying these observations remain 
mostly unknown, but progress with T-cell epitope mapping in Tg has recently shed light 
on some ofthe processes involved. 
So far, thirteen Tg peptides encompassing T-cell epitopes that cause EAT have been 
identified and none of them has been classified as dominant (Carayanniotis 2003). Eleven 
of these peptides elicit EAT of considerable severity, but do not contain iodine, clearly 
highlighting that iodine atoms per se are not necessary for thyroiditogenicity. However, 
processing of HI-Tg, containing 55-70 atoms per monomeric subunit, facilitates 
generation of one of these pathogenic peptides (aa 2494-2510) (Dai et al. 2002), in 
agreement with earlier studies showing that the proteolytic degradation of Tg is affected 
by its iodine content (Dunn et al. 1983, Pouchier et al. 1983, Lamas and Ingbar 1978). On 
the other hand, experiments with Tg peptides containing hormonogenic sites have shown 
that iodine atoms can be an integral part of ligands recognized by thyroid-infiltrating T 
cells. The 12mer Tg peptide (2549-2560), containing T4 at aa position 2553 - T4(2553) -
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has been reported to elicit both proliferative and cytotoxic T-cell responses (Kong et al. 
1995b, Hutchings et al. 1992, Wan et al. 1998) and to cause lymphocytic as well as 
granulomatous EAT (Braley-Mullen and Sharp 1997). Elegant studies by Wan et al. using 
the thyronine (TO)-containing analog T0(2553) --thyronine lacks the four iodine atoms of 
T4 -- found that LNC from mice challenged with the T4(2553) peptide could not be 
cross-stimulated in vitro with T0(2553), and this regimen failed to generate effector cells 
that could transfer EAT (Wan et al. 1997). These data suggested, for the first time, that 
iodine atoms sufficiently modify the peptide-MHC complex to elicit a distinct subset of 
thyroid-infiltrating T cells that recognize only the iodinated determinant. The presence of 
the bulky two-phenyl-ring side chain is not sufficient to impart immunogenicity, since 
other T4-containing peptides were either mildy pathogenic or were devoid of 
immunogenicity (Wan et al. 1997). 
Prompted by the above observations, and by the fact that most of the iodine in Tg is found 
in iodotyrosyls outside the hormonogenic sites (Dunn and Dunn 2000), we have 
hypothesized that Tg may harbour several pathogenic T -cell epitopes that contain 
iodotyrosyls. In this study, we undertook a systematic search of Tg to localize such post-
translationally modified neoantigenic determinants that would have escaped detection in 
earlier mapping studies. Further goals were to examine whether iodine-modified epitopes 
were present in normal or HI-Tg and whether they comprised immunodominant sites. 
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3.3 RESULTS 
Iodotyrosyls alter the immunogenicity ofTg peptides. 
Since 1-A k genes are known to control susceptibility to Tg-induced EAT (Beisel et al. 
1982a, Kong et al. 1997, Vladutiu and Steinman 1987), we scanned the complete murine 
Tg sequence (Kim et al. 1998) for the presence of 1-Ak-binding motifs flanked by Tyr 
residue(s), using the algorithm described by Altuvia et al. (Altuvia et al. 1994). Twenty 
sites meeting these criteria were identified and from these, a total of 13 peptides, ranging 
in size from 11 to 17 aa residues, were synthesized in their non-iodinated or iodinated, i.e. 
iodotyrosyl-containing, form (Table 3.1). 
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Table 3.1 Tg peptides encompassing I-A k-binding motifs flanked by Tyr. 
a.a. Motif-containing Peptide synthesized Peptide 
coordinates a sequence b denotation 
107-117 iYJAPVQCDLQRVc 
121-130 CVDTEGMEv!YI VQCWCVDTEGMEy00pT p117 
182-192 DMMIFDLIHN[I NTTDMMIFDLIHN[jNR p179 
228-239 ETGLELLLDEIIXj LAETGLELLLDEIIX]DTI p226 
306-316 IXjQTVQCQTEGM GHIXjQTVQCQTEGMCW p304 
612-620 IXjAGECWCVD QCIXjAGECWCVDSRGK p610 
684-689 IXjCVDTE SECIXjCVDTEGQVIP p681 
758-765 HEQVFEwiXj PHEQVFEWYERW p757 
841-847 NIFLDPIXj c 
1354-1364 DISVGSLPDLIXj c 
1393-1404 DSKTFSADTTLIX] LHLDSKTFSADTTLIX]FL p1390 
1404-1415 IXjFLNGDSFVTSP c 
1935-1942 NDKVNNFIXj KVVLNDKVNNFIXjTRL p1931 
2029-2035 DTEVHT[j GSEDTEVHTIXjP p2026 
2135-2143 IXjPDIQNCIH c 
2306-2314 NFIVVT ANIXj A VGNFIVVTAN!YIRLG N/A 
2532-2543 DARILAAAV~ EDSDARILAAA V~SL p2529 
2542-2552 [ITjSLEHSTDDIXj VW[ITjSLEHSTDDIXjAS p2540 
2596-2609 IXjGHGSLELLADVQIXj ESIX]GHGSLELLADVQIXjAFG N/A 
2619-2626 IXjQGQFSTE SAIXjQGQFSTEEQSL p2617 
105 
a Amino acid coordinates of the motif-containing sequence were assigned according to 
the mouse Tg sequence data by Kim et al. (Kim et al. 1998) and do not include the 20 
a.a. leader peptide. 
b The Tg sequence was scanned for the presence of two I -A k binding motifs, a heptamer 
motif A (underlined) or a pentamer motifB (bold-face), by using the algorithm of Altuvia 
et al. (Altuvia et al. 1994). Only peptides with motifs flanked by one or more Tyr 
residues (in boxes), within 5 aa positions from theN- or C-terminus of the motif, were 
selected. Motif A: [DEHNQ]-{NQPY}-{PY}-[ILTV]-{PY}-{FHWYP}-
[ACFILMTVWP]; Motif B: [CDEHNQ]-{DEPY}-{PY}-[ILTV]-[DEHQN]; [ ] denotes 
inclusion and {} denotes exclusion of indicated a. a. at this position. 
c Peptides containing Pro residues within the motif or between Tyr residues and the motif 
were excluded because of concerns that Pro may drastically affect the secondary 
structure. 
d Each peptide was synthesized as a pair of non-iodinated or iodotyrosyl-containing 
analogs. 
NIA The iodinated analogs of these peptides could not be synthesized commercially. 
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To determine their immunogenicity at the T-celllevel, CBA/J mice were s.c. challenged 
with 200 nmol of each peptide analog in adjuvant and nine days later, draining LNC were 
collected and cultured in the presence of varying concentrations of the respective 
peptides. Seven out of 13 peptides elicited no response, regardless of their iodination 
status. Three Tg peptides were immunogenic in their non-iodinated form and iodotyrosyl 
formation had variable effects, as it increased (p 179), decreased (p2540) or did not alter 
(p2529) their immunogenic profile (See Chapter 4). However, Three peptides - pll7, 
p304, and p 1931 - were non immunogenic in their non-iodinated form but their 
iodotyrosyl-containing analogs induced significant LNC responses (Fig. 3.1, A,B,C) 
accompanied by IL-2 as well as IFN-y secretion in vitro (Fig. 3.1, G,H,I). Furthermore, 
each iodinated analog activated LNC that did not cross react with the non-iodinated form 
of the peptide (Fig. 3.1, D,E,F), indicating that iodine heavily influenced the 
immunogenicity as well as the antigenicity of these determinants. This was confirmed at 
the clonal T-cell level using the hybridomas 4A6, lOCI, and 1H7 which secreted IL-2 
upon culture with dendritic cells (DC) presenting I-p117, I-p304, and I-p1931, 
respectively, but did not recognize equimolar amounts of the non-iodinated analogs (Fig. 
3.2, A, B, C). All three hybridomas were Ak-restricted CD4+ T cell hybridoma clones 
(Fig. 3.3 & 3.4). The same hybridoma clones were not activated by DC processing intact 
Tg or HI-Tg, suggesting that the iodinated peptides are not immunodominant in either 
normal Tg or HI-Tg (Fig. 3.2, D, E, F). 
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Figure 3.1. Iodotyrosyls impart immunogenicity to Tg peptides. 
A,B,C, CBA/J mice (2 mice per group) were primed with the non-iodinated (O) or 
iodinated (•) form of the indicated peptides and LNC responses were tested, 9 days later, 
against the respective peptide. D,E,F, Proliferative responses of LNC from mice primed 
with indicated iodinated peptide against the non-iodinated (O) or iodinated (•) form of 
the priming peptides. G,H,I, Determination of proliferative responses (G) and cytokine 
secretion (H,I) in 48-h culture of peptide-primed LNC incubated in the presence of 20 
)lM of the respective peptide. Results are representative of 2-4 independent groups. IL-4 
and IL-l 0 were undetectable in all experiment groups. 
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Figure 3.2. T cell hybridoma clones specific for I-p117, I-p304, I-p1931 do not 
respond to the non-iodinated analogs, intact Tg or HI-Tg. 
A,B,C, IL-2 secretion by the T cell hybridoma clones 4A6, lOCI, and 1H7 cultured in the 
presence of DC and iodinated (•) or non-iodinated (O) forms of p117, p304, and p1931, 
respectively. D,E,F, Activation of the T cell hybridoma clones 4A6, lOCI, and 1H7 by its 
ligand I-pll7, I-p304, I-p1931, as well as intact Tg (D) and HI-Tg (O). Data are 
representative of two to four independent experiments. Background values ranged from 
2000-5000 cpm. 
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Figure 3.3. MHC restriction ofT cell hybridoma clones 4A6, lOCl and 1H7. 
A,B,C, IL-2 secretion upon activation of the 4A6, 1 OC 1 and 1 H7 T cell hybridoma 
clones, by its ligand I -p 117, I -p304 and I -p 1931 ( • ), respectively, as well as by anti-A k 
(A), anti-Ek (T) and control (D.) antibodies, using LK35.2 as APC. D,E,F, Activation of 
4A6, lOCI and 1H7 clones in the presence of0.5 J.LM of its specific ligand and increasing 
concentrations of the anti-Ak (A), anti-Ek (T) and control (D.) antibodies. 
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Figure 3.4 Phenotypic analysis of surface markers on the T cell hybridoma clones 
4A6, lOCl and 1H7. 
Expression ofT cell surface markers on the 4A6.3, 10C1.8 and 1H7.16 T cell hybridoma 
clones was determined by F ACS. T cell hybridoma clones were harvested and double-
stained with FITC-anti-CD3 mAb, and PE-conjugated mAbs against CD4 or CD8. 
111 
Iodotyrosyl formation promotes peptide-binding to MHC or TcR recognition of the 
peptide-MHC complex 
To investigate whether iodine enhanced the immunogenicity of these peptides by 
promoting peptide binding to MHC, we performed a competition assay using the 4A12 T-
cell hybridoma clone which was previously (Rao et al. 1994) shown to beAk-restricted, 
and reactive against the p2498 (aa 2498-2506) epitope of Tg (Fig. 3.5 A). The 4A12 cells 
were activated with 1 J!M p2498 in the presence of increasing concentrations of inhibitor 
peptides using the LK35.2 (Ak-expressing) antigen presenting cell (APC) line. It was 
observed that p 117 and p304 could not inhibit 4A 12 activation at the 10-100. J!M range 
(Fig.3.5, B, C) whereas their iodinated analogs, at equimolar concentrations, significantly 
diminished 4A12 activation. These results suggested that p117 and p304 are not Ak-
binders and that iodotyrosyl formation within these sequences promoted their binding to 
the A k molecule, leading to enhancement of their immunogenicity in CBNJ mice. In 
contrast, both the iodinated and non-iodinated analogs of p 1931 significantly inhibited the 
activation of 4A12 (Fig. 3.5 D) suggesting that, in this case, the iodotyrosyl side chain 
must face away from the MHC cleft and make direct contact with the TcR. The enhanced 
immunogenicity of I -p 1931 would result from recruitment of T cells able to recognize 
only the iodine-modified peptide-MHC complex. 
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Figure 3.5. Iodotyrosyl formation promotes peptide binding to MHC or TcR 
recognition of the peptide-MHC complex. 
A, IL-2 secretion upon activation of the 4A12 T-cell hybridoma (Ak-restricted), by its 
ligand p2498 using LK352 cells as APC. B,C,D, Activation of 4A12 in the presence of 1 
M p2498 and increasing concentrations of the inhibitor peptides shown in their 
iodinated ( •) or non-iodinated ( o) form. The mouse lysozyme peptide 46-62 ( • ), known 
to bind to A k, was used as a positive control. 
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EAT and Ab responses induced by iodotyrosl-containing Tg peptides 
The pathogenicity of I -p 117, I -p304, and I -p 1931 was subsequently tested by direct 
challenge of CBA/J mice (6 mice per group) with the corresponding peptide in adjuvant 
or by adoptive transfer of peptide-primed LNC into naive CBA/J hosts. I-p117 and I-
p 1931 elicited thyroiditis by either experimental protocol, although the severity of EAT 
was higher by the adoptive transfer method (mean infiltration index of 0.67 vs 2.33 for I-
p117, and 0.83 vs 1.67 for I-p1931) (Table 3.2 and Fig. 3.6). I-p304 was thyroiditogenic 
only by the adoptive transfer method (mean infiltration index of 0.83). At the B-celllevel, 
only I-p117 was strongly immunogenic eliciting serum IgG responses to itself and native 
Tg (Table 3.2). There was no cross reactivity with the non-iodinated analog, suggesting 
that I-p117 is localized at the surface of the intact Tg molecule. Interestingly, previous 
studies have shown that the Tyr residue at position 130 is an early iodination site in Tg 
(Lamas et al. 1989) .. 
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Table 3.2 EAT and Ab responses induced by iodotyrosyl-containing Tg peptides 
Induction of EAT 
Serum IgG response c@ 1:30 dilution 
Priming Infiltration Index (I.I.) (OD 405 nm) against 
peptide 
Mode of # of mice Priming Non-iodinated 
challenge 0 1 2 3 4 5 Mean with EAT peptide analog Tg 
I-p117 Direct a 3 2 1 0 0 0 0.67 3/6 1.321 + 0.061 0.159 + 0.014 0.547 + 0.020 
ATb 2 0 1 1 1 1 2.33 4/6 
I-p304 Direct a 6 0 0 0 0 0 0.00 0/6 0.318 + 0.006 0.147 + 0.001 0.167 + 0.003 
ATb 3 1 2 0 0 0 0.83 3/6 
I-p1931 Direct a 3 2 0 1 0 0 0.83 3/6 0.169 + 0.001 0.154 + 0.001 0.139 + 0.004 
ATb 2 0 2 2 0 0 1.67 4/6 
a CBA/J mice were s.c. challenged with 100 nmol of the indicated peptide in CFA and boosted, 3 weeks later, with 50 nmol of 
the same peptide in IF A. EAT was assessed 3 5 days after the initial challenge. 
bEAT elicited by the adoptive transfer (AT) of2 x 107 peptide-primed LNC into naive syngeneic hosts. Thyroid pathology was 
assessed 14 days post-transfer. 
c Immune sera were obtained on day 35 from mice challenged as in (A). ELISA results are expressed as mean OD values of 
duplicate wells± SD. 
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3.4 DISCUSSION 
The iodine content of Tg varies widely (0.1 - 1.0% of weight) with iodine availability, 
but on average, 19 out of the 26 atoms of iodine within each 198 dimer are stored in the 
form of mono- and di-iodotyrosines (Dunn and Dunn 2000). The present findings 
demonstrate that iodotyrosyls at residues 130, 306, and 1942 contribute to the formation 
of neoantigenic T-cell epitopes which elicit EAT in CBA/J mice. These data and the lack 
of antigenicity of the non-iodinated analogs p 117, p304 and p 1931 further suggest that Tg 
harbors iodotyrosyls at these residues under normal, steady-state conditions. Despite their 
non-dominant nature, these peptides must be generated intrathyroidally and be recognized 
by the adoptively transferred effector cells mediating EAT. Thus, the current and earlier 
epitope mapping studies (Carayanniotis 2003) delineate at least three distinct categories 
of T-cell determinants with pathogenic potential in Tg: a) T4-containing peptides in 
which iodine atoms are an integral part of the TcR ligand (Dai et al. 2005, Dawe et al. 
1996, Hutchings et al. 1992, Kong et al. 1995b); b) iodotyrosyl- containing peptides, as 
described herein; and c) non-iodinated epitopes (Carayanniotis 2003). It is yet unknown 
whether di-iodotyrosyls contribute in the formation of determinants that elicit EAT. 
Formation of pathogenic Tg epitopes by iodine presents another example of post-
translational modifications associated with autoimmune responses at both the T-or B-cell 
levels (Anderton 2004, Doyle and Mamula 2001). The bulky iodine atoms (atomic radius 
of ~ 133 pm) in the iodotyrosyl side chain can be critical in forming a TcR-contact 
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residue, as suggested by the results with the I -p 1931 peptide herein, and by earlier studies 
showing that iodine atoms on the longer thyroxyl side chain in T4(2553) influence its 
recognition by clonal or polyclonal T cells (Dai et al. 2005, Kong et al. 1995b ). In 
addition, the findings with the I-p117 and I-p304, highlight, for the first time, that 
iodotyrosyl formation facilitates peptide binding to MHC. Specific recognition of iodine-
modified Tg epitopes by B cells has been suggested by earlier studies (Saboori et al. 
1998) and is demonstrated by the observation that I-p117-specific IgG does not bind to 
p117. The Y130 residue within I-p117 was reported as an early iodination site in Tg 
(Lamas et al. 1989) but this was not confirmed by another study (Xiao et al. 1996). 
Recognition of iodine-modified Tg peptides by antibodies has been also noted even 
following formation ofpeptide-MHC complexes. For example, a mAb recognizing the 5' 
iodine atom of the outer phenolic ring of T4 has been shown to inhibit T-cell recognition 
of the T4(2553)-MHC complex (Dai et al. 2005). 
Enhanced iodotyrosyl formation, catalyzed by thyroid peroxidase (Dunn and Dunn 2000), 
may account, in part, for the increased immunogenicity of highly iodinated Tg (Champion 
et al. 1987, Dai et al. 2002, Saboori et al. 1998, Sundick et al. 1987). At the level of 
individual determinants, however, iodotyrosyls not only contribute to the formation of 
neoantigenic epitopes, but may have neutral or immunomodulatory effects as shown by 
the p179, p2529, and p2540 results (Chapter 4). Iodine atoms per se do not necessarily 
impart immunogenicity, as exemplified by I-p681 and I-p757 which encompass early 
iodination sites (Xiao et al. 1996), but are not immunogenic. In addition, the non-
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iodinated Tg peptide (306-320) was previously identified as pathogenic (Verginis et al. 
2002) whereas the overlapping non-iodinated (304-318) fragment was not immunogenic 
in this study, possibly reflecting effects of flanking residues on recognition by TcR. These 
effects will be better understood once the relative position of iodotyrosyl vis a vis the 
minimal T cell epitopes within those sequences is delineated. 
The iodine content of Tg is known to affect its structure (Edelhoch et a!. 1969) as well as 
its proteolytic degradation (Pouchier eta!. 1983, Lamas et a!. 1989, Lamas and Ingbar 
1978) and altered processing of highly iodinated Tg in APC has been shown to facilitate 
generation of cryptic non-iodinated pathogenic determinants, such as the p2494 peptide 
(Dai eta!. 2002). The I-p117, I-p304, and I-p1931 peptides are not generated by the 
processing of highly iodinated Tg in DC (Fig3.2, D, E, F), but they could be generated 
following processing of Tg-Ab immune complexes, as has been shown for other non-
iodinated determinants (Dai et a!. 1999). Lastly, enhanced iodination of Tg may exert 
immunomodulatory influences as it has been reported that removal of iodine from tryptic 
human Tg fragments converts them from immunogenic to tolerogenic (Gardine et a!. 
2003). Our results demonstrate the existence of a new group of pathogenic Tg 
determinants which cannot be detected by conventional mapping methods. While their 
potential role in the development of clinical disease remains to be elucidated, they 
provide a new insight as to how an environmental trigger (iodine supply) may influence 
the development of thyroid disease. 
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CHAPTER4 
MODIFYING EFFECTS OF IODINE ON THE IMMUNOGENICITY 
OF THYROGLOBULIN PEPTIDES 
{This is a modified version of manuscript submitted for publication) 
Haiyan S. Li, Hong Jiang and George Carayanniotis 
Divisions of Endocrinology and Basic Sciences, Faculty of Medicine, Memorial 
University ofNewfoundland, St. John's, NL, Canada 
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4.1 ABSTRACT 
We have previously shown that iodotyrosyl formation within thyroglobulin {Tg) 
generates neoantigenic determinants that are immunopathogenic. In the current study, we 
have examined iodination effects on three tyrosyl-containing Tg peptides that are 
immunogenic in their non iodinated form. We found that iodotyrosyl formation can 
enhance (p179, aa. 179-194), suppress (p2540, aa. 2540-2554), or not alter (p2529, aa. 
2529-2545) the immunogenic profiles of these peptides at the T- cell level. On the other 
hand, iodination did not alter the MHC-restriction profile of p2529 and p2540 (A k-
binders) or p179 (Ak- and Ek-binder) and did not significantly influence the pathogenicity 
of these determinants. At the B-cell level, addition of an iodine atom on Y192 in p 179 
generated a neoantigenic determinant, but analogous effects were not discernible in p2529 
or p2540. Our results demonstrate that iodotyrosyl formation can exert variable effects on 
the immunogenic behavior of Tg epitopes which may not always result in enhanced 
pathology. These findings also suggest that variations in the iodine content of Tg may 
significantly alter the hierarchy of antigenic determinants, to which the immune system 
may or may not be tolerant. 
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4.2 INTRODUCTION 
Iodide ingestion has been well known to promote development of experimental 
autoimmune thyroiditis (EAT) in autoimmune-prone animals, such as obese-strain 
chickens (Bagchi et al. 1985), BB/W rats (Allen et al. 1986) and NOD.H-2h4 mice 
(Rasooly et al. 1996). Since the iodine content of thyroglobulin (Tg) varies widely (0.1-
1% of weight) according to the environmental supply of this element (Dunn and Dunn 
2000), it has been hypothesized that the iodination level of Tg is pivotal in precipitating 
autoimmune processes leading to disease. Indeed, it has been well documented that the 
post-translational modification of Tg by iodide affects not only hormone synthesis (Dunn 
et al. 1983, Dunn and Dunn 2000), but also the immunopathogenicity of this large 
autoantigen. Thus, the iodine content in normal Tg has been shown to be essential for 
induction of Tg-specific T- and/or B-cell responses as well as thyroid lesions in humans 
and experimental animals (Champion et al. 1987, Ebner et al. 1992, Rasooly et al. 1998). 
In addition, enhanced iodination of Tg has been reported to augment its immunoreactivity 
and disease-causing potential (Champion et al. 1987, Dai et al. 2002, Saboori et al. 1998, 
Sundick et al. 1987). 
Progress in Tg epitope mapping has begun to shed light on the molecular understanding 
of these observations. Tg harbors at least three distinct subsets of pathogenic T-cell 
determinants: a) thyroxine (T4)-containing epitopes in which iodine atoms within the T4 
structure are an integral part of the T cell receptor (TcR) ligand (Dai et al. 2005, Dawe et 
al. 1996, Hutchings et al. 1992, Kong et al. 1995a); b) determinants that become 
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immunopathogenic only after incorporation of iodine into iodotyrosyl residues (Li and 
Carayanniotis 2006); and c) non iodinated epitopes (Carayanniotis 2003). Enhanced 
iodine uptake by Tg can be viewed to promote formation of neoantigenic determinants in 
(a) and (b), but also it may facilitate generation of pathogenic non iodinated epitopes via 
its effects on Tg processing in antigen presenting cells (APC) (Dai et al. 2002). In this 
study, we have examined what effects iodotyrosyl formation may have within Tg peptides 
with established pathogenicity. To this end, we have focused on three Tyr-containing 
peptides, p179 (aa 179-194), p2529 (aa 2529-2545) and p2540 (aa 2540-2554) identified 
in an earlier study (Li and Carayanniotis 2006) which are immunopathogenic in their non 
iodinated form. 
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4.3 RESULTS 
Iodotyrosyls modifY the antigenicity and immunogenicity ofTg peptides 
As described in our previous report (Li and Carayanniotis 2006), thirteen Tg peptides, 
encompassing Ak-binding motifs (Altuvia et al. 1994) flanked by Tyr residue(s), were 
synthesized as analog pairs, representing the non iodinated and iodinated, i.e. iodotyrosyl-
containing, form. Among them, three peptides - p179, p2529 and p2540 (aa sequences 
shown in Table 4.1) containing one, two or three tyrosyls, respectively - were 
immunogenic in their non iodinated form, as they induced marked specific LNC 
proliferation following their administration in CBA/J mice (Fig. 4.1A-C). However, 
iodotyrosyl formation had variable effects on their antigenicity since the same LNC 
populations cross-reacted either weakly against the iodinated analogs (responses to l-p179 
and I-p2540, Fig. 4.1A and C) or equally well (response to I-p2529, Fig. 4.1B). When 
the iodinated analogs were used as priming antigens, it was again found that iodine 
variably modified their immunogenic profile. Thus, I-p179 elicited significantly stronger 
LNC responses than p179 (S.I. = 21.2 ± 1.3 vs 15.0 ± 0.7 at 20 JlM) (Fig. 4.1A and D), I-
p2540 was less immunogenic than p2540 (S.I. = 4.54 ± 0.5 vs 9.7 ± 0.9 at 20 JlM) (Fig. 
4.1 C and F) and l-p2529 elicited equivalent responses to those obtained by p2529 (S.I. = 
13.7 ± 0.9 vs 13.9 ± 1.0 at 20 JlM) (Fig. 4.1B and E). LNC primed with the iodinated 
analogs were again variably cross-reactive with the respective non-iodinated peptides 
(Fig. 4.1D-F). These data highlighted the fact that addition of iodine atoms to Tg peptides 
may have variable effects on both their antigenic and immunogenic behavior. 
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Table 4.1 The a.a. sequence ofTg peptides used in this study. 
a.a. coordinates a Motif-containing Peptide synthesized c Peptide 
sequence b denotation 
181-192 TDMMIFDLIHN[Yj NTTDMMIFDLI~ p179 
2532-2543 DARILAAA vw!YXI EDSDARILAAA vw!YX!sL p2529 
2542-2552 IITJSLEHSTDolYj V~SLEHSTDDQQAS p2540 
a Amino acid coordinates of the motif-containing sequence were assigned according to the mouse 
Tg sequence with Swiss-Prot accession number 008710 (http://ca.expasy.org/uniprot/008710) 
and do not include the 20 a.a. leader peptide. 
b Based on the algorithm of Altuvia eta!. (Altuvia eta!. 1994), Tg peptides were selected based on 
the presence of Ak -binding heptamer or pentamer motifs (underlined). Two out of the three 
peptides also encompass overlapping heptamer or pentamer Ek-binding motifs (bold face). 
c Each peptide was synthesized as a pair of non iodinated and iodotyrosyl-containing analogs. 
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Figure 4.1. Iodotyrosyls variably modify the immunogenicity ofTg peptides. 
CBNJ mice (2 mice per group) were primed with the non iodinated (A-C) or iodinated 
(D-F) peptide as indicated and LNC responses were tested, 9 days later, against the 
respective non iodinated (O) or iodinated (•) forms of these peptides. Data are 
representative of two to four independent experiments. Background values ranged from 
2000-5000 cpm. 
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Iodotyrosyl formation in Tg peptides does not alter their MHC-restricted recognition by T 
cells 
The above T g peptides were initially identified as putative A k -binders, but further 
analysis indicated that pl79 and p2529 also encompassed an overlapping Ek-binding 
motif (Table 4.1). To investigate the MHC context in which these peptides were 
presented and whether iodination could change their MHC-binding pattern, peptide-
specific LNC recall assays were performed in the presence of titrated concentrations of 
Ak-, Ek-, or NP (control) - specific mAbs. The proliferation of p179-reactive LNC was 
blocked by Ek-specific mAbs (% inhibition = 84.17 ± 4.14), and to a lesser extent by 
mAbs against Ak (% inhibition= 47.18 ± 12.44) (Fig. 4.2), suggesting the presence of 
non overlapping p179-reactive T cell subsets restricted by either MHC molecule. In 
contrast, for p2529 and p2540, LNC proliferation was significantly blocked by A k_ 
specific mAbs (% inhibition = 59.75 ± 3.45, 80.87 ± 3.7, respectively), whereas anti-Ek 
mAbs mediated only background inhibition similar to that observed by anti-NP mAbs. 
Interestingly, the inhibition pattern of proliferation was very similar for the two analogs 
of each pair strongly suggesting that, at least for these three peptide pairs, iodination was 
not sufficient to alter the MHC-restriction profile. 
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Figure 4.2. Iodination does not alter the MHC-restricted recognition of 
immunogenic tg peptides by T cells. 
Following priming of CBA/J mice with the indicated peptide, draining LNC were 
cultured in the presence of either non iodinated or iodinated p179, p2529 or p2540 at a 
final concentration of 10 J.1M, 2.5J.1M or 10 J.1M, respectively. Serial dilutions of mAbs 
specific for Ak, Ek or influenza NP (control) were added to the culture at the 
concentrations from 10 to 0.157 Jlglml. The% inhibition data express mean± SD values 
of triplicate wells at 5 J.lg/ml of mAb and are representative of three experiments. 
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EAT and Ab responses induced by Tg peptides and their iodinated analogs 
The thyroiditogenicity of the three peptide analog pairs was subsequently tested in CBA/J 
mice (6 mice per group), following challenge with each respective peptide emulsified in 
CF A. Each of the six peptides induced very mild EAT in less than half of experimental 
animals, with mean infiltration index ranging from 0.17 to 0.67, respectively (Table 4.2 
& Fig. 3.6). Interestingly, the incidence and severity of EAT induced by the iodinated 
analogs were not significantly different from those elicited by the non iodinated peptides, 
suggesting that alterations in immunogenicity do not always correlate with the 
histopathological picture. At the B-cell level, p2529, p2540, and their iodinated analogs 
induced significant specific IgG responses which were strongly cross-reactive within each 
pair (Table 4.2). The presence of the iodine atom seemed either not to influence the 
antigenicity or immunogenicity of the peptide (p2529) or to diminish it (p2540). p 179 
was not immunogenic, but interestingly, iodination of Y192 created a new B-cell epitope, 
which elicited strong IgG responses against both I-p179 and p179 (OD 405 nm = 1.865 ± 
0.138, 1.790 ± 0.077, respectively). There was no detectable lgG reactivity against intact 
Tg in all groups, suggesting that these peptides are not likely localized on the Tg surface 
to be accessible by Abs. 
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Table 4.2. Immunopathogenic properties ofTg peptides in CBA/J mice. 
Induction of EAT a Serum IgG response 6 @ 1 :240 dilution 
Priming # ofmice (OD 405 nm) against 
peptide Infiltration Index (1.1.) with Non iodinated Iodinated 
0 1 2 Mean EAT analog analog Tg 
p179 3 2 0.67 3/6 0.207 ± 0.009 0.166 ± 0.008 0.165 ± 0.006 
I-pl79 4 0.50 2/6 1.790 ± 0.077 1.865 ± 0.138 0.170 ± 0.003 
p2529 5 1 0 0.17 1/6 3.640 ± 0.071 3.503 ± 0.087 0.181 ± 0.002 
I-p2529 5 0 0.33 1/6 3.546 ± 0.077 3.632 ± 0.093 0.194 ± 0.007 
p2540 3 2 0.50 3/6 0.986 ± 0.052 0.736 ± 0.014 0.202 ± 0.004 
I-p2540 5 0 0.33 1/6 0.544 ± 0.045 0.620 ± 0.069 0.164 ± 0.011 
a Mice were s.c. challenged with 100 nmol of the indicated peptide in CFA and boosted, 3 weeks 
later, with 50 nmol of the same peptide in IF A. EAT was assessed 35 days after the initial 
challenge. 
b Immune sera were obtained on day 35 from mice challenged as in (a). ELISA results are 
expressed as mean OD values of duplicate wells± SD. 
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Dominance/Crypticity of the immunogenic Tg peptides 
To characterize the dominance and crypticity of the Tg immunogenic peptides described 
in Chapter 3 and herein, CBA/J mice were immunized with Tg or Tg peptides in CFA 
and, 9 days later, draining LNC were collected. Generation of the Tg peptide following 
processing of intact Tg in vivo (Fig. 4.3A) or in vitro (Fig. 4.3B) was tested by a 
proliferative LNC assay. Tg-primed LNC responded in vitro significantly to the intact 
protein at 1.25 ~M, as well as to free p 179 at higher doses (20 ~M), but not to other 
peptides (Fig. 4.3 A). Meanwhile, p179-primed LNC responded to the priming peptide 
and intact Tg at equimolar concentrations (1.25 ~) (Fig. 4.3 B). In contrast, LNC 
primed with other peptides proliferated in vitro against the priming peptide, but not intact 
Tg. Therefore, we conclude that among all the newly identified immunogenic Tg 
peptides, p 179 encompasses a subdominant epitope. 
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Figure 4.3. p179 contains a subdominant Tg epitope. 
A, CBA/J mice (3-6 mice per group) were immunized with Tg and, 9 days later, LNC 
proliferation was examined in the presence of 1.25 JlM of Tg (filled bars), and 20 11M of 
non-iodinated (open bars) or iodinated (striped bars) Tg peptides, respectively. B, Primed 
LNC from CBA/J mice immunized with Tg peptides were tested against their priming 
peptide (open bars) and intact Tg (filled bars), both at a concentration of 1.25 J!M. Data 
show the mean ± SO of S.l. values of triplicate wells and are representative of 2-3 
experiments. Background cpm varied from 3000 to 6000. * Data are in courtesy of Ms. 
Hong Jiang, a M.Sc. student in the laboratory. 
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4.4 DISCUSSION 
It has been previously shown that iodotyrosyl formation imparts immunopathogenicity to 
intact but poorly iodinated Tg (Champion et al. 1987, Ebner et al. 1992, Rasooly et al. 
1998) or innocuous Tg peptides (Li and Carayanniotis 2006), at both the T- and B-cell 
levels. The major aim of the present study was to examine modifying effects of iodine on 
three Tyr-containing Tg determinants- p179, p2529 and p2540- that are immunogenic in 
their non iodinated form. At the T-cell level, addition of iodine to Y192 enhanced the 
immunogenic properties of p179, but iodotyrosyl formation at Y2542 and Y2543 did not 
alter the immunogenicity of p2529. Furthermore, simultaneous iodination of Y2542, 
Y2543, as well as Y2552 - a major hormonogenic site (Malthiery and Lissitzky 1987), 
diminished the immunogenicity of p2540 at both the T- and B-cell level. These results 
demonstrate that iodination of individual Tg determinants can either enhance or suppress 
their immunogenicity. Iodination of the Tg molecule has a net enhancing effect on its 
immunogenicity (Ebner et al. 1992, Rasooly et al. 1998, Champion et al. 1987, Dai et al. 
2002, Saboori et al. 1998, Sundick et al. 1987) because the relative number of 
neoantigenic determinants may increase (Li and Carayanniotis 2006) or some cryptic but 
non iodinated peptides may be generated (Dai et al. 2002). 
A total of 67 Tyr residues in human Tg are mainly distributed among the three families of 
cysteine-rich repetitive structures and a region near the C-terminal end of the molecule 
(Malthiery and Lissitzky 1987), but only a few of them are subject to chemical or 
enzyme-mediated iodination (Lamas et al. 1989, Xiao et al. 1996). The three peptides 
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presented herein harbor four Tyr residues, one (Y192) localized within the 1.3 domain and 
three (Y2542, Y2543, Y2552) clustered in the C-terminal region. Y2552 is a major T4 
acceptor site, mediating the early formation of mono- or di-iodotyrosine when the 
availability of iodine is low (Lamas et al. 1989, Xiao et al. 1996). The two phenyl-ring 
side chain of T4 at this site is an integral part of the (2549-60) epitope recognized by A k-
restricted, Tg-induced hybridomas, because they do not react to the Y2552-carrying 
analog (Champion et al. 1991). This observation and our current finding that p2540 is 
mildy thyroiditogenic in CBA mice, strongly argue for the presence of an additional 
overlapping T-cell epitope within the (a.a. 2540-2554) sequence. Iodination of the Y2542 
and Y2543 residues diminish the antigenicity of this epitope. In contrast, the four iodine 
atoms within T4 promote the immunopathogenicity of (2549-60) although they are not 
essential for it (Kong et al. 1995b ). Thus, iodine atoms may have variable 
immunomodulatory effects on Tg fragments depending on their positioning within a T-
cell epitope. 
The peptides described herein encompass either A k -binding motifs (p2540), or 
overlapping A k and Ek- binding motifs (p 179 and p2529), and are presented in the context 
of A k (p2529 and p2450) or Ek (p 179). These results reaffirm the predictive value of the 
algorithm by Altuvia et a!. (Altuvia et al. 1994). We have previously shown that 
iodotyrosyls flanking such motifs can facilitate MHC binding of certain Tg peptides (Li 
and Carayanniotis 2006). In this study, iodination of p179, p2529 and p2549 does not 
seem to alter the MHC context in which these immunogenic determinants are presented 
and recognized by T cells. In this case, it is likely that the bulky iodine atoms contribute 
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to the formation of critical TcR-contacting iodotyrosyl residues, as suggested previously 
for the Y1942 within I-p1931 (Li and Carayanniotis 2006), with unpredictable - i.e. 
enhancing, neutral or suppressive - effects on immunogenicity. Iodination also seems to 
influence the subdominant nature of the p 179 peptide (Fig. 4.3), overlapping with the 
human sequence (aa 181-195) that has been reported to be immunogenic and activate 
human Tg-primed splenic cells in HLA-DR3 transgenic mice (Flynn et al. 2004b). 
The iodine content of normal Tg varies according to its environmental supply (Dunn and 
Dunn 2000, Sundick et al. 1987) and alters the Tg immunoreactivity by modifying its 3-D 
structure (Berg and Ekholm 1975, Edelhoch et al. 1969) and stability to enzymatic 
degradation (Lamas et al. 1989, Xiao et al. 1996). In terms of peptide antigenicity it is, 
therefore, plausible to see diminishing effects of iodination at the T -cell epitope level and 
simultaneous enhancing effects at the B- cell epitope level as is the case for p 179 (Fig. 
lA and Table 2). The unpredictable effects iodination may have at a single epitope level 
have been also highlighted by the studies of Saboori et al. (Saboori et al. 1998) in which 
highly iodinated Tg was not recognized by a mAb (133B1) reactive to non iodinated or 
normal Tg. Our results imply that the variable iodine content of Tg may alter the 
hierarchy of available antigenic determinants. How peripheral tolerance mechanisms 
control homeostasis to an autoantigen like Tg, that is continuously and differentially 
modified by iodine, remains a fascinating but mostly unexplored area of research. 
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CHAPTERS 
INDUCTION OF GOITROUS HYPOTHYROIDISM BY DIETARY 
IODIDE IN SJL MICE 
(This is a modified version of manuscript prepared for publication) 
Haiyan S. Li and George Carayanniotis 
Division of Endocrinology and Basic Sciences, Faculty of Medicine, Memorial 
University ofNewfoundland, St. John's, NL, Canada 
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5.1 ABSTRACT 
Prolonged intake of large amounts of iodide has been reported to increase the incidence of 
goiter and/or hypothyroidism in humans, as well as in animals prone to EAT. In the 
current study, we have investigated the role of dietary iodide on the development of 
hypothyroidism, as well as thyroiditis, in strains of mice which do not develop 
spontaneous thyroiditis. Intake of Nai via drinking water for 10 weeks induced 
hypothyroidism in SJLIJ but not CBA/J mice, as indicated by elevated TSH and 
depressed total T4 values in serum, as well as formation of colloidal goiter with an 
inactive flattened thyroid epithelium. Hypothyroidism did not appear to have an 
autoimmune basis since only focal mononuclear cell infiltrates were found 
intrathyroidally, and anti-thyroglobulin Abs or increased organification of iodide were not 
detected. These phenomena were not observed in similarly treated CBA/J mice 
suggesting polymorphisms in genes controlling events downstream of iodide uptake by 
thyrocytes. Interestingly, Tg-specific, but not ovalbumin (OVA)-specific IgG responses 
were suppressed in both SJL and CBA/J mice challenged with Tg following iodide 
administration, indicating selective immunosuppressive effects of iodide on the response 
to thyroid antigen(s). Our results point to the generation of a mouse model for the study 
of iodide-induced hypothyroidism which does not seem to have an autoimmune basis. 
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5.2 INTRODUCTION 
Endemic iodide goiter was previously reported in Japanese populations consuming 
iodine-rich seaweed (Suzuki et al. 1965) and in Chinese communities drinking water with 
high iodine contents (Li et al. 1987, Zhao et al. 1998), yet both populations had normal 
thyroid function. Large quantities of iodide ingestion have also been linked to 
development of hypothyroidism, assessed by elevated serum TSH concentrations, in 
schoolchildren (Gao et al. 2004), elder subjects (Laurberg et al. 1998, Szabolcs et al. 
1997) and healthy adults (Khan et al. 1998, Konno et al. 1993, Teng et al. 2006). In some 
studies, when the iodine intake was restricted, the increased TSH levels returned to 
normal in the absence of anti-thyroid antibodies (Konno et al. 1993). These observations, 
and several instances of iodide-induced hypothyroidism in patients with underlying 
thyroid disease or with chronic non thyroidal illnesses (Markou et al. 2001 ), have strongly 
suggested that excessive iodine intake may promote the development of hypothyroidism. 
However, in many studies it remained inconclusive as to what extent this iodide effect 
had an autoimmune basis. The mechanisms underlying these phenomena remain unclear 
but it has been postulated (Roti et al. 1997) that they may involve inhibitory effects of 
iodine excess on: a) iodide organification, i.e. an inability of some subjects to escape a 
persistent Wolff-Chaikoff effect, orb) the release of T4 or T3 from the thyroid. 
Iodide administration has been also clearly shown to increase the incidence and severity 
of disease in animals prone to develop spontaneous EAT, such as OS chickens (Bagchi et 
al. 1985), BB/W rats (Allen et al. 1986) and NOD.H-2h4 mice (Rasooly et al. 1996a). Yet, 
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the effect of iodine on thyroid function remains unclear, since serum thyroid hormones 
were either not examined (Allen et al. 1986, Bagchi et al. 1985) or found unchanged 
independent of the accelerated EAT (Rasooly et al. 1996a, Yu et al. 2006b). The 
enhanced immunogenicity of HI-Tg both at the B- and T- cell level (Champion et al. 
1987, Rasooly et al. 1998, Saboori et al. 1998, Sundick et al. 1987) is believed to 
contribute to pathogenesis with the genetic background of the host playing a pivotal role. 
In addition, excess iodide administration to strains of mice and rats that do not develop 
spontaneous EAT does not induce histological changes in the thyroid (Allen et al. 1986, 
Braley-Mullen and Sharp 1997, Hutchings et al. 1999). 
The thyroid is an endocrine organ specialized to concentrate and incorporate available 
iodide into Tg, forming thyroid hormones- T4 and T3. Serum iodide is actively absorbed 
from the basolateral membrane into thyrocytes via NIS (Spitzweg and Morris 2002) and 
translocated into the follicular lumen probably via pendrin - an iodide/chloride transporter 
present in the apical membrane (Royaux et al. 2000). On the outer site of apical surface, 
iodide is rapidly oxidated and incorporated into tyrosyl residues along the Tg backbone, 
which subsequently create T4 and T3 through intramolecular coupling (Carrasco et al. 
2000). This organification process is catalyzed by TPO in the presence of an H20 2 
generator- the thyroid nicotinamide adenine dinucleotide phosphate (NADPH) oxidases 
(THOXs), also called Dual Oxidase (DUOX), which contain DUOXI and DUOX2 two 
genes (De Deken et al. 2000). The pituitary-derived TSH, the main stimulator of synthesis 
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of thyroid hormones, interacts with the its receptor (TSHR) at the basolateral membrane 
of the thyrocytes (Carrasco et al. 2000). 
Our laboratory has previously reported that HI-Tg is highly immunopathogenic in SJL 
mice - a strain which does not develop spontaneous thyroiditis - causing EAT of higher 
incidence and severity as well as stronger B- and T -cell responses than those elicited by 
normal Tg (Dai et al. 2002). In vitro experiments demonstrated that altered processing of 
HI-Tg in APC can generate the cryptic pathogenic peptide (2495-2503), and allowed us to 
postulate that Tg iodination may promote generation of pathogenic epitopes to which 
immune tolerance has not been previously established. In the present study, we thought to 
explore a corollary of these findings, i.e. that iodine administration in SJL mice might 
promote Tg iodination in vivo, and sensitization of autoreactive T cells of the host to 
p2495 or other pathogenic determinants. Unexpectedly, we observed iodide-induced 
goiter, hypothyroidism and focal thyroiditis, as well as suppression of Tg-specific 
immune responses, in these mice. 
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5.3RESULTS 
High iodine intake induces thyroid goiter and focal thyroiditis in SJL mice 
Female mice from the non autoimmune-prone strains SJL and CBA/J mice (8 mice per 
group) were provided with drinking water supplemented or not with 0.05% Nal. Ten 
weeks later, all SJL mice placed on Nai developed an approximately 4-5 fold goitrous 
enlargement in both thyroid lobes- whereas the thyroids of mice fed normal water were 
unaffected (Fig. 5.1A).The majority of the follicles in the goitrous glands were lined with 
flattened epithelial cells, suggesting metabolic inactivity and hyposecretion of thyroid 
hormones (Fig. 5.1B, C, E, F). In addition, small foci of mononuclear cell infiltration 
were observed among the thyroid follicles (Fig. 5.1D & G), in all SJL mice with high 
iodine intake with a mean 1.1. = 2 (Table 2). These microscopic and histological changes, 
were not apparent at the 3 wk and 6 wk intervals following the initiation of high iodine 
intake. In addition, these symptoms were not observed in any of the similarly treated 
CBA/J mice, suggesting influence of polymorphic genes on the biological response to 
high iodine intake. 
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Flguro 5.1. Morphological and histological appearance ofSJL thyroid glands after 
10 "k of high Nal intake. 
A. Th)roidJ from SJL mice fed nonnal••tu<r(o I & 2) O<wmr suppl<1l1Cnled "ilh 
O.OS% 1\al <• 3 & 4): 8, £. 1fuu>logi<al appeoranc:e of normallh)roid follicles: c, F. 
Thyroid follicles of goitrous glands; D, G, Focal mononucltar cell infiltrates (arro"~) 
amonalh• follicles of goitroUS glands (Magnifications: B. c. D X 200: E. F. G X 400). 
142 
High iodine intake does not lead to increased iodide organification and inhibits thyroid 
hormone release in SJL mice 
To determine whether high iodine intake led to enhanced organification of iodide we 
examined the iodine content in Tg purified from 15 SJL glands after 10 wk of Nal 
administration. It was found that Tg derived from Nal-treated mice had a lower, although 
not statistically significant, iodine content than normal Tg (13 vs 20 iodine atoms per 
monomeric unit) (Fig. 5.2). To investigate the effect of iodide on thyroid hormone 
release, serological determination of TSH and total T4 was performed in 35 SJL mice (7 
mice per group per time point) at 1, 3, 6, and 10 wk following administration ofNal or 3 
wk after its withdrawal. An equal number of mice were used as controls. As shown in 
Fig.5.3A, the mean total T4 concentration in the experimental group was significantly 
lower than that of the control group (2.6 vs 3.6 Jlg/dl, p<0.0001), as early as I wk 
following iodide administration. This difference remained significant until 10 wk (1.9 vs 
3.0 flg/dl, p<0.0001) when goiter formation became evident (Fig. 5.3A). A compensatory 
elevation in mean serum TSH concentration (1.36 vs 0.90, 1.41 vs 1.03, 2.62 vs 0.98, 
3.83 vs 104 ng/ml at w1, w3, w6, w10, respectively) was observed in Nal-treated SJL 
mice vs the controls (Fig. 5.3B). Three weeks after Nal withdrawal, the mean total T4 
value increased (2.5 Jlg/dl), approaching that of the control group (2.8 Jlg/dl), and the 
mean TSH level decreased but remained significantly higher than that of the controls (218 
vs 100 ng/ml) (Fig 5.3 A& B). In contrast, hypothyroidism was not observed in CBA/J 
mice fed Nal at I, 3 and 6 wk (data not shown) or 10 wk (Fig. 3 A&B). These data 
suggested that high iodine intake exerted a prolonged inhibitory effect not only on 
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intrathyroidal iodide organification, but also on thyroid hormone release in SJL mice, and 
that this phenomenon was under the influence of polymorphic genes since it was not 
observed in CBA/J mice. 
144 
A o.5 
8 
C) 
~ 
(.) 
·.:::: 
Q) 
E 
:s 
... 
Q) 
Q. 
en 
E 
0 
-
C'G 
.5 0.4 
E ) 0.3 
8 0.2 
<l 0.1 
0.0+----r--r---r-----r--, 
0 1 2 3 4 5 
Iodine (nmoles/400 J.1l) 
p = 0.002 
SJL CBA 
D Iodinated Tg 
~ T g {Nal-treated) 
• NonnaiTg 
Figure 5.2. Determination of iodine content in Tg preparations. 
A, Reduction of absorbance at 410 nm in the first 60 s of the I -catalyzed Ce-As reaction 
as a function of I added (supplied as T4); B, Iodine content in normal Tg (filled bars), Tg 
purified from 15 goitrous glands 10 wk after the initiation of 0.05% Nai intake (striped 
bars) or Tg maximally iodinated in vitro by the Iodogen method (open bars), extrapolated 
from the standard curve. Results are expressed as mean values of two independent assays 
on the same Tg preparation± SD. Statistical analysis is performed in Graphpap Phrism 
using one-way ANOV A. 
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Figure 5.3. Determination of thyroid hormone levels in the sera of SJL and CBA/J 
mice. 
Sera were collected at lw, 3w, 6w and lOw after placing the animals on normal water (O) 
or water containing 0.05% Nal (•). After 10 wk ofNal supplementation some mice were 
placed on normal water for 3 more weeks (+3 w). A, Determination of total T4; B, 
Determination ofTSH. *, p<0.05; **, p<O.OOOI; n.s., not significant. 
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High iodine intake suppresses Tg-specific responses 
In order to assess whether the goitrous hypothyroidism was associated with an immune 
response to mouse Tg- the major thyroid autoantigen, splenocytes and sera from SJL or 
CBA/J mice, fed Nai for 10 wk, were tested against Tg, using OVA as a control. Neither 
T- nor B-cell responses to Tg were detected in these animals (Table 5.1). To further 
examine whether Nai intake predisposed SJL or CBA/J mice to mount an increased 
immune response to Tg, animals (nine mice per group) were placed on Nai for 10 wk and 
were subsequently immunized s.c.with 100 J..lg Tg or OVA in CF A. Nine days later, 
lymphocytes from draining LN as well as sera, were collected. Surprisingly, Tg-specific 
LNC or IgG responses were markedly suppressed in Nai-treated SJL as well as CBA/J 
mice in comparison to control mice placed on normal water (Fig. 5.4 A,C,E,G). This 
effect was antigen-specific because a similar decreased cellular or humoral response was 
not observed in mice challenged with OVA (Fig. 4 B, D, F, H). Yet, Nai-treated SJL- but 
not CBA/J - mice developed more severe EAT upon immunization with Tg (data not 
shown). These results demonstrated that the goitrous hypothyroidism of SJL mice is not 
associated with an autoimmune response to Tg. Instead, a selective down regulatory 
effect of high iodine intake on the immune response to Tg was evident in both SJL or 
CBA/J mice, indicating that this effect does not contribute to the development of 
hypothyroidism. 
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Table 5.1 Effects of high iodine intake on induction of thyroiditis and Tg-specific immune responses. 
Direct induction of thiroiditis a Splenocyte proliferative Serum IgG response c ( 405 
Strain of assay b in vitro (S.I.) nm) against 
mouse Infiltration Index {1.1.} against 
Drinking Tg OVA Tg OVA 
water 0 1 2 3 4 5 Mean Incidence 
SJL Normal 8 0 0 0 0 0 0.0 ± 0.0 0/8 0.91 ±0.14 1.28 ± 0.20 0.091 ± 0.002 0.130 ± 0.003 
Nal 0 6 1 0 0 2.0 ± 0.5 8/8* 0.98 ± 0.21 1.23±0.18 0.092 ± 0.001 0.135 ± 0.002 
CBA/J Normal 8 0 0 0 0 0 0.0 ±0.0 0/9 1.30 ± 0.32 1.08 ± 0.17 0.120 ± 0.018 0.130 ± 0.014 
Nal 8 0 0 0 0 0 0.0 ±0.0 0/9 1.82 ± 0.48 1.12 ± 0.24 0.114 ± 0.009 0.132 ± 0.021 
a SJL and CBA/J mice, treated with 0.05% Nal for 10 weeks, were sacrificed and assessed for thyroiditis induction. 
b Splenocytes were collected from mice challenged as in (a). S.l. values represent mean± S.D. values of triplicate wells in the 
presence of 40 J.tg/ml ofTg or OVA, respectively. Results are representative of2-4 independent experiments. 
c Sera were obtained from mice treated as in (a) and diluted at 1:50 in PBS/Tween/0.1% BSA. ELISA results are expressed as 
mean OD values of duplicate wells± SD. 
*, p = 0.0002. 
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Figure 5.4. Suppressive effects of high iodine intake on Tg-specific humoral and 
cellular immune responses in SJL and CBA/J mice placed on normal tap water (O) 
or water containing 0.05% Nal (•) for 10 wk. 
A-D, Mice were challenged with Tg or OVA in CF A and nine days later, recall LNC 
responses to the respective antigen were monitored in vitro. Data represent the mean S.l. 
values of triplicate wells and are representative of two independent experiments. 
Background cpm ranged from 2000-5000; responses to the control antigen were 
undetectable; E-H, serum IgG responses from the mice described above against Tg (E & 
G) or OVA (F & H). 
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Intrathyroidal expression of genes involved in iodide transportation and organification 
To identify candidate genes that might account for the development of goitrous 
hypothyroidism, we examined by RT-PCR (30 cycles, listed in Table 5.2) the expression 
levels of thyroidal mRNA encoding Tg, TSHR, NIS, Pendrin, TPO, DUOX1 and DUOX2 
at 1 or 10 wk following Nal administration (4 mice per group). It was found that the 
TSHR mRNA was significantly upregulated at 10 wk in hypothyroid SJL mice but not in 
similarly treated euthyroid CBA/J mice (Fig. 5.5 A, B). At the same time, the high iodine 
intake downregulated significantly the NIS mRNA expression in CBA/J mice. In contrast, 
the intrathyroidal expression of NIS mRNA in SJL remained unchanged throughout the 
duration of the experiment and was not significantly different between mice placed on 
Nal vs the controls (Fig. 5.5 A, B). No significant differences were observed regarding 
the relative mRNA expression of the other genes in hypothyroid vs euthyroid mice. 
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Table 5.2. The sequences of PCR primers used in Chapter 5 
Gene Primers Tm Product 
Size (bp) 
Tg Forward CGGGTACCATGGGGCTTATCAATAG 76 
654 
Reverse CGTCTAGATCATGCATCCTTGGCTC 76 
TSHR Forward TGCAACTTGGCCTTTGCAGAT 65.2 
520 
Reverse CCATCCTCTTGGCAATCTTGG 64 
NIS Forward TCTTCCTGGCCTGTGCCTACA 65.3 
506 
Reverse GCCCGAGTCCATTCCAGAACT 64.9 
Pendrin Forward TCCGAACTCCCGGTGAAAGTGAAT 60 
521 
Reverse TAACAGTAAGCGGATGGCTGCTGA 60 
TPO Forward GCACCTTGGATCTGGCATCAC 65.2 
502 
Reverse TGTGGGAAGGTCTCCCTCCAT 65.2 
Duox1 Forward TGGAGACCTTCTTCAGGCACCTTT 59.9 
555 
Reverse TCTTGATCACTTCCGGCACTTCCA 60 
Duox2 Forward TATGGCTGCAGTTGTCCTAGCTGT 59.9 
305 
Reverse TAGACACCAGGGTGGGGTCACAGA 60.8 
GAPDH Forward CCATCACCATCTTCCAGGAG 62 
577 
Reverse CCTGCTTCACCACCTTCTTG 62 
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Tg (654 bp) 
TSHR (520 bp) 
NIS (506 bp) 
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----
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Figure 5.5. Intrathyroidal mRNA expression of candidate genes involved in iodide 
transportation and organification. 
A, RT-PCR analysis of samples obtained from animals (4 mice per group) after 1 and 10 
wk of high iodine intake or controls. B, Relative expression of mRNA encoding TSHR 
and NIS in control (open bars) or Nal-treated (filled bars) SJL and CBA/J mice. Relative 
expression was calculated as the ratio of the optical density of the target gene band to that 
of the GAPDH band in the same sample and under similar conditions of amplification. 
The data represent the mean ± SD of 2 independent experiments. 
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5.4 DISCUSSION 
The current study was initiated to investigate the effects of intrathyrodial formation of HI-
Tg, via incorporation of enriched dietary iodine (Sundick et al. 1987), on the development 
of EAT. Serendipitously, we found both iodide organification and thyroid hormone 
release were significantly inhibited in SJL, but not CBA/J mice after 10 weeks' Nal 
administration, leading to the development of goitrous hypothyroidism. Our results are in 
concordance with previous epidemiological reports in humans (Gao et al. 2004, Khan et 
al. 1998, Konno et al. 1993, Laurberg et al. 1998, Szabolcs et al. 1997, Teng et al. 2006) 
and experimental findings in puppies (Castillo et al. 2001), representing the first murine 
model of iodide-induced hypothyroidism in a non autoimmune-prone strain. The 
hypothyroidism induced by excessive iodide intake is reversible after iodide withdrawal, 
confirming earlier studies in humans (Konno et al. 1993, Vagenakis et al. 1973). Our 
findings also highlight, for the first time, the critical role of genetic factors on iodide 
metabolism and provide a possible explanation for the prevalence of iodide-induced 
goiter and/or hypothyroidism in apparently healthy individuals (Gao et al. 2004, Khan et 
al. 1998, Konno et al. 1993, Laurberg et al. 1998, Szabolcs et al. 1997, Teng et al. 2006). 
The mild infiltration in these goitrous glands, together with the suppressed anti-Tg 
responses, indicate the development of iodide-induced hypothyroidsm is unlikely due to 
an anti-Tg reactivity (Kimura et al. 2005). The decrease in autoimmune reactivity against 
Tg was reported previously in Wistar rats placed on 0.05% Nal-supplemented drinking 
water (Mooij et al. 1994a). The mechanisms underlying this phenomenon are uncler, but 
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the effects of iodide on synthesis, release and antigen processing of Tg (Rasmussen et al. 
2002, Dai et al. 2002, Fouchier et al. 1983) may interfere the homeostasis of Tg-specific 
autoreactive T cells and/or Treg. Of note, we need to keep in mind that autoimmune 
responses against other thyroid A-Ags may develop following iodide administration, 
which have not been tested in the current study. It was reported in NOD- H2h4 that spenic 
T cell responses to TPO were detected three weeks after iodide administration, but no 
anti-TPO Abs were found at this or later time points (Allen et al. 1987). We do not know 
in the current murine model, however, whether goitrous hypothyroidism and EAT occur 
independently or synergistically. In other models, excessive iodide administration has 
been shown to induce goiter and hypothyroidism in hemithyroidectomized rats regardless 
of EAT development (Allen et al. 1986), or to strikingly increase the incidence of EAT in 
BB/W rats in the absence of hypothyroidism (Wolff and Chaikoff 1948, Wolff et al. 
1949). These findings argue that iodide-induced hypothyroidism occurs on an 
autoimmune basis. 
Large amounts of iodide have been shown to inhibit thyroid hormone biosynthesis (the 
"Wolff-Chaikoff effect") (Wolff et al. 1949) and its release (Vagenakis et al. 1973), 
caused by high levels of intrathyrodial iodide. Normal subjects, such as CBA/J mice 
herein, exposed to chronic iodide excess, do not develop hypothyroidism due to so-called 
"adaptation" or "escape" phenomenon (Eng et al. 1999, Eng et al. 2001, Ferreira et al. 
2005, Spitzweg et al. 1999b, Uyttersprot et al. 1997). It was suggested that this "escape" 
is mediated by a significant decrease in NIS expression following iodide administration 
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(Belshaw and Becker 1973, Mahmoud et al. 1986). In this study, we observed a 
significant reduction in intrathyrodal NIS mRNA mice following iodide administration in 
CBA/J, but not SJL mice. Expression of pendrin, another iodide transporter in the apical 
membrane of thyrocytes, did not differ before and after iodide administration in both SJL 
and CBA/J mice, which are in agreement with in vitro findings in a rat thyrocyte line 
FRTL-5 (Royaux et al. 2000). The unaffected NIS expression in SJL mice at the mRNA 
level, and possiblely at the protein level, may facilitate the uptake of iodide in the 
basolateral membrane of thyrocytes and increase intrathyroidal iodide concentrations in 
the presense of high iodide intake, leading to a prolonged "Wolff-Chaikoff effect". The 
elevated intrathyroidal iodide will probably continue exert their inhibitory effects on 
iodide organification to generate lowly iodinated Tg, as seen in SJL mice herein (Fig. 
5.2), and lead to the decrease in thyroid hormone synthesis and release (Fig.5.3). 
Interestingly, serum total T4, but not TSH, appeared to decrease with age in SJL mice 
placed on normal water, and this phenomenon has not been reported previously. 
However, serum total T4 in approximately 18w-old CBA/J mice was maintained at 
similar levels as in 9w-old SJL mice. It is unknown whether there exist age-related 
thyroid abnormalities in SJL mice, which may predispose the animals to iodide-induced 
hypothyroidism. 
The highly elevated intrathyroidal iodide level may interferes with thyrocyte growth and 
induces thyrocyte necrosis in situ due to its toxic effects (Gallucci and Matzinger 2001). 
These injured thyrocytes may lose their capability of thyroid hormone synthesis and 
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release, causing the development of goitrous hypothyroidism. Furthermore, disruption of 
cellular intergrity during cell necrosis releases many kinds of inflammatory stimuli, 
referred to "danger signals" (Drakesmith et al. 2000, Ludewig et al. 1999, Turley 2002), 
which may recruit the mononuclear cells into thyroid gland, leading to EAT. The 
presence of infiltrating cells may further accelerate the disfunction of thyroid follicles. 
Further studies are needed to define the polymorphic genes that confer SJL mice 
susceptibility to iodide-induced hypothyroidism and to determine the mechanisms 
underlying this phenomenon. 
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CHAPTER6 
MATURATION OF DENDRITIC CELLS BY NECROTIC 
THYROCYTES FACILITATES INDUCTION OF EXPERIMENTAL 
AUTOIMMUNE THYROIDITIS 
(This work was published in Clin. Exp. Immunol. 2006 May; 115 (1): 85-9. This is a 
modified version) 
Haiyan S. Li, Panayotis Verginis and George Carayanniotis 
Divisions of Endocrinology and Basic Sciences, Faculty of Medicine, Memorial 
University ofNewfoundland, St. John's, NL, Canada 
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6.1 ABSTRACT 
DC maturation is required for efficient presentation of autoantigens leading to 
autoimmunity. In this report, we have examined whether release of tissue antigens from 
necrotic thyroid epithelial cells can trigger DC maturation and initiation of a primary 
antiself response. DC were co-cultured with either viable (VT/DC) or necrotic (NT/DC) 
thyrocytes, and their phenotypic and functional maturation as well as immunopathogenic 
potential were assessed. Significant up-regulation of surface MHC class II and 
costimulatory molecule expression was observed in NT/DC but not in VT/DC. This was 
correlated with a functional maturation of NT/DC, determined by IL-12 secretion. 
Challenge of CBA/J mice with NT/DC - but not with VT/DC - elicited Tg-specific IgG 
as well as Tg-specific CD4+ T-cell responses and led to development of experimental 
autoimmune thyroiditis. These results support the view that thyroid epithelial cell necrosis 
may cause autoimmune thyroiditis via maturation of intrathyroidal DC. 
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6.2 INTRODUCTION 
DC, loaded with self proteins or peptides, are to provoke organ-specific autoimmune 
diseases (Knight et al. 1988). This was first observed in EAT with Tg-pulsed DC 
(Watanabe et al. 1999) and was later confirmed in the same (Dittel et al. 1999, Weir et al. 
2002) or other animal models (Turley 2002). These observations, the unrivalled capacity 
of DC to activate na'ive T cells, and the detection of DC in lesions associated with 
numerous autoimmune diseases (Canning et al. 2003, Many et al. 1995, Hala et al. 1996, 
Voorby et al. 1990), including thyroiditis (Hawiger et al. 2001, Turley 2002, Veeraswamy 
et al. 2003, Lutz and Schuler 2002), have strongly argued for DC involvement in the 
initiation of autoimmunity. The maturation stage of DC seems to play a pivotal role in 
this process: under homeostatic conditions, immature DC are believed to continually 
transport autoantigens to draining lymph nodes, process and present them to cognate T 
cells in a sub-stimulatory context, leading to T-cell tolerance (Gallucci and Matzinger 
2001). Under the influence of endogenous "danger signals" released by tissues 
undergoing stress, damage or abnormal death, or exogenous danger signals elaborated by 
pathogens, DC undergo maturation (Gallucci et al. 1999, Guermonprez et al. 2002, Sauter 
et al. 2000). During this terminal differentiation stage, DC generate high levels of 
peptide-MHC class II complexes on their surface and up-regulate costimulatory molecule 
expression, emerging as ideal APC for na'ive T -cells. 
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Necrotic cells, i.e. disintegrated cells which have released their cell contents prior to their 
ingestion by phagocytes, can cause mouse and human DC maturation in vitro (Savill et al. 
2002). However, the implications of these findings in the induction of organ-specific 
autoimmunity have not been adequately explored. Primary necrosis is triggered by 
noxious stimuli such as toxins, hypoxia and extremes of temperature (Li and Boyages 
1994, Bagchi et al. 1995, Ruwhof and Drexhage 2001a), whereas secondary necrosis 
refers to the eventual disintegration of cells that have initially undergone apoptosis but 
have not been captured by phagocytes. To the extent that chronic dietary iodine excess is 
known to have toxic effects on thyrocytes of animals prone to autoimmunity (Verginis et 
al. 2005, Macatonia et al. 1995), we sought in this study to test: a) whether necrotic 
primary thyrocytes can mediate maturation of DC; and b) whether DC that have ingested 
syngeneic necrotic thyrocytes can elicit EAT or thyroid antigen-specific responses, 
following their adoptive transfer in CBA/J hosts. LPS-matured DC loaded with Tg, the 
major thyroid antigen, were used as controls in the study to ensure the efficiency ofT cell 
priming by DC. 
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6.3 RESULTS 
Generation ofTg-secreting thyrocytes 
Primary thyrocytes were freshly prepared from CBA/J mouse thyroids, and cultured in 8-
well chamber slide in complete F-12 medium. After one week, thyrocytes were washed in 
PBS and treated with rabbit anti-Tg antibodies (primary antibody) and FITC-labeled goat-
anti-rabbit antibodies (secondary antibody). Thyrocytes directly labeled with secondary 
antibodies were used as control. As shown in Fig. 6.1, almost 100% of the cultured cells 
showed Tg labeling in their cytoplasm, confirming their thyrocyte origin. 
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Figure 6.1. Immunofluorescent labelin& of Intracellular T& Jn primary thyrocytes. 
A. Primal') Ill) 1"0<)1« "<re oolated from CBA,J mice. culrur.d f0t 7 da)-s, and <lained 
with rabbit nnti-Tg antibody followed by FITC-goat anti-robbit antibodies. 8, Control 
thyrocytes "ere stained "'ith second antibody only. 
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Necrotic thyrocytes stimulate DC maturation 
Necrotic thyrocytes were induced by 4 cycles of freeze- thaw as described in Chapter 2. 
To test whether exposure to necrotic thyrocytes triggers DC maturation, phenotypic 
markers of DC, co-cultured with necrotic (NT/DC) or viable thyrocytes (VT/DC) for 24 
hours, were assessed by flow cytometry. DC treated with LPS (LPS/DC) or untreated DC 
were used as controls. The expression of MHC class II, CD80, CD86, and CD40 markers 
in VT/DC, (70%, 70%, 31% and 4%, respectively), was similar to untreated DC (Fig 
6.2A). In contrast, these markers were significantly up-regulated in NT/DC (87%, 88%, 
48% and 9%, respectively) (Fig 6.2A), as well as in LPS/DC with the exception of CD86 
and CD40 which were higher in LPS/DC (68% and 29%, respectively). IL-12 secretion, a 
critical parameter of DC functional maturation (Ma et al. 2005), was also monitored by 
sandwich ELISA in culture supernatants. As shown in Fig 6.2B, necrotic, but not viable, 
thyrocytes activated DC to release significantly higher amounts of IL-12 (approximately 
400 pg/ml) than those found in cultures of untreated DC ( < 20 pg/ml). These data clearly 
demonstrated that exposure to necrotic thyrocytes can trigger both phenotypic and 
functional DC maturation. 
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Figure 6.2. Phenotypic and functional analysis of DC. 
A, Phenotypic analysis of DC after exposure to various stimuli by double labeling with 
PE-anti-CD 11 c mAb, and FITC-conjugated mAbs against MHC class II, CD80, CD86 or 
CD40. B, Functional analysis of DC exposed to the same stimuli as in (A), as determined 
by IL-12 secretion in the culture supernatants. The results are expressed as means ± S.D. 
of triplicate wells. Data are representative oftwo independent experiments in (A) and (B). 
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DC exposed to necrotic thyrocytes elicit Tg-specific T- and B-cell responses. 
To test the immunogenic potential of DC exposed to necrotic or viable thyrocytes, CBA/J 
mice (8 mice per group) were i.p. challenged twice (on d1, d15) with 2 x 106 NT/DC or 
VT/DC. Additional groups of mice received the same number of Tg- or OVA- loaded, 
LPS-matured DC (Tg/DC, OVA/DC). It was observed that splenic CD4+ T cells exhibited 
low but significant proliferative responses to Tg following priming with Tg/DC or 
NT/DC (S.I. = 3.3 ± 0.4 or 3.2 ± 0.6, respectively) (Fig 6.3A). In contrast, Tg-specific 
proliferative responses were undetectable in mice challenged with OVA/DC or VT/DC. 
Significant amounts of IL-2 and IFN-y were detected in culture supernatants of Tg/DC-
and NT/DC-activated CD4+ T cells (Fig 6.3 B,C), whereas IL-4 or IL-10 were 
undetectable (data not shown). As expected, challenge with OVA/DC elicited strong 
OVA-specific proliferative T-cell responses and IL-2 or IFN-y release. Interestingly, mice 
challenged with NT/DC mounted strong Tg-specific lgG responses which were 
significantly higher than those detected in the sera of Tg/DC-challenged mice (Mean OD 
405 nm = 1.195 vs 0.548, p<0.001) (Table 6.1). These results demonstrated that NT/DC 
were strongly immunogenic, as they could initiate both B- and T -cell responses against 
T g, the most abundant thyroid antigen. 
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Figure 6.3. NT/DC induce Tg-specific Thl responses. 
Response to 
.Tg 
DOVA 
A, On d1 and d15, CBA/J mice received an i.p.injection of 2 x 106 DC exposed to the 
stimuli shown. Two weeks after the last challenge, purified splenic CD4+ T cells were co-
cultured with syngeneic mitomycin C-treated DC (APC) to test recall proliferative 
responses to Tg or OVA. Data represent the mean S.l. values of triplicate wells, obtained 
at antigen concentration of 100 J..Lg/ml. Background cpm ranged from 1600 to 2200. B,C, 
Cytokine determination by sandwich ELISA in 48-h supernatants of the corresponding 
cultures is shown in (A). Results are representative of two separate experiments. 
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Table 6.1. EAT and IgG responses induced by DC exposed to various stimuli 
Induction of EAT Serum IgG response (OD 405 
om) against 
Infiltration Index (I.I.) # of 
mice 
0 1 2 3 Mean±SD with Tg OVA 
EAT 
NT/DC 4 2 1 1 0.88 ± 1.13 4/8 1.195 ± 0.010 0.193 ± 0.006 
VT/DC 8 0 0 0 0.00 0/8 0.285 ± 0.021 0.176 ± 0.005 
Tg/DC 3 1 1 3 1.50 ± 1.41 5/8 0.548 ± 0.001 0.197 ± 0.006 
OVA/DC 8 0 0 0 0.00 0/8 0.192 ± 0.004 1.615 ± 0.010 
CBA/J mice (8 mice per group) were i.p. challenged with 2 x 106 of the indicated DC and 
boosted, 2 weeks later, with the same number of DC. Thyroids were removed 28 days 
after the initial challenge for EAT assessment. At the same time, immune sera were 
collected, pooled and diluted at 1 :30 in PBS/Tween/0.1% BSA for IgG determination. 
ELISA results are expressed as mean OD values of duplicate wells± SD. 
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DC exposed to necrotic thyrocytes mediate EAT development 
To assess the pathogenicity of NT/DC, the thyroids of CBA/J mice (8 mice per group) 
treated as described above, were obtained on day 28 for histological assessment. As 
shown in Table 6.1, four out of eight mice receiving NT/DC developed EAT (mean 1.1.= 
0.9 ± 1.1) with thyroid infiltration indices ranging from 1-3 (Fig. 6.4). The EAT 
incidence was similar to that of the group challenged with Tg/DC, since five out of eight 
mice presented with thyroiditis, albeit of higher severity (mean 1.1.= 1.5 ± 1.4). 
Mononuclear cell infiltration of the thyroid was undetectable in mice challenged with 
either VT/DC or OVA/DC. These data directly support the notion that DC which engulf 
necrotic thyroid epithelial cells can initiate an autoimmune response leading to 
development of thyroiditis. 
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figure 6.4. Histological appnronce or £AT elicited b) :-o'TIDC. 
On dl and diS, CBNJ mice were i.p. chollenj~ed with 2 x 106 indicated NT/DC. Two 
v.eeks after boosting, lhe mice "ere sacrifteed and lhe thyroid glands were removed for 
EAT assessment. (A) 1\onmal gland, 1.1. • 0: (B) Interstitial accumulatK>n of 
inflammatory cells (nrrows), 1.1. • I; (C) One or two foci of inflammatory cells (arrows), 
1.1. 2 2; (0 ) Diffuse infiltration, 10-40'/0 of total area (arrows), 1.1.= 3. Ma~~J~ification: x 
100. 
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6.4 DISCUSSION 
Our present findings show that DC which have captured necrotic thyrocytes can undergo 
maturation, and enable the immunogenic presentation of thyroid antigen(s)- such as Tg-
on their surface, leading to development of EAT. To our knowledge, this is the first report 
showing that DC can precipitate an organ-specific autoimmune disease following 
ingestion of necrotic epithelial tissue. Analogous findings have been recently reported for 
a model of a systemic autoimmune disease in which DC ingesting necrotic splenocytes 
induced strong anti-dsDNA antibody responses and accelerated disease progression in 
lupus-prone mice (Golstein and Dumont 1996, Many et al. 1992). Excess iodide is well 
known to bring about thyrocyte necrosis both in vitro (Bagchi et al. 1995) and in 
experimental animals prone to thyroiditis such as OS chickens (Li and Boyages 1994), 
BB/W rats (Many et al. 1995) and NOD mice (Basaria and Cooper 2005). In humans, 
administration of the potent anti-arrhythmic drug amiodarone, which is very rich in 
iodine, has been linked to the pathogenesis of thyroiditis, possibly through the release of 
autoantigens from the injured thyroid (Arscott and Baker, Jr. 1998). Factors that promote 
enhanced apoptosis of thyrocytes (Ip and Lau 2004) may also contribute in these 
processes since apoptotic cells may undergo secondary necrosis if not removed in time 
(Ishii et al. 2001 ). 
The maturation stimuli released by the disintegrated necrotic thyrocytes are unknown but 
may include genomic DNA (Basu et al. 2000), heat shock proteins (Rovere-Querini et al. 
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2004), the high-mobility group B1 protein (Shi et al. 2003) or uric acid (Canning et al. 
2003). Under the conditions described herein (i.e. culturing of necrotic thyrocytes with 
DC at a 10:1 ratio), it is evident that enough antigenic material can be released to induce 
Tg-specific Th1 responses which were similar in magnitude to those obtained by DC 
loaded with purified Tg. Intrathyroidal DC are prime candidates for antigen capture in 
vivo and a small increase in the number of DC, clustering in the thyroidal interstitium, is 
one of the first signs of developing autoimmunity (Moine et al. 1994). Thyroid tissue, 
obtained predominantly from patients with Graves' disease, shows the presence of 
perifollicular immature DC at the basal surface of thyrocytes, with long cytoplasmic 
protrusions which penetrate the tight junctions between adjacent thyrocytes (Quadbeck et 
al. 2002). In addition, mature DC have been observed within lymphoid - like clusters in 
close proximity to CD4+ T cells (Sallusto and Lanzavecchia 1999) in agreement with the 
concept that mature DC that fail to migrate to lymph nodes may serve as nucleation sites 
for chronic inflammatory reaction (Knight et al. 1988, Watanabe et al. 1999). According 
to current theory, however, DC ingesting necrotic thyrocytes are expected to reach the 
draining lymph nodes and activate thyroid antigen-specific naive T cells there. 
Tg/DC induced EAT with similar incidence but higher severity than that elicited by 
NT/DC. These findings confirm earlier observations that Tg-pulsed DC can initiate EAT 
(Wykes et al. 1998). It is quite likely, however, that NT/DC display on their cell surface 
T -cell epitopes of other thyroid antigens such as thyroid peroxidase; but the extent of 
other antigen participation, or the involvement of antigenic competition in this process, 
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remains unknown. The capacity of Tg/DC or NT/DC to elicit significant Tg-specific lgG 
responses is also in agreement with the finding that DC can interact directly with naive B 
cells to transfer unprocessed antigen and initiate class switching (Casiano et al. 1998, 
Rodenburg et al. 2000). It is not clear why NT/DC induce stronger anti- Tg IgG responses 
than Tg/DC since maturation of DC was mediated by distinct stimuli, in each case. In 
addition, it is not known whether Tg freshly released from necrotic cells may have minor 
conformational differences from lyophilized Tg preparations which could be detected by 
B cells. Cleavage of autoantigens during necrotic cell death seems to differ from the 
caspase-dependent proteolysis observed in apoptosis (Rodenburg et al. 2000). An 
intriguing possibility is that Tg processing in NT/DC may take place in a different manner 
than in Tg/DC, revealing the generation of cryptic determinants to which tolerance has 
not been established (Carayanniotis 2003). This is a testable hypothesis given the large 
number of pathogenic but cryptic Tg determinants already mapped (Dai et al. 2002). A 
similar hypothesis can be made in iodide-induced thyrocyte necrosis since we have 
observed that the processing of highly iodinated Tg can promote the generation of a 
cryptic pathogenic determinant (Anderson and Kuchroo 2003, Kyewski et al. 2002). 
Lastly, it will be interesting to test whether use ofTg- pulsed tolerogenic DC may prevent 
EAT induction by NT/DC, as has been recently observed for EAT elicited by Tg in 
adjuvant, or whether apoptotic thyrocytes may be needed to generate tolerogenic DC for 
this purpose. 
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CHAPTER 7 
DETECTION OF THYROGLOBULIN MRNA AS TRUNCATED 
ISOFORM(S) IN MOUSE THYMUS 
(This work was published in Immunology 2005 May; 115 (1): 85-9. This is a modified 
version) 
Haiyan S. Li and George Carayanniotis 
Division of Endocrinology, Faculty of Medicine, Memorial University of Newfoundland, 
St. John's, NL, Canada 
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7.1 ABSTRACT 
Recent studies employing RT-PCR have demonstrated the intrathymic presence of 
mRNA for various autoantigens, including Tg. Deliberations on mechanisms of central 
tolerance usually assume that this approach detects intact mRNA transcripts that can be 
translated to express the whole autoantigen in the thymus. In this study, we have tested 
this assumption with mRNA transcripts of mouse Tg which encode at least thirteen 
pathogenic peptides, scattered over a large (8.5 kb) sequence. We found that mRNA 
encoding eleven out of these thirteen Tg peptides was present in both the thyroid and the 
thymus of CBA/J mice with no apparent temporal fluctuations in expression from birth to 
12 weeks of age. Interestingly, detection of these sequences was also demonstrable in 
liver and kidney, but not in muscle. However, mRNA encoding two pathogenic peptides, 
(a.a. 1-12) and (a.a. 1579-91), was detected intrathyroidally but not in the other tissues. 
Further analysis by RT-PCR showed that Tg mRNA transcripts in thymus, liver and 
kidney lack the 1-915 bp and 961-5013 bp segments, spanning exons 1-7 and 9-22, 
respectively. These data strongly suggest that certain known and perhaps other as yet 
unmapped pathogenic T-cell epitopes of Tg cannot be encoded by the truncated 
isoform(s) of intrathymic Tg mRNA. These findings also imply that central tolerance to 
endogenous Tg produced by thymic epithelial cells may be incomplete. 
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7.2 INTRODUCTION 
The physiological expression of peripheral tissue-specific antigens in the thymus has been 
well documented in recent years as reviewed in (Derbinski et al. 2001, Kyewski et al. 
2002). This phenomenon of "promiscuous gene expression" (Egwuagu et al. 1997, Liu et 
al. 200 la, Pugliese et al. 1997, Vafiadis et al. 1997) has been considered to play a pivotal 
role in the shaping of the autoreactive T-cell repertoire, since the levels of intrathymic 
expression of several tissue antigens inversely correlate with susceptibility to organ-
specific autoimmunity (Targoni and Lehmann 1998). Deletion of high affinity 
autoreactive T cells by the self antigen expressed in the thymus is one mechanism that 
could account for these observations (Nave et al. 1987). In some instances, however, self-
reactive cells may escape thymic deletion because the isoform of the antigen expressed in 
the thymus differs from that expressed in the target organ. This has been best illustrated in 
studies of EAE and the target antigen PLP, the main protein of the myelin sheath. 
Intrathymic PLP mRNA exists predominantly as a splice variant, DM20, which lacks a 
specific loop of 35 amino acids (Anderson et al. 2000, Klein et al. 2000). It has been 
shown that T cell tolerance to PLP is restricted to those epitopes included in DM20 
(Carayanniotis 2003, Gentile et al. 2004). 
Tg is the largest autoantigen known -with a molecular mass of 660 kDa in its 
homodimeric form - and the most abundant glycoprotein of the thyroid gland. Mapping 
studies have so far identified thirteen Tg peptides encompassing T-cell epitopes which 
elicit EAT when administered with adjuvant into mice (Carayanniotis and Kong 2000, 
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Carayanniotis 2003). However, none of these epitopes has been classified as dominant by 
proliferative assays in vitro, and the conditions that might promote their participation in 
the disease process remain speculative (Heath et al. 1998). Several studies using RT-PCR 
and other detection methods have demonstrated promiscuous intrathymic Tg gene 
expression in rats (Derbinski et al. 2001), mice (Spitzweg et al. 1999a) and humans (Mor 
et al. 1998). In contrast, Mor et al. (Carayanniotis 2003) could not find evidence for 
intrathymic expression of Tg in rats using RT-PCR and primers that amplified the 532-
832 bp fragment. These apparently contrasting results, the large size of the Tg molecule 
(2748 aa), and the expression of autoantigen isoforms in the thymus in other animal 
models, prompted us to examine whether intrathymic Tg gene detection by RT-PCR 
could be significantly influenced by the choice of the gene region used for primer design. 
In this effort, we used thymi of CBA/J mice from birth to 12 weeks of age and the eDNA 
sequences encoding the known pathogenic Tg peptides as landmarks, since they are 
scattered over the whole length of the Tg molecule. Tg gene detection in other 
extrathyroidal tissues such as liver, kidney and muscle was also investigated by the same 
approach. 
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7.3 RESULTS 
7. 3.1 mRNA encoding 2 out of 13 pathogenic Tg peptides is undetectable in the thymus 
The expression of mRNA encoding each known pathogenic peptide of Tg was first 
determined by RT-PCR in the thyroid, thymus and muscle tissues of 12 wk-old CBA/J 
mice (Primers are listed in Table 7.1). As expected, mRNA encoding all thirteen Tg 
peptides was abundantly expressed in the thyroid. However, the mRNA transcripts for 2 
peptides, p1 (a.a. 1-12) and p1579 (a.a. 1579-91) were undetectable in the thymus (Fig. 
7.1). An identical mRNA expression profile for all Tg peptides under investigation was 
obtained with thyroid and thymus tissues from newborn, 2-, 6-, and 12- wk old CBA/J 
mice (Fig. 7.2A&B), suggesting that these data did not reflect any temporal influences on 
expression. None of the 13 mRNA transcripts was detected in muscle (Fig. 7.1) and this 
was also confirmed at all the above time points tested. 
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Table 7.1 The sequences of PCR primers used in Chapter 7 . 
Peptide/ b.p. Forward primer . Reverse primer . Product a.a. 
fragment coordinates coordinates Size (bp) 
o1 1-12 1-36 AGGGTACCAACATCTTTGAG TGTCTAGAGGGGCGGAGTGG 58 
p306 306-320 916-960 AGGGTACCGATGGTCACTACCAA TGTCTAGACTGGGCATCCACACA 79 
p1579 1579-1591 4735-4773 AGGGTACCGACTCCCCGCTGGTG TGTCTAGAGAAGCTGCAGGCCTC 72 
o1672 1672-1711 5014-5133 AGGGTACCCAGAAGAGCTTCGAA TGTCTAGAACAGCAGGAATCATT 154 
p1826 1826-1836 5476--5508 AGGGTACCGACTTTCCAGGAGAT TGTCTAGAGGTAATGTCCACAGG 67 
p2102 2102-2116 6304-6348 AGGGTACCAGTAACTTCTCCATG TGTCTAGAAAGGCAGTCCTGGTG 79 
p2340 2340-2359 7018-7077 AGGGTACCCTGCTGGACCAAGTG TGTCTAGATGTCACACGCTGAGG 94 
p2494 2494-2510 7483-7533 CGGGTACCATGGGGCTTATCAATAG CGTCTAGATCAGCCTTGGCTCTCTT 73 
o2549 2549-2560 7645-7680 AGGGTACCTTGGAGCACTCCACA TGTCTAGAGGCATTCTCCAGTGC 70 
p2596 2596-2608 7786-7824 AGGGTACCCCCGAAAGCTATGGC TGTCTAGAAAAAGCATATTGAAC 73 
p2695 2695-2713 8083-8136 CGGGTACCATGTGCTCCTTCTGGT CGTCTAGATCATGCATCCTTGGCTC 82 
p2730 2730-2743 8188-8229 AGGGTACCGTTGGACCTGGATTA TGTCTAGATTTGCTGTAGCTCTT 82 
A 306-520 916-1560 AGGGTACCAACATCTTTGAG TGTCTAGACTTCTCAGACACACG 645 
B 516-745 1546-2235 ATGGTACCCGTGTGTCTGAGAAG TGTCTAGAAGAGGCACTGCACTGAG 690 
c 741-980 2221-2940 AGGGTACCCCTCAGTGCAGTGCC TGTCTAGACTGAGCAGCCAAGCG 720 
D 976-1225 2926-3675 AGGGTACCCGCTTGGCTGCTCAG TGTCTAGACTGCTGAACAGTCGT 750 
E 1221-1435 3661-4305 AGGGTACCACGACTGTTCAGCAG TGTCTAGAAGCATCCTGTCTGGT 645 
F 1436-1711 4306-5133 AGGGTACCCTGGGCTGTGTGAAA TGTCTAGAACAGCAGGAATCAT 828 
B-a~::tin GCTCTTTTCCAGCCTTCCTT CTTCTGCATCCTGTCAGCAA 177 
*All primers are given in 5' to 3' directions; underlined sequence is Kpnl site in forward and Xbal site in reverse primers 
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Thyroid 
Thymus 
Muscle 
Flgure 7.1. mRNA sequences encoding two pathogenic T g peptidcs (pt and pl579) 
a re detecta ble in the thyroid but not in the thymus of CBA/J mice. 
Dona are represenlative of individual samples from 5 mice, as de-tected by RT·I>CR with 
35 cycles. mRNA from muscle tissue was used as a control. • The expression of mRNA 
encoding the thirteen known pathogenic Tg pcptides was assessed in 12 tracks since the 
p2494 mRNA seque.nce codes for two overlapping pathogenic peptides (2495-2503) and 
(2498-2506) (Hea1h e1 al. 1998). 
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7.3.2 Relative expression ofmRNA encoding Tg peptides among various tissues 
Using the same set of primers, we subsequently determined the relative expression of Tg 
peptide mRNA in thyroid vs thymus, liver, and kidney using mRNA from P-actin as 
reference. As expected, the Tg mRNA transcripts were most prevalent in the thyroid 
gland, with their relative expression ranging from 33.6 ± 19.8% for p1 to 144.3 ± 49.1% 
for p306, (Fig. 7 .3) perhaps reflecting the relative efficiency of the selected primer pairs 
for each region. mRNA transcripts for all tested sequences also showed a lower and 
variable expression in thymus, liver and kidney, except for the mRNA transcripts for p1 
and p1579 which were detected only in the thyroid. These results (summarized in Fig. 
7.4) suggested the presence of Tg isoforms in extrathyroidal tissues, including the 
thymus, that were truncated at the 5' end (within the 1-915 bp segment) and carried 
internal deletion(s) within a large fragment spanning bp 961-5013. 
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Figure 7.3. Relative expression of mRNA encoding pathogenic Tg peptides in 
various tissues of CBA/J mice. 
Relative expression was calculated as the ratio of the relative optical density of the Tg 
fragment band to that of the ~ actin in the same sample and under similar conditions of 
amplification. The results are expressed as mean± SD of values obtained from 2-3 mice. 
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NH2I I II I I I II I Ill COOH 
Thyroid + + + + + + + +++++ 
Thymus - + - + + + + +++++ 
Liver + - + + + + +++++ 
Kidney 
- + - + + + + +++++ 
Figure 7.4. Summarized data on the relative expression of mRNA encoding 
pathogenic Tg peptides in various tissues of CBA/J mice. 
±, relative expression varies from 0-10% among samples; - , no detection. 
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7.3.3 mRNA encoding a large Tgfragment (bp 961-5013) is undetectable in the mouse 
thymus using RT-PCR 
To determine the approximate boundaries of a potential deletion between bp 961-5013 in 
intrathymic Tg mRNA, we used six pairs of overlapping primers to amplify, by RT-PCR, 
six 600-800 bp segments (A to F) spanning the 916-5133 bp region, as shown in Fig. 
7.5a. It was found that mRNA encoding all six Tg segments was present in the thyroid 
but absent in the thymus of the same donor (Fig. 7 .Sb ). These data strongly support the 
lack of a potentially large (4 kb) sequence segment within the 961-5013 bp of intrathymic 
TgmRNA. 
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Figure 7.5. A harge rragment (bp 961·5013) ofTg mRNA tr11nscripts is undetectable 
in mouse thymus. 
(a) A series of ovcrltlpping primers were designed and used in RT·I'CR to amplify the Tg 
mRNA fragmenl en«>ding lhe a.a. sequence from p306 10 pl672. (b) Visualiza1ion of 
PCR produelS in a I.S% agarose gel stained wi1h e1hidium bromide. Td lhyroid: Tm = 
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7.4 DISCUSSION 
In this study, we have tested the intrathymic expression of mRNA encoding 13 
pathogenic peptides scattered throughout the length of the large Tg autoantigen. It was 
found that mRNA encoding theN-terminal peptide (aa.1-12), and the peptide (aa 1579-
1591) toward the middle of the molecule, was detectable in the thyroid but not the 
thymus. In contrast, mRNA encoding all other peptides was easily detectable in both 
organs. Overlapping primer pairs, spanning the 916-513 3 bp region, were subsequently 
found to similarly amplify RT-PCR products of the expected size in thyroid but not 
thymic tissue. These results suggest that Tg mRNA in the mouse thymus exists as 
different isoform(s), either in the form of deletion or differently sliced alternatives. 
Further analysis of the size ofTg transcripts in the thymus vs thyroid by northern blotting 
may help to differentiate these probabilities. 
Our findings caution against using primers from random Tg sites to study extrathyroidal 
Tg gene expression by RT-PCR. Also, they indicate that apparently contrasting 
observations of other investigators on this issue may be explained on the basis of the Tg 
mRNA segment chosen for amplification. Heath et al. have reported intrathymic Tg gene 
expression in male PVG rats using primers amplifying the 7597-8241 bp fragment (Mor 
et al. 1998), whereas Mor et al. have not been able to detect Tg mRNA in thymocytes of 
Lewis rats (Spitzweg et al. 1999a) with primers amplifying the 532-832 bp segment, close 
to the N-terminus of the molecule. Furthermore, differential Tg transcripts between 
species may preclude RT-PCR-based extrapolations from mice to humans in regard to 
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intrathymic Tg expression. For example, Spitzweg et al. (Carayanniotis 2003) detected Tg 
gene expression in human thymus using primers amplifying the 4464-5146 bp region 
whereas we have been unable to detect Tg in mouse thymus via amplification of the 
4735-4773 bp segment (encoding p1579) which is localized within the above region. 
The presence of intrathymic Tg isoforms may have implications for mechanisms of 
central tolerance to Tg, since negative selection may not occur against dominant T-een 
epitopes if they map within regions not represented in the thymus. Also, the hierarchy of 
immunodominance resulting from the processing of intrathymic Tg may be different from 
that of the peripheral Tg. So far, an known pathogenic T cell-epitopes in Tg have been 
classified as non dominant (Dai et al. 1999) and some of them are known to be produced 
in vitro under certain conditions e.g. after processing of Tg-Ab immune complexes (Dai 
et al. 2002) or processing of highly iodinated Tg (Derbinski et al. 2001, Heath et al. 
1998). It is not known, however, to what extent non dominant T -cell epitopes can be 
generated in the thymus from endogenous Tg produced in thymic epithelial cens (Spencer 
2000), or blood-borne Tg molecules that leak from the thyroid in small amounts (Klein et 
al. 2000). One, therefore, cannot draw correlates between the presence of intrathymic 
mRNA encoding a non-dominant Tg epitope and the immunogenicity of this epitope, as 
has been done with dominant peptides in other systems (Wan et al. 1997). For example, 
the Tg peptide (aa 1-12) whose mRNA is undetectable in the thymus has been found to be 
weakly immunopathogenic (Senitti et al. 2000). 
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Our results confirm those of earlier studies reporting Tg gene expression in mouse - as 
well as human- kidney (Bugalho et al. 2001). On the other hand, it is not clear to what 
extent the detection of Tg mRNA transcripts in the liver is due to the presence of 
contaminant leukocytes since it has been reported that Tg is expressed in blood cells 
(Sellitti et al. 2000). Nevertheless, it is intriguing that the extrathyroidal expression 
patterns of various Tg transcripts in our study is similar among thymus, liver and kidney, 
i.e. they indicate lack of the 1-915 bp and 961-5013 bp segments, spanning exons 1-7, 
and 9-22, respectively. This concordant pattern of amplicon expression and the number of 
amplicons examined also supports the view that they originate from Tg mRNA, although 
this has not been formally shown by sequencing data. The possibility of an in situ 
production of Tg protein in the kidney has been previously raised (Alvino et al. 1995, 
Kohn 1995), but the functional properties, if any, of extrathyroidal Tg remain unknown. 
Tg has been reported to possess an intrinsic cAMP-dependent protein kinase activity, and 
it may autophosphorylate serine residues in vitro (Taurog 2000). The catalytic or ligand-
binding activity of Tg probably lies with two motifs comprised of a.a. residues (154 -160) 
and (468-475) i.e. sites which, as our data indicate, may be missing in extrathyroidal Tg. 
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CHAPTERS 
FUTURE DIRECTIONS 
Normal human Tg varies widely in iodine content from values as low as 0.1% to as high 
as 1.1 %, depending on the amount of iodine intake (Rose et al. 1997, Rose et al. 2002, 
Ruwhof and Drexhage 2001 b). Excessive iodine intake has been reported to be associated 
with increased prevalence of thyroid diseases in humans. Enhanced iodination of Tg 
conferred higher immunogenicity, probably by facilitating the generation of either 
iodotyrosyl-containing neoantigenic determinants (Chapter 3) or non-iodinated cryptic 
epitopes (Dai et al. 2002). Although enhanced iodination of Tg caused a net increase in its 
overall immunogenicity and pathogenicity in experimental animals (Sundick et al. 1987, 
Dai et al. 2002), at individual peptide level, iodotyrosyl formation may have increasing, 
decreasing and neutral effects on its immunogenic profile (Chapter 4). None of these 
newly identified and previously reported Tg peptides (Carayanniotis 2003) appeared to be 
immunodominant, as determined by LNC proliferative assays. Interestingly, all these 
peptides are expected to be present in the thyroid, as adoptive transfer of T cells specific 
for these Tg determinants can cause the development of EAT. These findings prompted 
us to hypothesize that pre-cleavage of Tg by protease or other enzymes specific in the 
thyroid may be required to generate those so called "cryptic" determinants. However, the 
current findings also brought our attention to how self tolerance against Tg - the largest 
A-Ag - is maintained under physiological conditions and broken upon immunological 
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challenge. We have reported in Chapter 7 that Tg mRNA is present in different isoform(s) 
in mouse thymus versus thyroid, but circulating Tg containing low iodine content can 
enter thymus via blood. The process via which Tg-specific autoreactive T cells are 
deleted, ignored or controlled by Treg is unknown. Yet, the fact that only Tg containing 
certain levels of iodine, but not LI-Tg, is immunopathogenic (Section 1.3.2) implies that 
self tolerance may be established against LI-Tg coming from circulating blood. 
Another interesting finding in my studies is that SJL - but not CBA/J - mice fed on 
drinking water supplemented with 0.05% Nal did not promote the generation of highly 
iodinated Tg in both SJL and CBA/J mice, but elicited the development of goitrous 
hypothyroidism in SJL but not CBA/J mice (Chapter 5). The iodide-induced 
hypothyroidism in SJL mice was accompanied by focal infiltration of mononuclear cells 
in thyroid glands, but no Tg-specific autoimmune responses were observed in these 
hypothyroid mice. These results highlight a critical role of genetic factors in controlling 
the susceptibility to iodide-induced hypothyroidism, and raise our concerns about the role 
of anti-thyroid responses in the development of hypothyroidism. To exclude the effects of 
MHC genes on iodide-induced hypothyroidism, other H-2s mouse strains, such as B 1 O.S, 
will be treated with Nal-supplemented water to determine the development of 
hypothyroidism. In our future studies, we will try to identify the polymorphic genes 
which control the susceptibility to iodide-induced hypothyroidism in SJL mice. We also 
want to examine the mechanisms underlying the iodide-induced hypothyroidism in SJL 
mice. 
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Hypothesis 8.1: NIS polymorphisms may account for the differential effects of iodine 
excess on the induction of hypothyroidism. 
The significant differences in development of iodide-induced hypothyroidism in female 
SJL vs CBA/J mice enable us to define the susceptible genetic factors underlying such 
phenomenon. In the current study, I have shown via RT-PCR that NIS gene is probably 
differentially regulated by excessive iodide in SJL vs CBA/J mice (Chapter 5). Mutations 
in the NIS gene in patients with congenital hypothyroidism have been previously reported 
to cause a defect in iodide transportation (Fujiwara 1997, Pohlenz et al. 1997). Therefore, 
I hypothesize that mutations or po1ymorphisms of NIS gene in SJL mice may lead to the 
induction of hypothyroidism following iodide administration. First, we need to confirm 
the effect of iodine on NIS expression in SJL and CBA/J mice at both mRNA and protein 
level, using real time-PCR and western blotting, respectively. Next, thyroid genomic 
DNA encoding NIS gene with the promoter region will be isolated, amplified and 
sequenced to define mutations or polymorphisms. If differences in encoding sequence 
are found between SJL vs CBA/J mice, we will test differences in the functionality ofNIS 
alleles using COS-7 cells transfected with plasmid DNA encoding these alleles, following 
an established protocol (Carrasco et al. 2000). 
The expected result from this experiment is that COS-7 cells transfected with plasmid 
DNA encoding NIS of SJL mice will take up significantly more Na 1251 than those 
transfected with plasmid DNA encoding NIS of CBA/J mice. These results may support 
191 
the view that intrathyroidal iodine in SJL mice will reach and will be maintained at high 
levels after iodide administration, preventing escape from "the Wolff-Chaikoff effect". 
The high concentration of intrathyroidal iodide may also exert direct toxic effects on 
thyrocytes, causing cell necrosis. As suggested in Chapter 6, necrotic thyrocytes in situ 
may facilitate the induction of EAT by triggering DC maturation (Hypothesis 8.2). 
Alternatively, the experimental results may not agree with the working hypothesis. 
Polymorphisms in other molecules in the process of iodine organification may account for 
the susceptibility to iodide-induced hypothyroidism. 
Hypothesis 8.2: Iodide-induced thyrocyte necrosis in situ releases both autoantigen and 
maturation signals to intrathyroidal DC, which activate autoreactive T cells leading to 
EAT. 
In the thyroid, iodide is concentrated by a factor of 20-to 40-fold with respect to its 
concentration in the plasma under physiologic conditions (Li et al. 1993). Elevated 
intrathyroidal iodine, following enhanced iodine intake, can recruit more DC into the site, 
as observed in BB/W rats (Mooij et al. 1994b ). Moreover, it was reported that thyroid 
hormones T3 or T4, or HI-Tg, increased the transition of human peripheral blood 
monocytes into veiled/dendritic cells ex vivo (Follis 1959, Li and Boyages 1994, Many et 
al. 1995, Bagchi et al. 1995). In several animal studies, it has been postulated that a direct 
toxic effect of iodine on thyrocytes in situ is involved in triggering thyroid-specific 
autoimmune reactions (Many et al. 1992). In the current study, we have shown that DC 
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exposed to necrotic thyrocytes readily present Tg released from the necrotic thyrocytes 
and activate thyroiditogenic T cells. Collectively, these data raise the hypothesis that 
iodine -induced thyrocyte necrosis could serve as an initial event that triggers DC 
maturation and antigen presentation, thus leading to AlTO. 
Cell necrosis occurred only in < 1 0% of the cultured thyrocytes in the presence of 1 o-3 M 
Nal (Fradkin and Wolff 1983), which is 10,000 times higher than normal plasma iodine 
levels in healthy population (Williamson et al. 2002). The low necrotic rate hampers the 
ex vivo generation of large numbers of thyrocytes necrotized by iodide. To circumvent 
this problem, we will investigate the effects of thyrocytes necrotized by iodide on thyroid-
resident DC in vivo. Thyroid-resident DC are expected to take up A-Ags, such as Tg, 
released from necrotic thyrocytes, while they receive maturation signals from the necrotic 
cells. Following migration to the thyroid-draining lymph nodes, DC will present the 
thyroid autoantigens to T cells, thus eliciting thyroid autoimmune disease. 
To test this hypothesis, various doses of Nal (0.1 %, 0.5%, 2.5%) will be administered to 
SJL and CBA/J mice for 10 weeks, and CD 11 c + DC will be purified from a single cell 
suspension of thyroid-draining lymph nodes using MACS separation columns (Miltenyi 
Biotec, Auburn, CA). To enrich DC population, these animals will be injected i.p. daily 
for 10 days before sacrifice with 10 Jlg Flt3 ligand, which expands all DC populations 
without inducing their activation (Voorby et al. 1990, Many et al. 1995, Hala et al. 1996). 
DC maturation markers (MHC, CD80, CD86, CD40) will be assessed by flow cytometry. 
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Mice maintained with normal water will be used as controls. Upregulation of surface 
markers such as MHC, CD80, CD86 and CD40 on DC from iodide-treated mice versus 
those from controls will indicate the phenotypic maturation of the DC. If DC in the 
thyroid-draining LNs from experimental mice express higher levels of MHC and 
costimulatory molecules than those from control mice, we will continue to examine the 
capability of such DC in activating thyroid-specific autoreactive T cells in naive recipient 
mice upon i.v. transfer. 
Hypothesis 8.3: Thyroid-infiltrating DC or macrophages secrete cytokines, such as IL-lfl, 
which suppress the release of thyroid hormones from thyrocytes. 
In most animal models of SAT, thyroid infiltration starts with the local accumulation of 
DC and macrophages (Gu et al. 1995). In 1994, it was reported that reduction of 
pancreas-infiltrating DC and macrophages via anti-CR3 mAb (5C6) treatment resulted in 
a consistent (25%) increase in the growth of islet cells, as well as a decrease in blood 
glucose level, an indicator for enhanced insulin secretion (Gaytan et al. 1995, Hayashi et 
al. 1994 ). Similarly, adult rats - depleted of testicular macrophages using liposome-
entrapped dichloromethylene diphosphonate - showed a significant increase in serum 
level of testosterone (Simons et al. 1998). In vitro, splenic DC were found to inhibit the 
growth of freshly isolated rat thyrocyte follicles in an IL-l ~-dependent manner (Gu et al. 
1995). Based on these observations, it has been postulated that DC and macrophages 
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infiltrating the endocrine organs may exert a downregulatory effect on the growth and 
function of endocrine cells. 
In our model of iodide-induced hypothyroidism in SJL mice (Chapter 5), we observed the 
coexistence of thyroid infiltration and hypothyroidism. However, the phenotype and 
function of the thyroid-infiltrating cells remains unknown. First, immunohistochemical 
staining of thyroid cryosections using anti-CD 11 b and anti-CD 11 c Abs will be performed 
to determine the presence of DC and macrophages in the thyroid lesions following iodine 
administration. Second, if DC and macrophages are found, we will examine whether DC 
and macrophages contribute to the decrease in the serum thyroid hormone levels. We will 
deplete these cells by modified Gu's regimen (Jung et al. 2002). Briefly, SJL mice will be 
depleted of DC and macrophages by i.p. injection of anti-CD11b 5C6 mAbs (500 
Jlg/mouse, 3 x per week for 1 month). The mice will then be placed on water 
supplemented with 0.05% Nai, while they continue receiving 5C6 mAbs for another 10 
weeks. Normal SJL mice treated similarly with or without Nai will be used as controls. 
At the end of the period, thyroid histology and serum thyroid hormones will be examined. 
The expected results will be that SJL mice depleted of DC and macro phages develop less 
or no hypothyroidism and thyroidal infiltration. If this hypothesis is supported by the 
experimental results, the role of iodine in this model will be mostly likely through its 
toxic effects on thyrocytes, and signals released from necrotic thyrocyte will recruit DC 
and macrophages, leading to hypothyroidism. 
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The above protocol depletes both DC and macrophages, to specifically examine the role 
of DC in iodide-induced hypothyroidism, a transgenic mouse line carrying a transgene 
encoding diphtheria toxin receptor (DTR) under control of the murine CD 11 c promoter 
will be used (Naglich et al. 1992). These mice were generated based on the strategy that 
murine DC will undergo apoptosis upon endocytosis of DT via its receptor (Jung et al. 
2002). To use these transgenic mice in our model, we need to backcross the DTR-CD11c 
transgenic mice, generated in Balb/c or C57bl/6 background, to SJL mice. To determine 
whether DC are required in early stages for the initiation of iodide-induced 
hypothyroidism, DTR-CD11c transgenic SJL mice will be depleted of DC via i.p. 
injection of 100 ng of DT at dO (Dunn and Dunn 1988, Dunn et al. 1991 ), and placed on 
water supplemented with 0.05% Nal for 10 weeks while continuously receiving DT for 
every 3 days. Other groups of mice will receive DT injection 2 or 4 weeks, respectively, 
after iodide administration. Mice treated similarly with Nal but not receiving DT will be 
used as controls. These mice will then be sacrificed to examine thyroid histology and 
thyroid hormone levels in the sera. If DC is required for early events during iodide 
administration, only mice receiving DT before or shortly after iodide administration will 
develop less hypothyroidism. As mentioned above, the toxic effects of iodine on 
thyrocytes will be considered as an initiation event to recruit DC and macrophages, 
leading to hypothyroidism. 
Hypothesis 8.4: Pre cleavage of Tg by intrathyroidal pro teases is required for generation 
ofTg cryptic determinants 
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In the human thyroid, cysteine protease - cathepsins B and L, as well as aspartic protease 
- cathepsin D, are the major lysosomal endopeptidases participating in Tg degradation 
(Dunn et al. 1991). The cleavage of Tg by these enzymes creates Tg fragments which 
may facilitate the generation of cryptic determinants. To test this hypothesis, these 
proteases will be incubated at their pH optimum at 37°C with Tg at different ratios of 
enzyme/substrate according to an established protocol (Ishisaka et al. 1998). Digestion 
products will then be added to the coculture of bone marrow-derived DC and T cell 
hybridoma clones specific for Tg cryptic determinants. Undigested Tg will be used as 
negative controls and free peptides will be used as positive controls. The activation ofT 
cell hybridoma will be assessed by IL-2 secretion using CTLL-2 cell proliferation. To 
confirm the role of candidate proteases in the generation of Tg cryptic determinants, 
specific inhibitors for cathepsin B (CA-074 Me) and L (Z-FY(t-Bu)-DMK) will be added 
in the culture at optimal doses according an established protocol (Casiano et al. 1998, 
Rodenburg et al. 2000). 
Hypothesis 8.5: Precleavage of Tg by cell death-activated proteases facilitates the 
generation ofTg cryptic determinants 
It has been proposed that proteolysis of A-Ags by activated caspases (cysteine aspartases) 
during apoptosis, or distinct but unknown proteases during necrosis, leads to the 
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generation of neoantigenic determinants (Sauter et al. 2000). With the availability of 
primary thyrocytes, we are able to test the role of cell death on the processing and 
presentation of cryptic Tg determinants. Following Sauter's protocol (Ip and Lau 2004), 
cell apoptosis will be induced by UV irradiation and necrosis will be induced by repeated 
freezing and thawing (as seen Chapter 6). Cell death will be evaluated using an apoptosis 
detection kit (lmmunotech, Marseilles, France). Briefly, cells will be stained with FITC-
labeled annexin V and propidium iodide (PI) according to the manufacturer's protocol, 
and dead cells will be detected by flow cytometry. Apoptotic cells at early stage will be 
annexin y+ Pr, and necrotic cells will become annexin y+ Pt (lshisaka et al. 1998). In 
addition, necrotic but not apoptotic cells incorporate trypan blue in the cytoplasm due to 
the loss of their membrane integrity (Current Protocol in Immunology, section 3.17). 
BM-DC will then be exposed to apoptotic or necrotic thyrocytes, respectively, at 2:1, 5:1 
or 10:1 ratios for overnight. To determine the efficiency of phagocytosis by DC, 
thyrocytes will be labeled with the red fluorescent dye PKH26 before death and immature 
BM-DC will be labeled with green fluorescent dye PKH67, according to the 
manufacturer's protocol (Sigma-Aldrich). Following coculture, phagocytosis of dead cells 
by DC will be defined by the percentage of DC with double-positive fluorescent signals 
using flow cytometry. The generation and presentation of Tg cryptic determinants on the 
surface of DC will be assessed by T cell activation assay using T cell hybridoma clones 
specific for Tg cryptic determinants. To confirm the function of caspases and to identify 
the candidate protease responsible for the generation of Tg cryptic determinants, protease 
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inhibitors, such as leupeptin, pepstatin A or aprotinin, will be added into the DC : dead 
thyrocytes coculture at optimal doses according to an established protocol. These 
experiments will support the fact that cryptic Tg determinants are normally present in 
thyroid glands, and provide evidence demonstrating that cryptic determinants can be 
generated when processing of Tg is altered under certain conditions. 
In summary, the future work is focused to explore the mechanisms underlying iodide-
induced hypothyroidism and EAT by determining the genetic susceptibility (hypothesis 
8.1), and effects of local inflammation caused by iodide (hypothesis 8.2 & 8.3). These 
experiments will provide information on how genetic and environmental factors may 
interplay with each other to cause EAT and/or hypothyrodism in mice, and help us in 
understanding the etiology of HT in humans and its prevention. We will also continue to 
define parameters that influence the processing of Tg in thyroid and conditions under 
which cryptic Tg determinants may be generated (hypothesis 8.4 & 8.5). These findings 
may provide an explanation to our current experimental results that autoreactive T cells 
specific for a cryptic Tg peptide can home to the thyroid gland and cause EAT upon 
adoptive transfer. Meanwhile, they may also have implications on how self tolerance to 
Tg is broken down during disease. 
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GLOSSARY 
Term 
ADCC 
Adjuvant 
Alleles 
Anergy 
Antibody 
Antigen 
Antigen 
Definition 
= Antibody-dependent cell-mediated cytotoxicity. The lysis of Ab-
coated target cells when interacting with Fe receptor on the surface of 
effector cells. 
A substance that, when mixed with antigen, increases its 
immunogenicity by provoking local inflammation. 
One of a number of slightly different DNA sequences that code for the 
same gene. 
A state of lymphocyte non-responsiveness to specific antigen. 
A Y -shaped glycoprotein produced by B lineage plasma cells. Each 
antibody recognizes a specific antigen that is either soluble or fixed in 
a tissue or on a cell surface. 
A substance that can bind to the antigen receptor of a B cell. This 
binding, however, does not necessarily lead to B cell activation. 
Cells expressing MHC class II molecules on their surface thus capable 
presenting cells of presenting peptide to CD4+ T cells. Professional APCs such as DC, 
(APC) B cells and macrophages, express high levels og MHC class II. 
200 
Term 
Apoptosis 
Autoantibody 
Autoantigen 
Autoimmune 
disease 
Congenic 
Costimulation 
Costimulatory 
molecules 
Definition 
Also called "programmed cell death", is a normal process of deliberate 
life relinquishment by a cell in a multicellular organism. It is mediated 
by certain intracellular proteases that cause the orderly breakdown of 
cell nucleus and DNA, without release of internal contents. 
Antibodies produced by plasma cell and directed against one or more 
of the host's own proteins. 
A self antigen that can be recognized by either autoantibody or self-
reactive T cells. 
A pathophysiological state of an organism due to the failure of its 
immune system to recognize its own constituent parts as "self'. It 
involves either a specific organ (organ-specific autoimmune disease) 
or many tissues of the body (systemic autoimmune disease). 
Two individual animals that carry identical alleles at all but one locus. 
The second signal required for optimal lymphocyte activation and 
differentiation. Supplied by engagement of CD28 by B7-l/B7-2 (T 
cell) and CD40 by CD40L (B cell). 
Molecules involved in mediating the costimulation of a cell, such as 
CD28 and B7-1/B7-2, or CD40 and CD40L. 
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Term 
Cross-
presentation 
Cross-priming 
Definition 
Presentaion of peptides from exogenous antigens on the MHC class I 
molecules of DC and macrophage. 
Activation of CDS T cells through cross-presentation of exogenous 
antigens by DC or macrophage. 
Epitope A small region of a macromolecule that is specifically recognized by 
the antigen receptor of a B or T lymphocyte. 
Experimental Animal model of Hashimoto's thyroiditis in humans, is a T cell-
autoimmune mediated autoimmune disease, characterized by destruction of thyroid 
thyroiditis follicles by infiltrating inflammatory cells. Induced by immunization 
(EAT) with thyroglobulin (Tg) or Tg peptides in complete Freund's adjuvant. 
Hashimoto's =Autoimmune thyroiditis (AT) or lymphocytic thyroiditis (LT). 
thyroiditis (HT) A type of autoimmune disease in which the immune system attacks 
and destroys the thyroid gland, leading to the development of 
hypothyroidism (elevated TSH and low T4). 
Homeostasis 
Hybridoma 
The tendency of a biological system to maintain a steady state. 
Immortalized cells that have been engineered to produce a desired 
antibody or express a specific T cell receptor; created by fusion of a 
myeloma or lymphoma cell with an activated B or T cell, respectively. 
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Term Definition 
Hypothyroidism A pathophysiological state caused by insufficient production and/or 
release ofthyroid hormone by the thyroid gland (low serum T4 level). 
The most common cause is Hashimoto's thyroiditis. 
Immunogenicity The ability of a particular substance to provoke an immune response. 
Inbred mice 
Iodination 
Monoclonal 
antibody 
Necrosis 
Priming 
Self tolerance 
Syngeneic 
Strains of mice in which all members are genetically identical at 
virtually all loci and each mouse is homozygous at all loci. 
The substitution or addition of iodine atoms in organic compounds. 
Antibodies that are identical with a single, known specificity. 
Produced by a single B cell clone. 
An accidental cell death due to injury, infection or inflammation. The 
cell loses its integrity and releases intracellular components. 
The first encounter of a naive lymphocyte with specific antigen. 
Lack of an immune response to self antigens in an individual's tissues. 
Animals that have the same alleles at all genetic loci. In some cases, 
"syngeneic" is used to refer to genetic identity at the MHC loci only. 
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Term 
Th cells 
Definition 
Helper T cells that recognize peptides presented in the context of 
MHC class II molecules on APCs. They may differentiate into either 
Thl or Th2 in phenotype. Thl cells secrete IFNy and IL-2, and induce 
production of IgG 1 and lgG3 in humans. Th2 cells secrete IL-4, IL-5 
and IL-l 0, and induce production of lgA, IgE and IgG4 in humans. 
Transgenic (Tg) A mutant mouse created by the introduction of a desired gene (the 
mouse "transgene") into the genome of a whole mouse embryo. The 
transgene is expressed along with the recipient's own genes. 
Wolff-Chaikoff Administration of large amounts of iodide into certain species results 
effect in a temporary decrease in the formation and release of thyroid 
hormone, due to inhibited iodide organification. 
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